UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended SeptemberJune 30, 2020

2023

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________to _________

001-39732

Commission File Number

HF Enterprises

Alset Inc.

(Exact name of registrant as specified in its charter)

NEVADAtexas83-1079861

State or other jurisdiction of

incorporation or organization

(I.R.S. Employer

Identification No.)

4800 Montgomery Lane, Suite 210,

Bethesda, Maryland

20814
(Address of principal executive offices)(Zip Code)
301-971-3940

301-971-3940

Registrant’s telephone number, including area code

Securities registered pursuant to Section 12(b) of the Act:

Title of Each ClassTrading Symbol(s)Name of Each Exchange on Which Registered
Common Stock, $0.001 par valueHFENAEIThe Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filerAccelerated filer
Non-accelerated filerSmaller reporting company
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

As of December 29, 2020,August 14, 2023, there were 8,570,000 9,235,119shares of the registrant’s common stock $0.001 par value per share, issued and outstanding.



 

Table of Contents

1F-1
F-1
F-1
F-2
F-3
F-5F-4
F-6 - F-40
F-5 – F-36
23
1412
1412
1412
1412
1512
1512
1512
1512
1513
1513
1614

2

Part I. FinancialFinancial Information

HF Enterprises

Item 1. Financial Statements.

Alset Inc.

Table of Contents
For the Nine Months Ended September 30, 2020 and 2019
F-1
F-2
F-3
F-5
F-6 - F-40
1
HF Enterprises Inc.
Condensed Subsidiaries

Consolidated Balance Sheets

 
 
September 30,
2020
 
 
December 31,
2019
 
Assets:
 
( Unaudited)
 
 
 
 
Current Assets:
 
 
 
 
 
 
    Cash
 $8,754,202 
 $2,774,587 
    Restricted Cash
  4,235,274 
  4,447,678 
    Account Receivables, Net
  56,191 
  170,442 
    Other Receivables
  369,888 
  681,677 
    Note Receivables - Related Parties
  209,398 
  - 
    Prepaid Expenses
  1,902,079 
  145,186 
    Inventory
  63,455 
  116,698 
    Investment in Securities at Fair Value
  59,745,321 
  3,015,698 
    Investment in Securities at Cost
  236,756 
  200,128 
    Investment in Securities at Equity Method
  2,245 
  - 
    Deposits
  50,539 
  48,717 
   Current Assets from Discontinued Operations
  - 
  139,431 
         Total Current Assets
  75,625,348 
  11,740,242 
 
    
    
Real Estate
    
    
Properties under Development
  24,990,366 
  23,884,704 
Operating Lease Right-Of-Use Asset
  546,519 
  146,058 
Deposit
  234,134 
  21,491 
Property and Equipment, Net
  77,663 
  80,285 
         Total Assets
 $101,474,030 
 $35,872,780 
 
    
    
Liabilities and Stockholders' Equity:
    
    
Current Liabilities:
    
    
    Accounts Payable and Accrued Expenses
 $4,812,881 
 $3,995,001 
    Advance from Related Party
  710,524 
  - 
    Accrued Interest - Related Parties
  33,828 
  834,536 
    Deferred Revenue
  3,046,687 
  258,594 
    Builder Deposits
  1,661,303 
  890,069 
    Operating Lease Liability
  339,849 
  58,865 
    Notes Payable
  228,468 
  157,105 
    Notes Payable- Related Parties
  160,000 
  410,000 
    Accumulated Losses on Equity Method Investment
  231,418 
  - 
    Income Tax Payable
  249,698 
  420,327 
   Current Liabilities From Discontinued Operations
  - 
  7,021 
         Total Current Liabilities
  11,474,656 
  7,031,518 
Long-Term Liabilities:
    
    
    Builder Deposits
  147,444 
  1,555,200 
    Operating Lease Liability
  202,038 
  91,330 
    Note Payable, Net of Debt Discount
  619,329 
  - 
    Notes Payable - Related Parties
  2,056,183 
  4,971,401 
         Total Liabilities
  14,499,650 
  13,649,449 
 
    
    
Stockholders' Equity:
    
    
    Preferred Stock, $0.001 par value; 5,000,000 shares authorized, none issued
    
    
        Common Stock, $0.001 par value; 20,000,000 shares authorized;
    
    
        6,400,000 shares issued and outstanding on September 30, 2020
    
    
        and 10,001,000 shares issued and outstanding on December 31, 2019
  6,400 
  10,001 
    Additional Paid In Capital
  94,053,568 
  54,263,717 
    Accumulated Deficit
  (49,803,606)
  (40,494,115)
    Accumulated Other Comprehensive Income
  1,045,584 
  1,468,269 
        Total Stockholders' Equity
  45,301,946 
  15,247,872 
    Non-controlling Interests
  41,672,434 
  6,975,459 
       Total Stockholders' Equity
  86,974,380 
  22,223,331 
 
    
    
       Total Liabilities and Stockholders' Equity
 $101,474,030 
 $35,872,780 

  June 30, 2023 December 31, 2022
Assets:        
Current Assets:        
Cash $28,827,961  $17,827,383 
Restricted Cash  664,174   694,520 
Account Receivables, Net  63,778   46,522 
Other Receivables  7,951,914   446,798 
Note Receivables - Related Parties  2,857,383   3,617,176 
Prepaid Expense  237,772   188,070 
Inventory  38,015   35,020 
Investment in Securities at Fair Value  6,695,823   6,288,236 
Investment in Securities at Fair Value - Related Party  24,804,737   13,193,089 
Investment in Securities at Cost  99,802   98,129 
Investment in Securities at Equity Method  32,202,734   52,987,224 
Total Current Assets  104,444,093   95,422,167 
         
Real Estate        
Rental Properties  31,388,691   31,169,031 
Properties under Development  8,056,513   23,449,698 
Operating Lease Right-Of-Use Assets, net  1,805,482   1,614,159 
Deposits  422,313   536,947 
Cash and Marketable Securities Held in Trust Account  20,831,983   - 
Goodwill  274,234   - 
Property and Equipment, Net  1,218,502   1,298,334 
Total Assets $168,441,811  $153,490,336 
         
Liabilities and Stockholders’ Equity:        
Current Liabilities:        
Accounts Payable and Accrued Expenses $6,131,700  $2,983,470 
Deferred Revenue  2,100   21,198 
Operating Lease Liabilities - current  186,380   45,556 
Notes Payable  167,898   181,846 
Notes Payable - Related Parties  16,481   12,668 
Total Current Liabilities  6,504,559   3,244,738 
         
Long-Term Liabilities:        
Operating Lease Liabilities - noncurrent  1,647,909   1,582,483 
Total Liabilities  8,152,468   4,827,221 
         
Temporary Equity      
Class A Common Stock of Alset Capital Acquisition Corp subject to possible redemption; 1,976,036 shares at approximately $10.16 per share as of June 30, 2023  

19,416,835

   

-

 
         
Stockholders’ Equity:        
Preferred Stock, $0.001 par value; 25,000,000 shares authorized, none issued and outstanding  -   - 
Common Stock, $0.001 par value; 250,000,000 shares authorized; 9,235,119 and 7,422,846 shares issued and outstanding on June 30, 2023 and December 31, 2022, respectively*  9,235   7,423 
Additional Paid in Capital  325,967,000   322,534,891 
Accumulated Deficit  (198,390,147)  (188,724,411)
Accumulated Other Comprehensive Income  2,923,279   3,836,063 
Total Alset Inc. Stockholders’ Equity  130,509,367   137,653,966 
Non-controlling Interests  10,363,141   11,009,149 
Total Stockholders’ Equity  140,872,508   148,663,115 
         
Total Liabilities and Stockholders’ Equity $168,441,811  $153,490,336 

*The numbers of outstanding common stock were adjusted retrospectively to reflect 20-for-1 reverse stock split on December 28, 2022

See accompanying notes to condensed consolidated financial statements.

F-1
F-1
HF Enterprises

Alset Inc.

Condensed and Subsidiaries

Consolidated Statements of OperationsOperations and Other Comprehensive Loss

Income

For the Three and NineSix Months Ended SeptemberJune 30, 20202023 and 2019

(Unaudited)
 
 
Three Months Ended September 30,
 
 
Nine Months Ended September 30,
 
 
 
2020
 
 
2019
 
 
2020
 
 
2019
 
Revenue
 
 
 
 
 
 
 
 
 
 
 
 
Property Sales
 $2,146,992 
 $4,938,017 
 $7,148,786 
 $21,509,197 
Biohealth Product Sales
  1,931 
  360,351 
  31,133 
  1,406,951 
  Others
  - 
  8,495 
  - 
  28,350 
        Total Revenue
  2,148,923 
  5,306,863 
  7,179,919 
  22,944,498 
Operating Expenses
    
    
    
    
Cost of Sales
  1,616,377 
  4,130,484 
  5,609,303 
  19,177,800 
General and Administrative
  798,186 
  1,445,678 
  4,196,939 
  4,330,751 
Impairment of Real Estate
  - 
  - 
  - 
  3,938,769 
         Total Operating Expenses
  2,414,563 
  5,576,162 
  9,806,242 
  27,447,320 
 
    
    
    
    
Loss From Continuing Operations
  (265,640)
  (269,299)
  (2,626,323)
  (4,502,822)
 
    
    
    
    
Other Income (Expense)
    
    
    
    
Interest Income
  2,504 
  16,440 
  14,995 
  44,021 
Interest Expense
  (19,825)
  (86,347)
  (160,341)
  (286,805)
Gain on Disposal of Subsidiary
  - 
  - 
  - 
  299,255 
Gain on Deconsolidation
  53,200,752 
  - 
  53,200,752 
  - 
Loss on Consolidation
  (21,909,596)
    
  (21,909,596)
    
Foreign Exchange Transaction Gain (Loss)
  (415,203)
  757,068 
  960,268 
  438,608 
Unrealized (Loss) Gain on Securities Investment
  (43,761,763)
  507,727 
  (42,169,116)
  (146,470)
Loss on Investment on Security by Equity Method
  (52,392)
  - 
  (193,132)
  (30,166)
Other Income
  8,563 
  2,887 
  52,847 
  38,993 
        Total Other Income (Expense)
  (12,946,960)
  1,197,775 
  (10,203,323)
  357,436 
 
    
    
    
    
Net (Loss) Income from Continuing Operations Before Income Taxes
  (13,212,600)
  928,476 
  (12,829,646)
  (4,145,386)
 
    
    
    
    
Income Tax Expense from Continuing Operations
  (74,106)
  - 
  (188,759)
  - 
 
    
    
    
    
Net (Loss) Income from Continuing Operations
  (13,286,706)
  928,476 
  (13,018,405)
  (4,145,386)
 
    
    
    
    
Loss from Discontinued Operations, Net of Tax
  (56,053)
  (128,554)
  (417,438)
  (388,931)
Net Loss
  (13,342,758)
  799,922 
  (13,435,843)
  (4,534,317)
 
    
    
    
    
Net (Loss) Income Attributable to Non-Controlling Interest
  (3,505,919)
  36,181 
  (4,126,352)
  (1,437,202)
 
    
    
    
    
Net (Loss) Income Attributable to Common Stockholders
 $(9,836,839)
 $763,741 
 $(9,309,491)
 $(3,097,115)
 
    
    
    
    
Other Comprehensive Income (Loss), Net
    
    
    
    
   Unrealized Gain on Securities Investment
  29,123 
  (53,681)
  29,639 
  (36,747)
   Foreign Currency Translation Adjustment
  462,064 
  (584,561)
  (585,085)
  (325,518)
Comprehensive Loss
  (12,851,571)
  161,680 
  (13,991,289)
  (4,896,582)
 
    
    
    
    
Comprehensive Loss Attributable to Non-controlling Interests
  (3,276,947)
  (160,972)
  (4,190,100)
  (1,549,106)
 
    
    
    
    
Comprehensive Income (Loss) Attributable to Common Stockholders
 $(9,574,624)
 $322,652 
 $(9,801,189)
 $(3,347,476)
 
    
    
    
    
Net Income (Loss) Per Share - Basic and Diluted
    
    
    
    
Continuing Operations
 $(1.53)
 $0.08 
 $(1.07)
 $(0.31)
Discontinued Operations
 $(0.01)
 $- 
 $(0.03)
 $(0.00)
Net (Loss) Income Per Share
 $(1.54)
 $0.08 
 $(1.10)
 $(0.31)
 
    
    
    
    
Weighted Average Common Shares Outstanding - Basic and Diluted
  6,400,000 
  10,001,000 
  8,712,081 
  10,001,000 
2022

  2023  2022  2023  2022 
  Three- Months Ended June 30,  Six- Months Ended June 30, 
  2023  2022  2023  2022 
             
Revenue                
Rental $690,967  $403,900  $1,324,778  $636,482 
Property  18,190,950   246,910   18,190,950   1,288,434 
Biohealth  

-

  132,222   12,786   749,693 
Digital Transformation Technology – related party  14,034   7,701   28,074   7,701 
Other  257,897   135607   524,196   196,267 
Total Revenue  19,153,848   926,340   20,080,784   2,878,577 
Operating Expenses                
Cost of Sales  11,738,493   550,677   12,427,774   1,665,227 
General and Administrative  2,305,859   2,029,925   4,633,244   4,521,153 
Total Operating Expenses  14,044,352   2,580,602   17,061,018   6,186,380 
                 
Income (Loss) from Operations  5,109,496   (1,654,262)  3,019,766   (3,307,803)
                 
Other Income (Expense)                
Interest Income  92,388   196,639   131,666   369,039 
Foreign Exchange Transaction Gain  1,150,830   2,077,709   362,528   2,485,804 
Unrealized Gain (Loss) on Securities Investment  9,027,846   (407,407)  6,543,729   (1,230,648)
Unrealized Gain (Loss) on Securities Investment - Related Party  9,812,880   (6,459,968)  11,109,151   (9,535,742)
Realized Loss on Securities Investment  (10,557,229)  (2,918,668)  (10,688,542)  (6,355,451)
Gain (Loss) on Investment on Security by Equity Method  219,888   (79,670)  (48,388)  (216,050)
Loss on Consolidation of Alset Capital Acquisition Corp.  (21,657,036)  -   (21,657,036)  - 
Finance Costs  -   (2,879)  -   (450,887)
Other Income (Expense)  987,531   (734,355)  1,090,538   550,538 
Total Other Expense, Net  (10,922,902)  (8,328,599)  (13,156,354)  (14,383,397)
                 
Net Loss Before Income Taxes  (5,813,406)  (9,982,861)  (10,136,588)  (17,691,200)
                 
Income Tax Expense  -   -   -   (222,114)
                 
Net Loss  (5,813,406)  (9,982,861)  (10,136,588)  (17,913,314)
                 
Net Loss Attributable to Non-Controlling Interest  (5,556)  (995,502)  (470,852)  (2,458,669)
                 
Net Loss Attributable to Common Stockholders $(5,807,850) $(8,987,359) $(9,665,736) $(15,454,645)
                 
Other Comprehensive Loss, Net                
Unrealized Loss on Securities Investment  -   (591)  -   (9,714)
Foreign Currency Translation Adjustment  (2,183,883)  (3,514,595)  (1,087,940)  (4,163,735)
Comprehensive Loss  (7,997,289)  (13,498,047)  (11,224,528)  (22,086,763)
                 
Comprehensive Loss Attributable to Non-controlling Interests  (320,903)  (2,286,174)  (626,520)  (3,371,569)
                 
Comprehensive Loss Attributable to Common Stockholders $(7,676,386) $(11,211,873) $(10,598,008) $(18,715,194)
                 
Net Loss Per Share - Basic and Diluted $(0.63) $(1.46) $(1.09) $(2.77)
Net Loss Per Share - Basic $(0.63) $(1.46) $(1.09) $(2.77)
                 
Weighted Average Common Shares Outstanding - Basic and Diluted  9,235,119   6,144,550*  8,845,250   5,586,433*
Weighted Average Common Shares Outstanding - Basic  9,235,119   6,144,550*  8,845,250   5,586,433*

*The numbers of weighted average outstanding common stock - basic and diluted were adjusted retrospectively to reflect 20-for-1 reverse stock split on December 28, 2022

See accompanying notes to condensed consolidated financial statements.

F-2
F-2
HF Enterprises

Alset Inc.

Condensed Consolidated Statements of Stockholders’ Equity
For the Nine Months Ended September 30, 2020
 (Unaudited) 
 
 
Preferred Stock
 
 
Common Stock
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Shares
 
 
Par Value $0.001
 
 
Shares
 
 
Par Value $0.001
 
 
Additional Paid in Capital
 
 
Accumulated Other Comprehensive Income
 
 
Accumulated Deficit
 
 
Non-Controlling Interests
 
 
Total Stockholders Equity
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance at January 1, 2020
   
   
  10,001,000 
 $10,001 
 $54,263,717 
 $1,468,269 
 $(40,494,115)
 $6,975,459 
 $22,223,331 
 
    
    
    
    
    
    
    
    
    
Subsidiary's Issuance of Stock
    
    
    
    
  96,042 
    
    
  50,811 
  146,853 
 
    
    
    
    
    
    
    
    
    
Proceeds from Selling Subsidiary Equity
    
    
    
    
  3,270 
    
    
  1,730 
  5,000 
 
    
    
    
    
    
    
    
    
    
Change in Unrealized Loss on Investment
    
    
    
    
    
  (8,240)
    
  (4,359)
  (12,599)
 
    
    
    
    
    
    
    
    
    
Foreign Currency Translations
    
    
    
    
    
  (1,094,810)
    
  (579,211)
  (1,674,021)
 
    
    
    
    
    
    
    
    
    
Distribution to Non-Controlling Shareholder
    
    
    
    
    
    
  (197,400)
  (197,400)
 
    
    
    
    
    
    
    
    
    
Net Income
    
    
    
    
    
    
  1,447,666 
  567,985 
  2,015,651 
 
    
    
    
    
    
    
    
    
    
Balance at March 31, 2020
    
    
  10,001,000 
 $10,001 
 $54,363,029 
 $365,219 
 $(39,046,449)
 $6,815,015 
 $22,506,815 
 
    
    
    
    
    
    
    
    
    
Cancellation of Outstanding Stock
    
    
  (3,601,000)
  (3,601)
  3,601 
    
    
    
  - 
 
    
    
    
    
    
    
    
    
    
Subsidiary's Issuance of Stock
    
    
    
    
  1,262,990 
    
    
  770,156 
  2,033,146 
 
    
    
    
    
    
    
    
    
    
Change in Minority Interest
    
    
    
    
  (445,936)
  (18,317)
    
  464,253 
  - 
 
    
    
    
    
    
    
    
    
    
Proceeds from Selling Subsidiary Equity
    
    
    
    
  16,959 
    
    
  10,341 
  27,300 
 
    
    
    
    
    
    
    
    
    
Change in Unrealized Gain on Investment
    
    
    
    
    
  8,147 
    
  4,968 
  13,115 
 
    
    
    
    
    
    
    
    
    
Foreign Currency Translations
    
    
    
    
    
  389,413 
    
  237,459 
  626,872 
 
    
    
    
    
    
    
    
    
    
Net Loss
    
    
    
    
    
    
  (920,318)
  (1,188,418)
  (2,108,736)
 
    
    
    
    
    
    
    
    
    
Balance at June 30, 2020
    
    
  6,400,000 
 $6,400 
 $55,200,643 
 $744,462 
 $(39,966,767)
 $7,113,774 
 $23,098,512 
 
    
    
    
    
    
    
    
    
    
Subsidiary's Issuance of Stock
    
    
    
    
  5,494,373 
    
    
  5,270,464 
  10,764,837 
 
    
    
    
    
    
    
    
    
    
Proceeds from Selling Subsidiary Equity
    
    
    
    
  74,008 
    
    
  70,992 
  145,000 
 
    
    
    
    
    
    
    
    
    
Change in Minority Interest
    
    
    
    
  (989,342)
  50,420 
    
  (394,507)
  (1,333,429)
 
    
    
    
    
    
    
    
    
    
Stock Exchange with Related Party
    
    
    
    
  34,273,886 
    
    
  32,877,145 
  67,151,031 
 
    
    
    
    
    
    
    
    
    
Change in Unrealized Gain on Investment
    
    
    
    
    
  14,865 
    
  14,258 
  29,123 
 
    
    
    
    
    
    
    
    
    
Foreign Currency Translations
    
    
    
    
    
  235,837 
    
  226,227 
  462,064 
 
    
    
    
    
    
    
    
    
    
Net Loss
    
    
    
    
    
    
 $(9,836,839)
 $(3,505,919)
 $(13,342,758)
 
    
    
    
    
    
    
    
    
    
Balance at September 30, 2020
    
    
  6,400,000 
 $6,400 
 $94,053,568 
 $1,045,584 
 $(49,803,606)
 $41,672,434 
 $86,974,380 
F-3
HF Enterprises Inc.
Condensed  and Subsidiaries

Consolidated Statements of Stockholders’ Equity

For the NineSix Months Ended SeptemberJune 30, 2019

 (Unaudited) 
 
 
Preferred Stock
 
 
Common Stock
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Shares
 
 
Par Value $0.001
 
 
Shares
 
 
Par Value $0.001
 
 
Additional Paid in Capital
 
 
Accumulated Other Comprehensive Income
 
 
Accumulated Deficit
 
 
Non-Controlling Interests
 
 
Total Stockholders Equity
 
Balance at January 1, 2019
   
   
  10,001,000 
 $10,001 
 $53,717,424 
 $1,582,788 
 $(35,263,650)
 $9,155,051 
 $29,201,614 
 
    
    
    
    
    
    
    
    
    
Proceeds from Selling Subsidiary Equity
    
    
    
    
  127,508 
    
    
  56,992 
  184,500 
 
    
    
    
    
    
    
    
    
    
Change in Unrealized Gain on Investment
    
    
    
    
    
  11,681 
    
  5,221 
  16,902 
 
    
    
    
    
    
    
    
    
    
Foreign Currency Translations
    
    
    
    
    
  74,262 
    
  33,194 
  107,456 
 
    
    
    
    
    
    
    
    
    
Net Income
    
    
    
    
    
    
  344,151 
  50,766 
  394,917 
 
    
    
    
    
    
    
    
    
    
Balance at March 31, 2019
    
    
  10,001,000 
 $10,001 
 $53,844,932 
 $1,668,731 
 $(34,919,499)
 $9,301,224 
 $29,905,389 
 
    
    
    
    
    
    
    
    
    
Proceeds from Selling Subsidiary Equity
    
    
    
    
  10,367 
    
    
  4,633 
  15,000 
 
    
    
    
    
    
    
    
    
    
Change in Unrealized Gain on Investment
    
    
    
    
    
  22 
    
  10 
  32 
 
    
    
    
    
    
    
    
    
    
Foreign Currency Translations
    
    
    
    
    
  104,762 
    
  46,825 
  151,587 
 
    
    
    
    
    
    
    
    
    
Distribution to Non-Controlling Shareholder
    
    
    
    
    
    
  (740,250)
  (740,250)
 
    
    
    
    
    
    
    
    
    
Net Loss
    
    
    
    
    
    
  (4,205,007)
  (1,524,149)
  (5,729,156)
 
    
    
    
    
    
    
    
    
    
Balance at June 30, 2019
    
    
  10,001,000 
 $10,001 
 $53,855,299 
 $1,773,515 
 $(39,124,506)
 $7,088,293 
 $23,602,602 
 
    
    
    
    
    
    
    
    
    
Proceeds from Selling Subsidiary Equity
    
    
    
    
  20,733 
    
    
  9,267 
  30,000 
 
    
    
    
    
    
    
    
    
    
Change in Unrealized Loss on Investment
    
    
    
    
    
  (37,099)
    
  (16,582)
  (53,681)
 
    
    
    
    
    
    
    
    
    
Foreign Currency Translations
    
    
    
    
    
  (403,990)
    
  (180,571)
  (584,561)
 
    
    
    
    
    
    
    
    
    
Net Income
    
    
    
    
    
    
  763,741 
  36,181 
  799,922 
 
 ��  
    
    
    
    
    
    
    
    
Balance at September 30, 2019
    
    
  10,001,000 
 $10,001 
 $53,876,032 
 $1,332,426 
 $(38,360,765)
 $6,936,588 
 $23,794,282 
2023

                                     
  Series A
Preferred Stock
  Series B
Preferred Stock
  Common Stock  Additional  Accumulated Other     Total Alset  Non-  Total 
  Shares  Par Value $0.001  Shares  Par Value $0.001  Shares  Par Value $0.001  Paid in Capital  Comprehensive Income  Accumulated Deficit  Stockholders’ Equity  Controlling Interests  Stockholders’ Equity 
Balance at January 1, 2023  -  $-   -  $-   7,422,846  $7,423  $322,534,891  $3,836,063  $(188,724,411) $137,653,966  $11,009,149  $148,663,115 
                                                 
Issuance of Common Stock                  1,812,273   1,812   3,432,109   -   -   3,433,921   -   3,433,921 
                                                 
Foreign Currency Translations                  -   -   -   936,265   -   936,265   159,678   1,095,943 
                                                 
Net Loss      -        -    -   -   -   -   (3,857,886)  (3,857,886)  (465,296)  (4,323,182)
                                                 
Balance at March 31, 2023  -  $-   -  $-   9,235,119  $9,235  $325,967,000  $4,772,328  $(192,582,297) $138,166,266  $10,703,531  $148,869,797 
                                                 
Foreign Currency Translations                  -  $-  $-   (1,849,049)  -   (1,849,049)  (334,834)  (2,183,883)
                                                 
Net Loss      -           -      -  $-  $-   -   (5,807,850)  (5,807,850)  (5,556)  (5,813,406)
                                                 
Balance at June 30, 2023  -   $-   -   $-   9,235,119   9,235   325,967,000   2,923,279   (198,390,147)  130,509,367   10,363,141  $140,872,508 

Alset Inc. and Subsidiaries

Consolidated Statements of Stockholders’ Equity

For the Six Months Ended June 30, 2022

                                     
  Series A
Preferred Stock
  Series B
Preferred Stock
  Common Stock  Additional  Accumulated Other     Total Alset  Non-  Total 
  Shares  Par Value $0.001  Shares  Par Value $0.001  Shares  

Par Value $0.001

  Paid in Capital  Comprehensive Income  Accumulated Deficit  Stockholders’ Equity  Controlling Interests  Stockholders’ Equity 
Balance at January 1, 2022  -  $-   -  $-   87,368,446  $87,368  $296,181,977  $341,646  $(148,233,473) $148,377,518  $21,912,268  $170,289,786 
                                                 
Issuance of Stock by Exercising Warrants      -        -    15,819,452   15,820   (11,925)  -   -   3,895   -   3,895 
                                                 
Convert Related Party Note to Common Stock                  10,000,000   10,000   6,203,000   -   -   6,213,000   -   6,213,000 
                                                 
Deconsolidate Alset Capital Acquisition                  -   -   17,160,800   -   -   17,160,800   2,227,744   19,388,544 
                                                 
Gain from Purchase Stock DSS                  -   -   737,572   -   -   737,572   -   737,572 
                                                 
Beneficial Conversion Feature Intrinsic Value, Net                  -   -   450,000   -   -   450,000   -   450,000 
                                                 
Change in Non-Controlling Interest                  -   -   (316,459)  459,069   -   142,610   (142,610)  - 
                                                 
Change in Unrealized Loss on Investment                  -   -   -   (7,027)  -   (7,027)  (2,096)  (9,123)
                                                 
Foreign Currency Translations                  -   -   -   (499,967)  -   (499,967)  (149,173)  (649,140)
                                                 
Net Loss                  -   -   -   -   (6,467,286)  (6,467,286)  (1,463,167)  (7,930,453)
                                                 
Balance at March 31, 2022  -  $-   -  $-   113,187,898  $113,188  $320,404,965  $293,721  $(154,700,759) $166,111,115  $22,382,966  $188,494,081 
Balance  -  $-   -  $-   113,187,898  $113,188  $320,404,965  $293,721  $(154,700,759) $166,111,115  $22,382,966  $188,494,081 
                                                 
Issuance of Common Stock      -        -    35,319,290   35,319   (35,319)  -   -   -   -   - 
                                                 
Change in Valuation on Investment                  -   -   (2,624,585)  -   -   (2,624,585)  (206,377)  (2,830,962)
                                                 
Change in Non-Controlling Interest                  -��  -   4,557,454   3,266,996   -   7,824,450   (7,824,450)  - 
                                                 
Change in Unrealized Loss on Investment                  -   -   -   (505)  -   (505)  (86)  (591)
                                                 
Foreign Currency Translations                  -   -   -   (3,002,167)  -   (3,002,167)  (512,428)  (3,514,595)
                                                 
Net Loss                  -   -   -   -   (8,987,359)  (8,987,359)  (995,502)  (9,982,861)
                                                 
Balance at June 30, 2022  -  $-   -  $-   148,507,188  $148,507  $322,302,515  $558,045  $(163,688,118) $159,320,949  $12,844,123  $172,165,072 
Balance  -  $-   -  $-   148,507,188  $148,507  $322,302,515  $558,045  $(163,688,118) $159,320,949  $12,844,123  $172,165,072 

See accompanying notes to condensed consolidated financial statements.

F-3
F-4
HF Enterprises

Alset Inc. and Subsidiaries

Condensed

Consolidated Statements of CashCash Flows

For the NineSix Months Ended SeptemberJune 30, 20202023 and 2019

2022

(Unaudited)

 
 
 2020
 
 
 2019
 
 
 
 
 
 
 
 
Cash Flows from Operating Activities
 
 
 
 
 
 
Net Loss from Continuing Operations
 $(13,018,405)
 $(4,145,386)
Adjustments to Reconcile Net Loss from Continuing Operations to Net Cash Provided (Used in) by Operating Activities:
    
    
Depreciation
  15,225 
  20,697 
Amortization of Right -Of - Use Asset
  182,120 
  55,726 
Amortization of Debt Discount
  9,217 
  - 
Gain on Disposal of Subsidiary
  - 
  (299,255)
Share-based Compensation
  1,584,412 
  - 
Foreign Exchange Transaction Gain
  (960,268)
  (438,608)
Unrealized Loss on Securities Investment
  42,169,116 
  146,470 
Loss on Equity Method Investment
  193,132 
  - 
Gain from Deconsolidation
  (53,200,752)
    
Loss from Consolidation
  21,909,596 
    
Impairment of Real Estate
  - 
  3,938,769 
Changes in Operating Assets and Liabilities
    
    
Real Estate
  (544,419)
  12,565,198 
Trade Receivables
  454,109 
  (125,855)
Prepaid Expense
  (1,801,795)
  9,542 
   Deferred Revenue
  2,747,121 
  (36,467)
Inventory
  55,486 
  (21,253)
Accounts Payable and Accrued Expenses
  1,534,838 
  (1,130,721)
Accrued Interest - Related Parties
  (788,748)
  275,245 
Operating Lease Liability
  (221,838)
  (62,707)
Builder Deposits
  (636,522)
  (1,340,086)
Income Tax Payable
  (170,630)
  - 
Net Cash (Used in) Provided by Continuing Operating Activities
  (489,005)
  9,411,309 
Net Cash Used in Discontinued Operating Activities
  (522,435)
  (446,409)
Net Cash (Used in) Provided by Operating Activities
  (1,011,440)
  8,964,900 
 
    
    
Cash Flows From Investing Activities
    
    
Purchase of Fixed Assets
  (10,133)
  - 
Proceeds from Global Opportunity Fund Liquidation
  301,976 
  - 
Purchase of Investments
  (158,667)
  - 
Promissory Note to Related Party
  (200,000)
  - 
Net Cash Provided by (Used in) Continuing Investing Activities
  (66,824)
  - 
Net Cash from Discontinued Investing Activities
  - 
  (36,000)
Net Cash Provided by (Used in) Investing Activities
  (66,824)
  (36,000)
 
    
    
Cash Flows From Financing Activities
    
    
   Proceeds from Exercise of Subsidiary Warrants
  10,764,837 
  - 
Proceeds from Sale of Subsidiary Shares
  177,300 
  229,500 
Borrowings
  738,783 
  - 
Financing Fee
  (82,062)
  - 
Repayments of Note Payable
  (250,000)
  (13,899)
Distribution to Minority Shareholder
  (197,400)
  (740,250)
Repayment to Notes Payable - Related Parties
  (4,450,572)
  (2,507,840)
Net Cash Provided by (Used in) Continuing Financing Activities
  6,700,886 
  (3,032,489)
Net Cash Provided by Discontinued Financing Activities
  - 
  - 
Net Cash Provided by (Used in) Financing Activities
  6,700,886 
  (3,032,489)
 
    
    
Net Increase in Cash and Restricted Cash
  5,622,622 
  5,896,411 
Effects of Foreign Exchange Rates on Cash
  35,858 
  9,287 
 
    
    
Cash and Restricted Cash - Beginning of Year
  7,330,996 
  5,508,198 
Cash and Restricted Cash- End of Period
 $12,989,476 
 $11,413,896 
 
    
    
Supplementary Cash Flow Information
    
    
Cash Paid for Interest
 $13,843 
 $4,663 
 
    
    
Supplemental Disclosure of Non-Cash Investing and Financing Activities
    
    
Amortization of Debt Discount Capitalized
 $- 
 $381,823 
Stock Acquired by disposal of a Subsidiary
 $67,208,173 
 $- 

  2023  2022 
       
Cash Flows from Operating Activities        
Net Loss from Operations $(10,136,588) $(17,913,314)
Adjustments to Reconcile Net Loss to Net Cash Provided by (Used in) Operating Activities:        
Depreciation  606,434   349,403 
Amortization of Right-Of-Use Assets  523,591   180,092 
Amortization of Debt Discount  -   450,000 
Loss on Consolidation of Alset Capital Acquisition Corp.  

21,657,036

   

-

 
Foreign Exchange Transaction Gain  (362,528)  (2,485,804)
Unrealized (Gain) Loss on Securities Investment  (6,543,729)  1,230,648 
Unrealized (Gain) Loss on Securities Investment - Related Party  (11,109,151)  9,535,742 
Realized Loss on Securities Investment  10,688,542   6,355,451 
(Gain) Loss on Exchange of Investment Securities  (502,497)  852,061 
PPP Loan Forgiveness  -   (68,502)
Director Compensation Adjustment  -   (1,185,251)
Loss on Equity Method Investment  48,388   216,050 
Changes in Operating Assets and Liabilities, net of acquisitions        
Real Estate  15,393,185   (2,274,959)
Account Receivables  (7,280,286)  (160,327)
Prepaid Expense  (11,664)  515,568 
Deposits  2,935   - 
Trading Securities  (4,593,961)  1,072,263 
Inventory  (3,889)  7,470 
Accounts Payable and Accrued Expenses  (364,372)  (9,398,591)
Other Receivables - Related Parties  (55,000)  (2,551,127)
Deferred Revenue  (19,098)  (638,463)
Operating Lease Liabilities  (527,578)  (182,661)
Builder Deposits  -   (31,553)
Net Cash Provided by (Used in) Operating Activities  7,409,770   (16,125,804)
         
Cash Flows from Investing Activities        
Loan Receivable - Related Party  -   (111,112)
Purchase of Fixed Assets  (11,726)  (210,319)
Purchase of Real Estate Properties  -   (722,817)
Real Estate Improvements  (734,688)  (602,161)
Purchase of Investment Securities  (692,219)  (6,662,017)
Acquisition of Subsidiary  (214,993)  - 
Issuing Loan Receivable - Related Party  (1,628,010)  - 
Proceeds from Loan Receivable - Related Party  2,674,653   - 
Net Cash Used in Investing Activities  (606,983)  (8,308,426)
         
Cash Flows from Financing Activities        
Proceeds from Common Stock Issuance  3,433,921   6,213,000 
Repayment to Notes Payable  (16,950)  (171,861)
Net Cash Provided by Financing Activities  3,416,971   6,041,139 
         
Net Increase (Decrease) in Cash and Restricted Cash  10,219,758   (18,393,091)
Effects of Foreign Exchange Rates on Cash  750,474   (412,821)
Cash and Restricted Cash - Beginning of Year  18,521,903   60,802,179 
Cash and Restricted Cash- End of Period $29,492,135  $41,996,267 
         
Cash $28,827,961  $41,326,946 
Restricted Cash $664,174  $669,321 
Total Cash and Restricted Cash $29,492,135  $41,996,267 
         
Supplementary Cash Flow Information        
Cash Paid for Interest $2,007  $1,524 
Cash Paid for Taxes $-  $- 
         
Supplemental Disclosure of Non-Cash Investing and Financing Activities        
Unrealized Gain on Investment $-  $727,858 
Initial Recognition of ROU / Lease Liability $157,647  $- 
Deconsolidate Alset Capital Acquisition $-  $16,557,582 
Intrinsic Value of BCF $-  $(450,000)
Issuance of Stock by Exercising Warrants $-  $3,895 

See accompanying notes to condensed consolidated financial statements.

F-5
F-4
 1.
NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Alset Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

For the Six Months Ended June 30, 2023 and 2022

(Unaudited)

1. NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of Operations

HF Enterprises

Alset Inc. (the “Company” or “HFE”“AEI”), formerly known as Alset EHome International Inc. and HF Enterprises Inc., was incorporated in the State of Delaware on March 7, 2018 and 1,000 shares of common stock2018. On October 4, 2022, through a merger transaction, the Company was issued to Chan Heng Fai, the founder, Chairman and Chief Executive Officer of the Company. HFEreincorporated in Texas. AEI is a diversified holding company principally engaged through its subsidiaries in propertythe development of EHome communities and other real estate, financial services, digital transformation technology,technologies, biohealth activities and other related business activitiesconsumer products with operations in the United States, Singapore, Hong Kong, Australia and South Korea. The Company manages its principalWe manage a significant portion of our businesses primarily through itsour 85.4% owned subsidiary, Alset International Limited (“Alset International”, f.k.a. Singapore eDevelopment Limited)), a public company publicly traded on the Singapore Stock Exchange.

On October 1, 2018, Chan Heng Fai transferred his 100% interest in Hengfai International Pte. Ltd. (“Hengfai International”) to HF Enterprises Inc. in exchange for 8,500,000 shares of the Company’s common stock. Hengfai International holds a 100% interest in Hengfai Business Development Pte. Ltd. (“Hengfai Business Development”). Both Hengfai International and Hengfai Business Development are holding companies with no business operations. On September 30, 2020, the Company held 791,150,294 shares and 359,834,471 warrants of Alset International, which is the primary operating company of HFE. The Company held 761,150,294 shares and 359,834,471 warrants of Alset International on December 31, 2019. On September 30, 2020 and December 31, 2019, the Company’s ownership of Alset International was 51.04% and 69.08%, respectively.
Also, on October 1, 2018, Chan Heng Fai transferred his 100% ownership interest in Heng Fai Enterprises Pte. Ltd. (“Heng Fai Enterprises”) and Global eHealth Limited (“Global eHealth”) to HF Enterprises Inc. in exchange for 500,000 and 1,000,000 shares of the Company’s common stock, respectively.
The contributions to HFE on October 1, 2018 of Hengfai International, Heng Fai Enterprises, and Global eHealth from Chan Heng Fai represented transactions under common control.
On June 24, 2020, HFE Holdings Limited surrendered 3,600,000 shares of our common stock to the treasury of our Company, and Chan Heng Fai surrendered 1,000 shares of our common stock to the treasury of our Company, and all such shares were cancelled.

The Company has four operating segments based on the products and services offered. Thesewe offer, which include three of our three principal businesses – property development,real estate, digital transformation technology and biohealth – as well as a fourth category consisting of certain other business activities.

Property Development
The Company’s property development segment is comprised of LiquidValue Development Inc. ("LiquidValue Development") and SeD Perth Pty Ltd.
In 2014, Alset International commenced operations developing property projects and participating in third-party property development projects. LiquidValue Development Inc. (f.k.a. SeD Intelligent Home Inc.) a 99.9%-owned subsidiary of Alset International, owns, operates and manages real estate development projects with a focus on land subdivision developments. 
Development activities are generally contracted out, including planning, design and construction, as well as other work with engineers, surveyors, architects and general contractors. The developed lots are then sold to builders for the construction of new homes. LiquidValue Development's primary real estate projects are two subdivision development projects, one near Houston, Texas, known as Black Oak, consisting of 162 acres and currently projected to have approximately 512 units, and one in Frederick, Maryland, known as Ballenger Run, consisting of 197 acres and currently projected to have approximately 689 units. 
F-6
Digital Transformation Technology
The Company’s digital transformation technology segment is comprised of HotApp Blockchain Inc. and its subsidiaries.
The Company’s digital transformation technology business is involved in mobile application product development and other businesses, providing information technology services to end-users, service providers and other commercial users through multiple platforms. This technology platform consists of instant messaging systems, social media, e-commerce and payment systems, direct marketing platforms, e-real estate, brand protection and counterfeit and fraud detection. HotApp Blockchain Inc. (“HotApp Blockchain" or “HotApp”), a 99.9%-owned subsidiary of Alset International, focuses on business-to-business solutions such as enterprise messaging and workflow. Through HotApp, the Company has successfully implemented several strategic platform developments for clients, including a mobile front-end solution for network marketing, a hotel e-commerce platform for Asia and a real estate agent management platform in China.  
On October 25, 2018, HotApps International Pte. Ltd. (“HIP”) entered into an Equity Purchase Agreement with DSS Asia Limited (“DSS Asia”), a Hong Kong subsidiary of DSS International Inc. (“DSS International”), pursuant to which HIP agreed to sell to DSS Asia all of the issued and outstanding shares of HotApps Information Technology Co. Ltd., also known as Guangzhou HotApps Technology Ltd. (“Guangzhou HotApps”). The transaction closed on January 14, 2019. Chan Heng Fai is the CEO of DSS Asia and DSS International. For further details on this transaction, refer to Note 11 – Discontinued Operations and Note 8 – Related Party Transactions. 
Biohealth
The Company’s biohealth segment is comprised of Global BioMedical Pte. Ltd. and Health Wealth Happiness Pte. Ltd. and is committed to both funding research and developing and selling products that promote a healthy lifestyle.
Impact BioMedical Inc., a subsidiary of Global BioMedical Pte. Ltd, is focusing on research in three main areas: (i) development of a universal therapeutic drug platform; (ii) a new sugar substitute; and (iii) a multi-use fragrance. Global BioLife established a joint venture, Sweet Sense, Inc., with Quality Ingredients, LLC for the development, manufacture, and global distribution of the new sugar substitute. On November 8, 2019, Impact BioMedical Inc. purchased 50% of Sweet Sense Inc. from Quality Ingredients, LLC for $91,000. Sweet Sense Inc. is an 81.8% owned subsidiary of Impact BioMedical Inc.
On April 27, 2020, Global BioMedical Pte Ltd (“GBM”), a wholly owned subsidiary of Alset International, entered into a share exchange agreement with DSS BioHealth Security, Inc. (“DBHS”), a wholly owned subsidiary of Document Securities Systems Inc. (“DSS”), pursuant to which, DBHS will acquire all of the outstanding capital stock of Impact BioMedical Inc., through a share exchange. The transaction was closed on August 21, 2020 and Impact BioMedical became a direct wholly owned subsidiary of DBHS. For further details on this transaction, refer to Note 11, Discontinued Operations.
Currently, revenue from our biohealth segment comes from iGalen Inc. (f.k.a. iGalen USA, LLC), which is 100% owned by iGalen International Inc., Alset International’s 53%-owned subsidiary. During the nine months ended September 30, 2020 and 2019, the revenue from iGalen Inc. was $30,533 and $1,406,951, respectively. During the three months ended September 30, 2020 and 2019, the revenue from iGalen Inc. were $1,331 and $360,351, respectively. As of September 30, 2020 and December 31, 2019, the deferred revenue was $0 and $37,120, respectively. All deferred revenue came from unrecognized membership fee. The Company recognizes revenue associated with the membership over the one-year period of the membership. Before the membership fee is recognized as revenue, it is recorded as deferred revenue. 
F-7
In October 2019, the Company expanded its biohealth segment to Korean market through one of the subsidiaries of Health Wealth Happiness Pte. Ltd., HWH World Inc (“HWH World”). HWH World, similarly to iGalen Inc., operates based on a direct sale model of health supplements. HWH World is at the beginning stage of operations recognized only approximately $600 in revenue in three and nine months ended September 30, 2020. No revenue was recognized in three and nine months ended on September 30, 2019. As of September 30, 2020 and December 31, 2019, the deferred revenue was $3,046,687 and $221,474, respectively. All deferred revenue came from unrecognized membership fee.
Other Business Activities
In addition to the segments identified above, the Company provides corporate strategy and business development services, asset management services, corporate restructuring and leveraged buy-out expertise. These service offerings build relationships with promising companies for potential future collaboration and expansion. We believe that our other business activities complement our three principal businesses. 
The Company’s other business activities segment is primarily comprised of Alset International, SeD Capital Pte. Ltd., BMI Capital Partners International Limited and Singapore Construction & Development Pte. Ltd. 
2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation and Principles of Consolidation

The Company’s condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and following the requirements of the Securities and Exchange Commission ("SEC"(“SEC”) for interim reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP can be condensed or omitted. These interim financial statements have been prepared on the same basis as the Company'sCompany’s annual financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for a fair statement of the Company'sCompany’s financial information. These interim results are not necessarily indicative of the results to be expected for the year ending December 31, 20202023 or any other interim periodperiods or for any other future year.years. These unaudited condensed consolidated financial statements should be read in conjunction with the Company'sCompany’s audited consolidated financial statements and the notes thereto included in the Company’s Form 10-K for the year ended December 31, 2019, in Form S-1 as2022 filed with the SEC on November 11, 2020. 

The balance sheet as of DecemberMarch 31, 2019 has been derived from audited financial statements at that date but does not include all of the information required by U.S. GAAP for complete financial statements. 
2023.

The condensed consolidated financial statements include all accounts of the Company and its majority owned and controlled subsidiaries. The Company consolidates entities in which it owns more than 50% of the voting common stock and controls operations. All intercompany transactions and balances among consolidated subsidiaries have been eliminated.

F-5
F-8

The Company'sCompany’s condensed consolidated financial statements include the financial position, results of operations and cash flows of the following entities as of September June 30,, 2020 2023 and December 31, 2019, and for the three and nine month periods ended September 30, 2020 and 20192022, as follows:

SCHEDULE OF SUBSIDIARIES

Name of subsidiary State or other jurisdiction of Attributable interest as of, 

consolidated under AEI

 

incorporation or organization

 June 30, 2023  December 31, 2022 
    %  % 
Alset Global Pte. Ltd. Singapore  100   100 
Alset Business Development Pte. Ltd. Singapore  100   100 
Global eHealth Limited Hong Kong  100   100 
Alset International Limited Singapore  85.4   85.4 
Singapore Construction & Development Pte. Ltd. Singapore  85.4   85.4 
Art eStudio Pte. Ltd. Singapore  43.6*  43.6*
Singapore Construction Pte. Ltd. Singapore  85.4   85.4 
Global BioMedical Pte. Ltd. Singapore  85.4   85.4 
Alset Innovation Pte. Ltd. Singapore  85.4   85.4 
Health Wealth Happiness Pte. Ltd. Singapore  85.4   85.4 
SeD Capital Pte. Ltd. Singapore  85.4   85.4 
LiquidValue Asset Management Pte. Ltd. Singapore  85.4   85.4 
Alset Solar Limited Hong Kong  85.4   85.4 
Alset F&B One Pte. Ltd Singapore  76.9   76.9 
Global TechFund of Fund Pte. Ltd. Singapore  -   100 
Singapore eChainLogistic Pte. Ltd. Singapore  -   100 
BMI Capital Partners International Limited. Hong Kong  85.4   85.4 
SeD Perth Pty. Ltd. Australia  85.4   85.4 
SeD Intelligent Home Inc. United States of America  85.4   85.4 
LiquidValue Development Inc. United States of America  85.4   85.4 
Alset EHome Inc. United States of America  85.4   85.4 
SeD USA, LLC United States of America  85.4   85.4 
150 Black Oak GP, Inc. United States of America  85.4   85.4 
SeD Development USA Inc. United States of America  85.4   85.4 
150 CCM Black Oak, Ltd. United States of America  85.4   85.4 
SeD Texas Home, LLC United States of America  100   85.4 
SeD Ballenger, LLC United States of America  85.4   85.4 
SeD Maryland Development, LLC United States of America  71.4   71.4 
SeD Development Management, LLC United States of America  72.6   72.6 
SeD Builder, LLC United States of America  85.4   85.4 
Hapi Metaverse Inc. (f.k.a. GigWorld Inc.) United States of America  99.7   99.7 
HotApp BlockChain Pte. Ltd. Singapore  99.7   99.7 
HotApp International Limited Hong Kong  99.7   99.7 
HWH International, Inc. (Delaware) United States of America  85.4   85.4 
Health Wealth & Happiness Inc. United States of America  85.4   85.4 
HWH Multi-Strategy Investment, Inc. United States of America  85.4   85.4 
SeD REIT Inc. United States of America  85.4   85.4 
Gig Stablecoin Inc. United States of America  99.7   99.7 
HWH World Inc. (Delaware) United States of America  99.7   99.7 
HWH World Pte. Ltd. Singapore  85.4   85.4 
UBeauty Limited Hong Kong  85.4   85.4 
WeBeauty Korea Inc Korea  85.4   85.4 
HWH World Limited Hong Kong  85.4   85.4 
HWH World Inc. Korea  85.4   85.4 
GDC REIT Inc. United States of America  85.4   85.4 

F-6

Name of subsidiary State or other jurisdiction of Attributable interest as of, 
consolidated under AEI incorporation or organization June 30, 2023  December 31, 2022 
BioHealth Water Inc. United States of America  85.4   85.4 
Impact BioHealth Pte. Ltd. Singapore  85.4   85.4 
American Home REIT Inc. United States of America  100   85.4 
Alset Solar Inc. United States of America  68.3   68.3 
HWH KOR Inc. United States of America  85.4   85.4 
Open House Inc. United States of America  -   100 
Open Rental Inc. United States of America  -   100 
Hapi Cafe Inc. (Nevada) United States of America  -   100 
Global Solar REIT Inc. United States of America  -   100 
Alset EV Inc. (f.k.a. OpenBiz Inc.) United States of America  100   100 
Hapi Cafe Inc. (Texas) United States of America  85.4   85.4 
HWH (S) Pte. Ltd. Singapore  85.4   85.4 
LiquidValue Development Pte. Ltd. Singapore  100   100 
LiquidValue Development Limited Hong Kong  100   100 
EPowerTech Inc. United States of America  -   100 
Alset EPower Inc. United States of America  -   100 
AHR Asset Management Inc. United States of America  85.4   85.4 
HWH World Inc. (Nevada) United States of America  85.4   85.4 
Alset F&B Holdings Pte. Ltd. Singapore  85.4   85.4 
Credas Capital Pte. Ltd. Singapore  42.7*  42.7*
Credas Capital GmbH Switzerland  42.7*  42.7*
Smart Reward Express Limited Hong Kong  49.8*  49.8*
AHR Texas Two LLC United States of America  100   85.4 
AHR Black Oak One LLC United States of America  85.4   85.4 
Hapi Air Inc. United States of America  92.7   92.7 
AHR Texas Three, LLC United States of America  100   85.4 
Alset Capital Pte. Ltd. Singapore  -   100 
Hapi Cafe Korea, Inc. Korea  85.4   85.4 
Green Energy REIT Inc. United States of America  -   100 
Green Energy Management Inc. United States of America  -   100 
Alset Metaverse Inc. United States of America  97.2   97.2 
Alset Management Group Inc. United States of America  83.4   83.4 
Alset Acquisition Sponsor, LLC United States of America  93.4   93.4 
Alset Spac Group Inc. United States of America  93.4   93.4 
Alset Mining Pte. Ltd. Singapore  85.4   85.4 
Hapi Travel Pte. Ltd. Singapore  85.4   85.4 
Hapi WealthBuilder Pte. Ltd. Singapore  85.4   85.4 
HWH Marketplace Pte. Ltd. Singapore  85.4   85.4 
HWH International Inc. (Nevada) United States of America  85.4   85.4 
Hapi Cafe SG Pte. Ltd. Singapore  85.4   85.4 
Alset Reits Inc. United States of America  100   100 
Robotic gHome Inc. United States of America  76.9   76.9 
HWH Merger Sub, Inc. United States of America  85.4   85.4 
Alset Home REIT Inc. United States of America  100   100 
Hapi Metaverse Inc. (Texas) United States of America  99.7   99.7 
Hapi Café Limited Hong Kong  99.7   99.7 
MOC HK Limited Hong Kong  99.7   99.7 
AHR Texas Four, LLC United States of America  100   100 
Alset F&B (PLQ) Pte. Ltd. Singapore  85.4   85.4 
Hapi Café Sdn. Bhd. Malaysia  51.3   - 
Shenzhen Leyouyou Catering Management Co., Ltd. China  100   100 
Dongguan Leyouyou Catering Management Co., Ltd. China  100   - 
Guangzho Leyouyou Catering Management Co., Ltd. China  100   - 
Hapi Travel Ltd. Hong Kong  100   - 
Alset Capital Acquisition Corp. 

United States of America

  

57.1

   

-

 

*Although the Company indirectly holds percentage of shares of these entities less than 50%, the subsidiaries of the Company directly hold more than 50% of shares of these entities, and therefore, they are still consolidated into the Company.

F-7
    Attributable interest  
    as of, 
Name of subsidiary consolidated under HFE 
State or other jurisdiction of
incorporation or organization
 
September 30,
2020
  
December 31,
2019
 
    %  % 
Hengfai International Pte. Ltd Singapore  100   100 
Hengfai Business Development Pte. Ltd Singapore  100   100 
Heng Fai Enterprises Pte. Ltd. Singapore  100   100 
Global eHealth Limited Hong Kong  100   100 
Alset International Inc. (f.k.a. Singapore eDevelopment Limited) Singapore  51.04   65.4 
Singapore Construction & Development Pte. Ltd. Singapore  51.04   65.4 
Art eStudio Pte. Ltd. Singapore  26.03*  33.36*
Singapore Construction Pte. Ltd. Singapore  51.04   65.4 
Global BioMedical Pte. Ltd. Singapore  51.04   65.4 
Alset Innovation Pte. Ltd. (f.k.a. SeD Investment Pte. Ltd.) Singapore  51.04   65.4 
Health Wealth Happiness Pte. Ltd. Singapore  51.04   65.4 
iGalen International Inc. United States of America  27.05*  34.38*
iGalen Inc. (f.k.a iGalen USA LLC) United States of America  27.05*  34.38*
SeD Capital Pte. Ltd. Singapore  51.04   65.4 
LiquidValue Asset Management Pte. Ltd. (f.k.a. HengFai Asset Management Pte. Ltd.) Singapore  41.85  53.6 
SeD Home Limited Hong Kong  51.04   65.4 
SeD Reits Management Pte. Ltd. Singapore  51.04   65.4 
Global TechFund of Fund Pte. Ltd. Singapore  51.04   65.4 
Singapore eChainLogistic Pte. Ltd. Singapore  51.04   65.4 
BMI Capital Partners International Limited. Hong Kong  51.04   65.4 
SeD Perth Pty. Ltd. Australia  51.04   65.4 
SeD Intelligent Home Inc. (f.k.a SeD Home International, Inc.)  United States of America  51.04   65.4 
LiquidValue Development Inc. (f.k.a. SeD Intelligent Home Inc.) United States of America  51.03   65.39 
Alset iHome Inc. (f.k.a. SeD Home & REITs Inc. and SeD Home, Inc.) United States of America  51.03   65.39 
SeD USA, LLC United States of America  51.03   65.39 
150 Black Oak GP, Inc. United States of America  51.03   65.39 
SeD Development USA Inc. United States of America  51.03   65.39 
150 CCM Black Oak, Ltd. United States of America  51.03   65.39 
SeD Texas Home, LLC United States of America  51.03   65.39 
SeD Ballenger, LLC United States of America  51.03   65.39 
SeD Maryland Development, LLC United States of America  42.64  54.63 
SeD Development Management, LLC United States of America  43.38  55.58 
SeD Builder, LLC United States of America  51.03   65.39 
HotApp Blockchain Inc. United States of America  50.95   65.39 
HotApps International Pte. Ltd. Singapore  50.95   65.39 
HotApp International Limited Hong Kong  50.95   65.39 
HWH International, Inc. United States of America  51.04   65.4 
Health Wealth & Happiness Inc. United States of America  51.04   65.4 
HWH Multi-Strategy Investment, Inc. United States of America  51.04   65.4 
SeDHome Rental Inc United States of America  51.03   65.39 
SeD REIT Inc. United States of America  51.03   65.39 
Crypto Exchange Inc United States of America  50.95   65.39 
HWH World Inc. United States of America  50.95   65.39 
HWH World Pte. Ltd. Singapore  50.95   65.39 
UBeauty Limited Hong Kong  51.04   65.4 
WeBeauty Korea Inc Korea  51.04   65.4 
HWH World Limited Hong Kong  51.04   65.4 
HWH World Inc. Korea  51.04   65.4 
Alset BioHealth Pte. Ltd. Singapore  51.04   - 
Alset Energy Pte. Ltd. Singapore  51.04   - 
Alset Payment Inc. United States of America  51.04   - 
Alset World Pte. Ltd. Singapore  51.04   - 
BioHealth Water Inc. United States of America  51.04   - 
Impact BioHealth Pte. Ltd. Singapore  51.04   - 
American Home REIT Inc. United States of America  41.85*  - 
Alset Solar Inc. United States of America  40.83*  - 
*Although the Company indirectly holds percentage of shares of these entities less than 50%, the subsidiaries of the Company directly hold more than 50% of shares of these entities, and therefore, they are still consolidated into the Company. 
F-9

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant estimates made by management include, but are not limited to, allowance for doubtful accounts, valuation of real estate assets, allocation of development costs and capitalized interest to sold lots, fair value of the investments, the valuation allowance of deferred taxes, and contingencies. Actual results could differ from those estimates.

In our property development business, land acquisition costs are allocated to each lot based on the area method, the size of the lot compared to the total size of all lots in the project. Development costs and capitalized interest are allocated to lots sold based on the total expected development and interest costs of the completed project and allocating a percentage of those costs based on the selling price of the sold lot compared to the expected sales values of all lots in the project.

If allocation of development costs and capitalized interest based on the projection and relative expected sales value is impracticable, those costs could also be allocated based on area method, the size of the lot compared to the total size of all lots in the project.

When the Company purchases properties but does not receive the assessment information from the county, the Company allocates the values between land and building based on the data of similar properties. The Company makes appropriate adjustments once the assessment from the county is received. At the same time, any necessary adjustments to depreciation expense are made in the income statement. On June 30, 2023 and December 31, 2022, the Company adjusted $951,349 and $4,791,997 between building and land, respectively. During the three months ended June 30, 2023 and 2022, the Company adjusted depreciation expenses of $17,525 and $0, respectively. During the six months ended June 30, 2023 and 2022, the Company adjusted depreciation expenses of $17,525 and $0, respectively.

Cash and Cash Equivalents

The Company considers all highly liquid investments with a maturity of three months or less at the date of acquisition to be cash equivalents. Cash and cash equivalents include cash on hand and at the bank and short-term deposits with financial institutions that are readily convertible to a known amount of cash and are subject to an insignificant risk of changes in values. There were no cash equivalents as of SeptemberJune 30, 20202023 and December 31, 2019. 

2022.

Restricted Cash

As a condition to the loan agreement with the Manufacturers and Traders Trust Company (“M&T Bank”), the Company iswas required to maintain a minimum of $2,600,000$2,600,000 in an interest-bearing account maintained by the lender as additional security for the loans.loan. The fund isfunds were required to remain as collateral for the loan until the loan is paid off in full and the loan agreement terminated. On March 15, 2022 approximately $2,300,000 was released from collateral, leaving approximately $300,000 as collateral for outstanding letters of credit. The Company also has an escrow account with M&T Bank to deposit a portion of cash proceeds from lot sales. The fundfunds in the escrow account iswere specifically to be used for the payment of the loan from M&T Bank. The fund isfunds were required to remain in the escrow account for the loan payment until the loan agreement terminates. In May 2022 the funds from this escrow account were released and the account closed. As of SeptemberJune 30, 20202023 and December 31, 2019,2022, the total balance of these two accounts was $4,106,497$309,372 and $4,229,149,$309,219, respectively.

As a condition to the loan agreement with National Australian Bank Limited in conjunction with the Perth project, an Australian real estate development project, the Company iswas required to maintain Australian Dollar 50,000, in a non-interest-bearing account. As of September 30, 2020 and December 31, 2019,2021, the account balance was $35,710 and $35,068, respectively. These funds will remain as collateral for the loans until paid in full. 

On July 20, 2018, 150 CCM Black Oak Ltd received $4,592,079 in district reimbursement payments for previous construction costs incurred in land development. Of this amount, $1,650,000 will remain on deposit in the District’s Capital Projects Fund for the benefit of 150 CCM Black Oak Ltd and will be released upon receipt of the evidence of: (a) the execution of a purchase agreement between 150 CCM Black Oak Ltd and a home builder with respect to the Black Oak development and (b) the completion, finishing and readying for home construction of at least 105 unfinished lots in the Black Oak development. After entering the purchase agreement with Houston LD, LLC, the above requirements were met. The amount of the deposit will be released to$36,316. In February 2022 the Company by presentingrepaid the invoices paidloan and the funds were subsequently released.

F-8

The Company puts money into brokerage accounts specifically for land development. After releasing funds to the Company, the amount on deposit was $0 and $90,394 on Septemberequity investment. As of June 30, 20202023 and December 31, 2019,2022, the cash balance in these brokerage accounts was $354,802 and $385,304, respectively.

F-10
As a condition to use the credit card services for the Company’s bio product direct sale business, provided by Global Payroll Gateway, Ltd. (“GPG”), a financial service company,

Investments held in Trust Account

At June 30, 2023 the Company is required to deposit 10% revenue from the direct sales to a non-interest-bearing GPG reserve account with a maximum amount of $200,000. The Company is allowed to temporarily use the moneyhad approximately $20.8 million, in this deposit account upon request and pay back on a short-term basis. As of both, September 30, 2020 and December 31, 2019, the balanceinvestments in treasury securities held in the reserve account was $93,067.Trust Account. The fund will not be fully refundedfunds in the Trust Account are subject to the Company until the service agreement with GPG terminates. 

Accounts Receivableredemption by investors of Alset Capital Acquisition Corp. (“SPAC”).

Account Receivables and Allowance for Doubtful Accounts

Accounts receivable are

Account receivables is stated at amounts due from buyers, contractors, and all third parties, net of an allowance for doubtful accounts. As of June 30, 2023 and December 31, 2022, the balance of account receivables was $63,778 and $46,522, respectively.

The Company monitors its accounts receivableaccount receivables balances on a monthly basis to ensure that they are collectible. On a quarterly basis, the Company uses its historical experience to estimate its allowance for doubtful accounts receivable.account receivables. The Company’s allowance for doubtful accounts represents an estimate of the losses expected to be incurred based on specifically identified accounts as well as nonspecific amount, when determined appropriate. Generally, the amount of the allowance is primarily decided by division management’s historical experience, the delinquency trends, the resolution rates, the aging of receivables, the credit quality indicators and financial health of specific customers. As of SeptemberJune 30, 20202023 and December 31, 2019,2022, the allowance was $0.

$0.

Inventories

Inventories are stated at the lower of cost or net realizable value. Cost is determined using the first-in, first-out method and includes all costs in bringing the inventories to their present location and condition. Net realizable value is the estimated selling price in the ordinary course of business less the estimated costs necessary to make the sale. As of SeptemberJune 30, 20202023 and December 31, 2019,2022, inventory consisted of finished goods from iGalen IncHWH International Inc. and HWH World Inc.its subsidiaries. The Company continuously evaluates the need for reserve for obsolescence and possible price concessions required to write-down inventories to net realizable value.

Investment Securities

Investment Securities at Fair Value

The Company holds investments in equity securities with readily determinable fair values, equity investments without readily determinable fair values, investments accounted for under the equity method, and investments at cost.

Prior to the adoption of Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 2016-01, Financial Instruments-Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities, investments in equity securities were classified as either 1) available-for-sale securities, stated at fair value, and unrealized holding gains and losses, net of related tax effects, were recorded directly to accumulated other comprehensive income (loss) or 2) trading securities, stated at fair value, and unrealized holding gains and losses, net of related tax benefits, were recorded directly to net income (loss). With the adoption of ASU 2016-01 on January 1, 2018, investments in equity securities are still stated at fair value, quoted by market prices, but all unrealized holding gains and losses are credited or charged to net income (loss) based on fair value measurement as the respective reporting date. 
The Company accounts for certain of its investments in equity securities in accordance with ASU 2016-01 Financial Instruments—Overall (Subtopic 825- 10): Recognition and Measurement of Financial Assets and Financial Liabilities (“ASU 2016-01”). In accordance with ASU 2016-01, the Company records all equity investments with readily determinable fair values at fair value calculated by the publicly traded stock price at the close of the reporting period. Holista CollTech Limited (“Holista”), Amarantus BioScience Holdings, Inc. (“AMBS”) True Partner Capital Holding Limited (“True Partner”) and Lucy Scientific Discovery Inc. (“Lucy”) are publicly traded companies. The Company does not have significant influence over Holista, AMBS, True Partner and Lucy, as the Company is the beneficial owner of approximately 14.7% of common shares of Holista, 4.3% of the common shares of AMBS and less than 0.1% of common shares of True Partner. The stock’s fair value is determined by quoted stock prices. The Company disposed the shares of Lucy in the first six months of 2023.

Since 2021, the Company’s subsidiaries have maintained a portfolio of trading securities. The objective is to generate profits on short-term differences in market prices. The Company does not have significant influence over any trading securities in our portfolio and fair value of these trading securities are determined by reference to quoted stock prices.

F-9

The Company has elected the fair value option for the equity securities noted below that would otherwise be accounted for under the equity method of accounting. Amarantus BioScience Holdings (“AMBS”), Holista CollTech Limited (“Holista”), Document Securities SystemsDSS, Inc. (“DSS”), AlsetNew Electric CV Corporation (“NECV” formerly known as “American Premium Mining Corporation” (“APM”)), Value Exchange International Inc. (“Value Exchange International” or “VEII”) and American Premium Water CorpSharing Services Global Corp. (“APW”SHRG”) are publicly traded companies and fair value is determined by quoted stock prices. The Company has significant influence but does not have a controlling interest in these investments, and therefore, the Company’s investment could be accounted for under the equity method of accounting or elect fair value accounting.

F-11

The Company has significant influence over DSS. As of June 30, 2023 and December 31, 2022, the Company owned approximately 44.8% of the common stock of DSS, respectively. Our CEO is a stockholder and the Chairman of the Board of Directors of DSS. Chan Tung Moe, our Co-Chief Executive Officer and the son of Chan Heng Fai, is also a director of DSS. William Wu, Wong Shui Yeung and Joanne Wong Hiu Pan, directors of the Company, are each also directors of DSS.

The Company has significant influence over NECV as the Company is the beneficial owner of approximately 0.5% of the common shares of NECV and one officer from the Company held a director position on NECV’s Board of Directors until April of 2023. Additionally, our CEO is a significant stockholder of NECV shares.

The Company has significant influence over Value Exchange International as the Company is the beneficial owner of approximately 38.3% of the common shares of VEII. Mr. Chan and another member of the Board of Directors of Hapi Metaverse, Lum Kan Fai Vincent, are both members of the Board of Directors of VEII. In addition to Mr. Chan, two other members of the Board of Directors of Alset Inc. are also members of the Board of Directors of VEII (Mr. Wong Shui Yeung and Mr. Wong Tat Keung).
The Company has significant influence over SHRG as the Company is the beneficial owner of approximately 33.4% of the common shares of SHRG, our CEO holds a director position on SHRG’s Board of Directors and one of the officers of the Company is the CFO of SHRG. Additionally, our CEO is a significant stockholder of SHRG shares.

On March 2, 2020 and October 29, 2021, the Company received warrants to purchase shares of American Medical REIT Inc. (“AMRE”), a related party private company, in conjunction with the Company lending two $200,000 promissory notes. For further details on this transaction, refer to Note 8 - Related Party Transactions, Note Receivable from a Related Party Company. As of SeptemberJune 30, 2020,2023 and December 31, 2022, AMRE was a private company. Based on management’s analysis, the fair value of the AMRE warrants was $0 as of December 31, 2021. In March 2022 both loans, together with warrants were converted into common shares of AMRE. After the conversion, the Company owns 9.7%approximately 15.8% of the common stock of DSS and 46,868 shares of preferred stock, which could covert to 7,232,716 common shares, subject to a 19.9% beneficial ownership conversion limitation (a so-called “blocker”) based on the total issued outstanding shares of common stock of DSS beneficially owned by Global BioMedical Pte Ltd (“GBM”), one of our subsidiaries. Our CEO is the owner of approximately 14.5% of the outstanding shares of DSS (not including any common or preferred shares we hold) and is a member of the Board of Directors of DSS. Chan Tung Moe, the son of Chan Heng Fai, is also a director of DSS.

The Company has significant influence over AMBS as the Company is the beneficial owner of approximately 19.5% of the common shares of AMBS.
The Company has significant influence over Holista as the Company and its CEO are the beneficial owner of approximately 16.8% of the outstanding shares of Holista, and our CEO holds a position on Holista's Board of Directors.
The Company has significant influence over APW as the Company is the beneficial owner of approximately 9.99% of the common shares of APW.
The Company had significant influence over Alset International during the period of deconsolidation as the company’s beneficial ownership ranged between 49.62% and 49.11% in that period and our CEO is the CEO of Alset international. Chan Heng Fai is a director of both companies.
AMRE.

The Company accounts for certain of its investments in real estate funds without readily determinable fair values in accordance with ASU No. 2015-07, Fair Value Measurement (Topic 820): Disclosures for Investments in Certain Entities That Calculate Net Asset Value per Share (or Its Equivalent) (“ASC 820”2015-07”). AsIn the first six months of December 31, 20192022 the Company maintained an investmentinvested $100,000 in a real estate fund, TheClass A Shares of Novum Alpha Global Opportunity Fund.Digital Asset Fund I SP, a segregated portfolio of Novum Alpha SPC (“Novum Alpha Fund”). This fund invests primarily in the U.S. and met the criteria within ASC 820. Chan Heng Fai, the Chairman and CEO of the Company, was also one of the directors of the Global Opportunity Fund. The fair values of the investments in this class have been estimated using the net asset value of the Company’s ownership interest in Global Opportunity Fund. The fund was closed during November 2019 and is being liquidated. As of December 31, 2019, the Company recorded a receivable $307,944 from the Global Opportunity Fund. These monies were received on January 23, 2020.

long-short digital assets. The Company invested $50,000subscribed in a convertible promissory note of Sharing Services, Inc. (“Sharing Services Convertible Note”), a company quoted onparticipating shares which are redeemable and non-voting. The Company closed the US OTC market. The value of the convertible note was estimated by management using a Black-Scholes valuation model. The fair value of the note was $77,477 and $26,209 on September 30, 2020 and December 31, 2019, respectively.
On March 2, 2020, the Company received warrants to purchase shares of American Medical REIT Inc. (“AMRE”), a related party private startup company,fund in conjunction with the Company lending a $200,000 promissory note. For further detailsJuly 2022 recording $74,827 loss on this transaction, refer to Note 8 Related Party Transactions, Note Receivable from a Related Party Company. The Company holds a stock option to purchase 250,000 shares of Vivacitas common stock at $1 per share at any time prior to the date of public offering. As of September 30, 2020 and December 31, 2019, both AMRE and Vivacitas were private companies. Based on management’s analysis, the fair value of the warrants and the stock option was $0 as of September 30, 2020 and December 31, 2019.
On July 17, 2020, the Company purchased 122,039,000 shares, approximately 9.99% ownership, and 122,039,000 warrants with an exercise price of $0.0001 per share, from APW, for an aggregated purchase price of $122,039. Based on the management’s analysis, the fair value of the warrants from APW was $0 as of September 30, 2020.
F-12
On April 27, 2020, Global BioMedical Pte Ltd (“GBM”), one of our subsidiaries, entered into a share exchange agreement with DSS BioHealth Security, Inc. (“DBHS”), a wholly owned subsidiary of Document Securities Systems Inc. (“DSS”), a related party of the Company, pursuant to which, DBHS agreed to acquire all of the outstanding capital stock of Impact BioMedical Inc., a wholly owned subsidiary of GBM, through a share exchange. On August 21, 2020, the transaction closed and Impact BioMedical Inc became a direct wholly owned subsidiary of DBHS. GBM received 483,334 shares of DSS common stock and 46,868 shares of DSS preferred stock, which preferred shares could be converted to 7,232,716 common shares. The Company has elected the fair value option for the DSS common stock that would otherwise be accounted for under the equity method of accounting. We value DSS preferred stock under level 3 category through a Monte Carlo simulation model. As of September 30, 2020, the fair market value of the DSS preferred stock was $54,864,632. For further details on this transaction, refer to Note 8 – Related Party Transactions, Note 11 – Discontinued Operations and Note 12 – Investments Measured at Fair Value.
The changes in the fair values of the investment were recorded directly to accumulated other comprehensive income (loss). Due to the inherent uncertainty of these estimates, these values may differ materially from the values that would have been used had a ready market for these investments existed. 
investment.

Investment Securities at Cost

The Company has an

Investments in equity holding in Vivacitas Oncology Inc. (“Vivacitas”), a private company that is currently not listed on an exchange. Vivacitas was acquired after the adoption of ASU 2016-01. The Company applied ASC 321, Investments – Equity Securities, and elected the measurement alternative for equity investments that do not havesecurities without readily determinable fair values and do not qualify for the practical expedient in ASC 820 to estimate fair value using the NAV per share. Under the alternative, we measure Vivacitasare measured at cost less anyminus impairment plus or minus changes resulting fromadjusted by observable price changes in orderly transactions for anthe identical or a similar investment of the same issuer.

These investments are measured at fair value on a nonrecurring basis when there are events or changes in circumstances that may have a significant adverse effect. An impairment loss is recognized in the condensed consolidated statements of comprehensive income equal to the amount by which the carrying value exceeds the fair value of the investment.

On September 8, 2020, the Company acquired 1,666 shares, approximately 1.45%1.45% ownership, from Nervotec Pte Ltd (“Nervotec”), a private company, at the purchase price of $36,628.$37,826. The Company applied ASC 321 and measured Nervotec at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer.

On September 30, 2020, the Company acquired 3,800 shares, representing the ownership of approximately 19%, from HWH World Company Limited (f.k.a. Hyten Global (Thailand) Co., Ltd.) (“HWH World Co.”), a private company, at a purchase price of $42,562.

F-10

During 2021, the Company invested $19,609 in K Beauty Research Lab Co., Ltd (“K Beauty”) for 18% of such company. K Beauty was established for sourcing, developing and producing variety of Korea-made beauty products as well as Korea - originated beauty contents for the purpose of distribution to HWH’s membership distribution channel.

There has been no indication of impairment or changes in observable prices via transactions of similar securities and investments are still carried at cost.

Investment Securities under

Equity Method Accounting

Investment

The Company accounts for equity investment in entities with significant influence under equity-method accounting. Under this method, the Group’s pro rata share of income (loss) from investment is recognized in the condensed consolidated statements of comprehensive income. Dividends received reduce the carrying amount of the investment. When the Company’s share of loss in an equity-method investee equals or exceeds its carrying value of the investment in that entity, the equity method investment can be reduced below zero based on losses, if the Company either is liable for the obligations of the investee or provides for losses in excess of the investment when imminent return to profitable operations by the investee appears to be assured. Otherwise, the Company does not recognize its share of equity method losses exceeding its carrying amount of the investment, but discloses the losses in the footnotes. Equity-method investment is reviewed for impairment by assessing if the decline in market value of the investment below the carrying value is other-than-temporary. In making this determination, factors are evaluated in determining whether a loss in value should be recognized. These include consideration of the intent and ability of the Group to hold investment and the ability of the investee to sustain an earnings capacity, justifying the carrying amount of the investment. Impairment losses are recognized in other expense when a decline in value is deemed to be other-than-temporary.

American Medical REIT Inc.

LiquidValue Asset Management Pte. Ltd. (“LiquidValue”), a subsidiary of the Company, owns 36.1%15.8% of American Medical REIT Inc. (“AMRE”), as of June 30, 2023, a startup REIT company concentrating on medical real estate. AMRE acquires state-of-the-art, purpose-built healthcare facilities and leases them to leading clinical operators with dominant market share under secure triple net leases. AMRE targets hospitals (both Critical Access and Specialty Surgical), Physician Group Practices, Ambulatory Surgical Centers, and other licensed medical treatment facilities. Chan Heng Fai, our Chairman and CEO, is the executive chairman and director of AMRE. LiquidValue did not invest equity but provided a loanDSS, of which we own 44.8% and have significant influence over, owns 80.8% of AMRE. Therefore, the Company has significant influence on AMRE.

American Pacific Bancorp, Inc.

Pursuant to AMRE (For further details on this transaction, refer to Note 8, Related Party Transactions)Securities Purchase Agreement from March 12, 2021 the Company purchased 4,775,523 shares of the common stock of American Pacific Bancorp Inc. (“APB”) and gained majority ownership in that entity. APB was consolidated into the Company under common control accounting (See Transactions between Entities under Common Control for details). On balance sheet,September 8, 2021 APB sold 6,666,700 shares Series A Common Stock to DSS, Inc. for $40,000,200 cash. As a result of the prorate loss from AMREnew share issuances, the Company’s ownership percentage of APB fell below 50% to 41.3%, and subsequently to 36.9% and the entity was recorded as a liability, accumulated losses ondeconsolidated in accordance with ASC 810-10. Upon deconsolidation the Company elected to apply the equity method investment.accounting as the Company still retained significant influence. As a result of the deconsolidation, the Company recognized gain of approximately $28.2 million. The gain represents the difference between the fair value of retained equity method investment of $30.8 million and the investment percentage of carrying amount of APB’s net assets of $2.9 million. Considering the transaction was between related parties, the Company recorded the gain as additional paid in capital in its equity. During three and six months ended SeptemberJune 30, 2020 and 2019,2023 the investment losses from AMRE were $52,392gain was $136,751 and $0, respectively. During nine$119,002, respectively, and during three and six months ended SeptemberJune 30, 2020 and 2019,2022 the investment losses from AMRE were $193,132gain was $18,678 and $0,$160,021, respectively. As of SeptemberJune 30, 2020,2023 and December 31, 2019,2022, the accumulated losses on equity method investment were $231,418in APB was $31,787,248 and $0,$31,668,246, respectively.

F-11
Sweet Sense, Inc.
BioLife Sugar,

Ketomei Pte Ltd

On June 10, 2021 the Company’s indirect subsidiary Hapi Cafe Inc. (“BioLife’Hapi Cafe”) lent $76,723 to Ketomei Pte Ltd (“Ketomei”). On March 21, 2022 Hapi Cafe entered into an agreement pursuant to which the principal of the loan together with accrued interest were converted into an investment in Ketomei. At the same time, Hapi Cafe invested an additional $179,595 in Ketomei. After the conversion and fund investment the Company now holds 28% of Ketomei. Ketomei is in the business of selling cooked food and drinks. During three and six months ended June 30, 2023 and 2022 the investment loss was $10,446 and $63,645, aand $29,786 and $33,059, respectively. Investment in Ketomei was $143,757 and $207,402 at June 30, 2023 and December 31, 2022, respectively.

Sentinel Brokers Company Inc.

On May 22, 2023 the Company’s indirect subsidiary, consolidated under Alset InternationalSeD Capital Pte Ltd (“SeD Capital”), entered into a joint venture agreement on April 25, 2018 with Quality Ingredients, LLC (“QI”Stock Purchase Agreement, pursuant to which SeD Capital purchased 39.8 shares (19.9%). The agreement created an entity called Sweet Sense, of the Common Stock of Sentinel Brokers Company Inc. (“Sweet Sense”Sentinel”) which is 50% owned by BioLife and 50% owned by QI. Management believes its 50% investment represents significant influence over Sweet Sense and accounts for the investment underaggregate purchase price of $279,719. Sentinel is a broker-dealer operating primarily as a fiduciary intermediary, facilitating institutional trading of municipal and corporate bonds as well as preferred stock, and is registered with the equity method of accounting.

F-13
On November 8, 2019, Impact BioMedical Inc., a subsidiary of the Company, purchased 50% of Sweet Sense from QI for $91,000Securities and recorded a loss from acquisition $90,001. As of November 8, 2019, the total investment in joint venture was equal to $91,000 and the proportionate losses totaled $90,001. The transaction was not in the scope of ASC 805 Business Combinations since the acquisition was accounted for an asset purchase instead of a business combination. As an asset acquisition, the Company recorded the transaction at cost and applied ASC 730 to expense in-process research and development cost, the major cost of Sweet Sense. Consequently, Sweet Sense was an 81.8% owned subsidiary of Impact BioMedical Inc. and therefore, was consolidated into the Company’s condensed consolidated financial statements as of September 30, 2020 and December 31, 2019. During the three and nine month ended September 30, 2019, the investment losses from Sweet Sense were $894 and $30,166, respectively. As a subsidiary of Impact BioMedical Inc., Sweet Sense was in the discontinued operations of Impact BioMedical Inc.  For further details on this transaction, refer to Note 11 Discontinued Operations.
Veganburg International Pte. Ltd.
On February 5, 2020, SeD Capital Pte Ltd, a subsidiary of the Company, invested $2,176 in VeganBurg International Pte. Ltd. (“VeganBurg International”), a related party company, in exchange for 30% ownership of such company. Chan Heng Fai, our founder, Chairman and Chief Executive Officer,Exchange Commission, is a member of the BoardFinancial Industry Regulatory Authority, Inc. (“FINRA”), and is a member of Directors of VeganBurg International andthe Securities Investor Protection Corporation (“SIPC”). The Company has significant influence over Sentinel as its CEO holds a director position on such company. VeganBurg International is focusedSentinel’s Board of Directors. Additionally, DSS, of which we own 44.8% and have significant influence over, owns 80.1% of Sentinel. During three and six months ended June 30, 2023 the investment loss in Sentinel was $7,990 and $7,990, respectively. Investment in Sentinel was $271,729 at June 30, 2023.

Investment in Debt Securities

Debt securities are reported at fair value, with unrealized gains and losses (other than impairment losses) recognized in accumulated other comprehensive income or loss. Realized gains and losses on promoting environmentally friendly, healthy plant-based burgersdebt securities are recognized in the Asiannet income in the condensed consolidated statements of comprehensive income. The Company monitors its investments for other-than-temporary impairment by considering factors including, but not limited to, current economic and market conditions, the operating performance of the companies including current earnings trends and other company-specific information.

The Company invested $50,000 in a convertible promissory note of Sharing Services Global Corporation (“SHRG Convertible Note”), a company quoted on the US OTC market. VeganBurg InternationalThe value of the convertible note was estimated by management using a Black-Scholes valuation model. The fair value of the note was $9,799 on December 31, 2021. The note was redeemed on July 14, 2022 and $50,000 principal together with $28,636 accrued interests were received from Sharing Services.

On February 26, 2021, the Company invested approximately $88,599 in the convertible note of Vector Com Co., Ltd (“Vector Com”), a private company in South Korea. The interest rate is 2% per annum and maturity is two years. The conversion price is approximately $21.26 per common share of Vector Com. As of June 30, 2023 and December 31, 2022, our management estimated the fair value of the note to be $88,599, the initial transaction price.

Variable Interest Entity

Under Financial Accounting Standards Board (“FASB”) Accounting Standard Codification (“ASC”) 810, Consolidation, when a reporting entity is the primary beneficiary of an entity that is a variable interest entity (“VIE”), as defined in ASC 810, the VIE must be consolidated into the financial statements of the reporting entity. The determination of which owner is the primary beneficiary of a VIE requires management to make significant estimates and judgments about the rights, obligations, and economic interests of each interest holder in the VIE.

The Company evaluates its interests in VIEs on an ongoing basis and consolidates any VIE in which it has no operations till September 30, 2020a controlling financial interest and $2,194 was recorded as investment in Securities at equity method on balance sheet on September 30, 2020.is deemed to be the primary beneficiary. A controlling financial interest has both of the following characteristics: (i) the power to direct the activities of the VIE that most significantly impact its economic performance; and (ii) the obligation to absorb losses of the VIE that could potentially be significant to it or the right to receive benefits from the VIE that could be significant to the VIE.

F-12

Real Estate Assets

Real estate assets are recorded at cost, except when real estate assets are acquired that meet the definition of a business combination in accordance with Financial Accounting Standards Board (“FASB”) ASC 805 - “Business Combinations”, which acquired assets are recorded at fair value. Interest, property taxes, insurance and other incremental costs (including salaries) directly related to a project are capitalized during the construction period of major facilities and land improvements. The capitalization period begins when activities to develop the parcel commence and ends when the asset constructed is completed. The capitalized costs are recorded as part of the asset to which they relate and are reduced when lots are sold.

The Company capitalized interestconstruction costs of approximately $6.3 million and finance expenses from third-party borrowings of $0 and $43,020$2.6 million for the three months ended SeptemberJune 30, 20202023 and 2019,2022, respectively. The Company capitalized construction costs of $2,763,068approximately $8.8 million and $1,464,998$3 million for the threesix months ended SeptemberJune 30, 20202023 and 2019,2022, respectively. The Company capitalized interest and finance expenses from third-party borrowings of $0 and $514,985 for the nine months ended September 30, 2020 and 2019, respectively. The Company capitalized construction costs of $8,898,329 and $5,023,396 for the nine months ended September 30, 2020 and 2019, respectively. 

The Company’s policy is to obtain an independent third-party valuation for each major project in the United States as part of our assessment of identifying potential triggering events for impairment. Management may use the market comparison method to value other relatively small projects, such as the project in Perth, Australia.Australia, which was completed during the year 2022. In addition to the annual assessment of potential triggering events in accordance with ASC 360 – Property Plant and Equipment (“ASC 360”), the Company applies a fair value basedvalue-based impairment test to the net book value assets on an annual basis and on an interim basis if certain events or circumstances indicate that an impairment loss may have occurred.

F-13

The Company did not record impairment on any of its projects during the three and six months ended on June 30, 2023 and 2022.

Recent Agreements to Sell Lots

On October 12, 2018,28, 2022, 150 CCM Black Oak Ltd. (the “Seller”), a Texas Limited Partnership and subsidiary of the Company, entered into a Contract for Purchase and Sale and Escrow Instructions (the “Agreement”) with Century Land Holdings of Texas, LLC, a Colorado limited liability company (the “Buyer”). Pursuant to the terms of the Agreement, the Seller agreed to sell approximately 242 single-family detached residential lots comprising a residential community in the city of Magnolia, Texas known as the “Lakes at Black Oak.” On November 28, 2022, the parties to the Agreement entered into an Amended and Restatedamendment to the Agreement (the “Amendment”). Pursuant to the Amendment, the parties agreed that the Buyer would purchase approximately 131 single-family detached residential lots, instead of 242 lots. This transaction closed on April 13, 2023.

On March 16, 2023, 150 CCM Black Oak Ltd. (the “Seller”) entered into a Purchase and Sale Agreement for 124 lots.(the “Purchase and Sale Agreement”) with Rausch Coleman Homes Houston, LLC, a Texas limited liability company (“Rausch Coleman”). Pursuant to the Amended and Restatedterms of the Purchase and Sale Agreement, the purchase price remained $6,175,000,Seller has agreed to sell approximately 110 single-family detached residential lots which comprise a section of the Lakes at Black Oak. The transaction closed on May 15, 2023.

On March 17, 2023, 150 CCM Black Oak Ltd. was required(the “Seller”) entered into a Purchase and Sale Agreement (the “Purchase and Sale Agreement”) with Davidson Homes, LLC, an Alabama limited liability company (“Davidson”). Pursuant to meet certain closing conditionsthe terms of the Purchase and Sale Agreement, the timing for the closing was extended. On January 18, 2019, theSeller has agreed to sell approximately 189 single-family detached residential lots developed within section 2 of Black Oak project. The sale of 124the first 94 lots closed on May 30, 2023. The sale of remaining lots is estimated to close at the Company’s Black Oak project in Magnolia, Texas was completed. After allocating costsend of revenue to this sale, the Company incurred a loss of approximately $1.5 million from this sale and recognized a real estate impairment of approximately $1.5 million for the year ended December 31, 2018. 

On June 30, 2019, the Company recorded approximately $3.9 million of impairment on the Black Oak project based on discounted estimated future cash flows after updating the projection of market value of the project.
F-14
On December 31, 2019, the Company recorded approximately $1.3 million of additional impairment on the Black Oak project based on discounted estimated future cash flows after updating the projected cost of the project.
2023.

Properties under development

Properties under development are properties being constructed for sale in the ordinary course of business, rather than to be held for the Company’s own use, rental or capital appreciation.

Equipment
Property

Rental Properties

Rental properties are acquired with the intent to be rented to tenants. As of June 30, 2022 and equipmentDecember 31, 2022, the Company owned 132 homes. The aggregate purchase cost of all the homes is $30,998,258. These homes are recordedlocated in Montgomery and Harris Counties, Texas. All of these purchased homes are properties of our rental business.

Investments in Single-Family Residential Properties

The Company accounts for its investments in single-family residential properties as asset acquisitions and records these acquisitions at cost, less depreciation. Repairstheir purchase price. The purchase price is allocated between land, building, improvements and maintenanceexisting leases based upon their relative fair values at the date of acquisition. The purchase price for purposes of this allocation is inclusive of acquisition costs which typically include legal fees, title fees, property inspection and valuation fees, as well as other closing costs.

Building improvements and buildings are expensed as incurred. Expenditures incurred as a consequence of acquiring or using the asset, or that increase the value or productive capacity of assets are capitalized (such as removal, and restoration costs). When property and equipment is retired, sold, or otherwise disposed of, the asset’s carrying amount and related accumulated depreciation are removed from the accounts and any gain or loss is included in operations. Depreciation is computed by the straight-line method (after considering their respective estimated residual values)depreciated over the estimated useful lives of approximately 10 to 27.5 years, respectively, using the respective assets as follows: 

Office and computer equipment3 - 5 years
Furniture and fixtures3 - 5 years
Vehicles10 years
Leasehold ImprovementsRemaining life of the lease
straight-line method.

The Company reviews the carrying value of property and equipmentassesses its investments in single-family residential properties for impairment whenever events andor changes in business circumstances indicate that carrying amounts of the carrying value of an assetassets may not be recoverable fromfully recoverable. When such events occur, management determines whether there has been impairment by comparing the estimated future cash flows expected to result from its use and eventual disposition. In cases where undiscounted expected future cash flows are less than theasset’s carrying value anwith its fair value. Should impairment lossexist, the asset is recognized equalwritten down to an amount by which the carrying value exceeds theits estimated fair value of assets.value. The factors considered by management in performing this assessment include current operating results, trends,Company did not recognize any impairment losses during three and prospects, as well as the effects of obsolescence, demand, competition,six months ended June 30, 2023 and other economic factors.2022.

F-14

Revenue Recognition and Cost of Sales

Revenue

ASC 606 - Revenue from Contracts with Customers (" (“ASC 606"606”), establishes principles for reporting information about the nature, amount, timing and uncertainty of revenue and cash flows arising from the entity'sentity’s contracts to provide goods or services to customers. The Company adopted this new standard on January 1, 2018 under the modified retrospective method. The adoption of this new standard did not have a material effect on our financial statements.

In accordance with ASC 606, revenue is recognized when a customer obtains control of promised goods or services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for these goods or services. The provisions of ASC 606 include a five-step process by which the determination of revenue recognition, depicting the transfer of goods or services to customers in amounts reflecting the payment to which the Company expects to be entitled in exchange for those goods or services. ASC 606 requires the Company to apply the following steps:

(1) identify the contract with the customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when, or as, performance obligations are satisfied.

F-15

The following represents the Company’s revenue recognition policies by Segments:

Property Development

Real Estate

Property Sales

The Company'sCompany’s main business is land development. The Company purchases land and develops it for building into residential communities. The developed lots are sold to builders (customers) for the construction of new homes. The builders enter ainto sales contractcontracts with the Company before they take the lots. The prices and timeline are determined and agreed upon in the contract.contracts. The builders do the inspections to make sure all conditions and requirements in contracts are met before purchasing the lots. A detailed breakdown of the five-step process for the revenue recognition of the Ballenger project and Black Oak projects,project, which represented approximately 99%0% and 94%,42% for Ballenger and 91% and 0% for Black Oak, respectively, of the Company’s revenue in the ninesix months ended on SeptemberJune 30, 20202023 and 2019,2022, is as follows:

Identify the contract with a customer.

The Company has signed agreements with the builders for developing the raw land to ready to build lots. The contract has agreed upon prices, timelines, and specifications for what is to be provided.

Identify the performance obligations in the contract.

Performance obligations of the Company include delivering developed lots to the customer, which are required to meet certain specifications that are outlined in the contract. The customer inspects all lots prior to accepting title to ensure all specifications are met.

 ●Determine the transaction price.

The transaction price per lot is fixed and specified in the contract. Any subsequent change orders or price changes are required to be approved by both parties.

Allocate the transaction price to performance obligations in the contract.

Each lot or a group of lots is considered to be a separate performance obligation, for which the specified price in the contract is allocated to.

Recognize revenue when (or as) the entity satisfies a performance obligation.

F-15

The builders do the inspections to make sure all conditions/requirements are met before taking title of lots. The Company recognizes revenue at a point in time when title is transferred. The Company does not have further performance obligations or continuing involvement once title is transferred.

Rental Revenue

The Company leases real estate properties to its tenants under leases that are predominately classified as operating leases, in accordance with ASC 842, Leases (“ASC 842”). Real estate rental revenue is comprised of minimum base rent and revenue from the collection of lease termination fees.

Rent from tenants is recorded in accordance with the terms of each lease agreement on a straight-line basis over the initial term of the lease. Rental revenue recognition begins when the tenant controls the space and continues through the term of the related lease. Generally, at the end of the lease term, the Company provides the tenant with a one-year renewal option, including mostly the same terms and conditions provided under the initial lease term, subject to rent increases.

The Company defers rental revenue related to lease payments received from tenants in advance of their due dates. These amounts are presented within deferred revenues and other payables on the Company’s condensed consolidated balance sheets.

Rental revenue is subject to an evaluation for collectability on several factors, including payment history, the financial strength of the tenant and any guarantors, historical operations and operating trends of the property, and current economic conditions. If our evaluation of these factors indicates that it is not probable that we will recover substantially all of the receivable, rental revenue is limited to the lesser of the rental revenue that would be recognized on a straight-line basis (as applicable) or the lease payments that have been collected from the lessee. Differences between rental revenue recognized and amounts contractually due under the lease agreements are credited or charged to straight-line rent receivable or straight-line rent liability, as applicable. For the three and six months ended June 30, 2023, the Company did not recognize any deferred revenue and collected all rents due.

Sale of the Front Foot Benefit Assessments

We have established a front foot benefit (“FFB”) assessment on all of the NVR lots. This is a 30-year annual assessment allowed in Frederick County which requires homeowners to reimburse the developer for the costs of installing public water and sewer to the lots. These assessments become effective as homes are settled, at which time we can sell the collection rights to investors who will pay an upfront lump sum, enabling us to more quickly realize the revenue. The selling prices range from $3,000 $3,000 to $4,500$4,500 per home depending the type of the home. Our total revenue from the front foot benefit assessment is approximately $1$1 million. To recognize revenue of the FFB assessment, both our and NVR’s performance obligation have to be satisfied. Our performance obligation is completed once we complete the construction of water and sewer facility and close the lot sales with NVR, which inspects these water and sewer facility prior to close lot sales to ensure all specifications are met. NVR’s performance obligation is to sell homes they build to homeowners. Our FFB revenue is recognized on quarterly basis after NVR closes sales of homes to homeowners. The agreement with these FFB investors is not subject to amendment by regulatory agencies and thus our revenue from the FFB assessment is not either. During the nine months ended on September 30, 2020 and 2019, we recognized revenue $169,349 and $365,645 from FFB assessment, respectively. During the three months ended on SeptemberJune 30, 20202023 and 2019,2022, we recognized revenue $54,147of $0 and $129,031$37,725 from the FFB assessment,assessments, respectively.

F-16
During the six months ended on June 30, 2023 and 2022, we recognized revenue of $0 and $116,088 from the FFB assessments, respectively.

Cost of Sales

Revenues

Real Estate

Cost of Real Estate Sale

All of the costs of real estate sales are from our land development business. Land acquisition costs are allocated to each lot based on the area method, the size of the lot comparing to the total size of all lots in the project. Development costs and capitalized interest are allocated to lots sold based on the total expected development and interest costs of the completed project and allocating a percentage of those costs based on the selling price of the sold lot compared to the expected sales values of all lots in the project.

F-16

If allocation of development costs and capitalized interest based on the projection and relative expected sales value is impracticable, those costs could also be allocated based on area method, the size of the lot comparing to the total size of all lots in the project.

Cost of Rental Revenue

Cost of rental revenue consists primarily of the costs associated with management and leasing fees to our management company, repairs and maintenance, depreciation and other related administrative costs. Utility expenses are paid directly by tenants.

Biohealth

Product Direct Sales

Product Direct Sales

The Company’s net sales consist of product sales. The Company'sCompany’s performance obligation is to transfer ownership of its products to its third-party independent distributors (“Distributors”).members. The Company generally recognizes revenue when product is shippeddelivered to its Distributors. 

The Company’s Distributors may receive distributormembers. Revenue is recorded net of applicable taxes, allowances, which are comprised of discounts, rebates and wholesale commission payments from the Company. Distributor allowances resulting from the Company’s sales of its products to its Distributors are recorded against net sales because the distributor allowances represent discounts from the suggested retail price.
In addition to distributor allowances, the Company compensates its sales leader Distributors with leadership incentives for services rendered, relating to the development, retention, and management of their sales organizations. Leadership Incentives are payable based on achieved sales volume, which are recorded in general and administrative expenses. The Company recognizes revenue when it ships products.refund or returns. The Company receives the net sales price in cash or through credit card payments at the point of sale.

If a Distributorany member returns a product to the Company on a timely basis, they may obtain a replacement product from the Company for such returned products. In addition,We do not have buyback program. However, when the Company maintainscustomer requests a buyback program pursuant to which it will repurchase products sold toreturn and management decides that the refund is necessary, we initiate the refund after deducting all the benefits that a Distributor whomember has decided to leave the business.earned. The returns are deducted from our sales revenue on our financial statements. Allowances for product and membership returns primarily in connection with the Company’s buyback program, are provided at the time the sale is recorded. This accrual is based upon historical return rates for each country and the relevant return pattern, which reflects anticipated returns to be received over a period of up to 12 months following the original sale.

Annual Membership
Product and membership returns for the three months ended June 30, 2023 and 2022 were approximately $0 and $15,412, respectively. Product and membership returns for the six months ended June 30, 2023 and 2022 were approximately $1,143 and $50,940, respectively.

Annual Membership

The Company collects an annual membership fee from its Distributors.members. The fee is fixed, paid in full at the time upon joining the membership and non-refundable.membership; the fee is not refundable. The membership providesCompany’s performance obligation is to provide its members the memberright to (a) purchase products from the Company, (b) access to purchase products at a discount, use to certain back officeback-office services, (c) receive commissions for signing up new members, and (d) attend corporate events. The Company recognizes revenue associated withperformance obligation is satisfied over time, generally over the term of the membership over the period of the membership.agreement which is for a one-year period. Before the membership fee is recognized as revenue, it is recorded as deferred revenue. Deferred revenue relating to membership was $3,046,687$0 and $258,594$21,198 at SeptemberJune 30, 20202023 and December 31, 2019.2022, respectively. Starting in 2020 the revenue from sale of membership declined to $0 in 2022. The Company is currently working on a new membership model.

Other Businesses

Food and Beverage

The Company, through Alset F&B One Pte. Ltd. (“Alset F&B One”) and Alset F&B (PLQ) Pte. Ltd. (“Alset F&B PLQ”) each acquired a restaurant franchise licenses at the end of 2021 and 2022 respectively, both of which have since commenced operations. These licenses will allow Alset F&B One and Alset F&B PLQ each to operate a Killiney Kopitiam restaurant in Singapore. Killiney Kopitiam, founded in 1919, is a Singapore-based chain of mass-market, traditional kopitiam style service cafes selling traditional coffee and tea, along with a range of local delicacies such as Curry Chicken, Laksa, Mee Siam, and Mee Rebus.

The Company, through Hapi Café Inc. (“HCI-T”), commenced operation of two cafés during 2022 and 2021, which are located in Singapore and South Korea.

F-17
Shipping

The cafes are operated by subsidiaries of HCI-T, namely Hapi Café SG Pte. Limited (“HCSG”) in Singapore and Handling

ShippingHapi Café Korea Inc. (“HCKI”) in Seoul, South Korea. Hapi Cafes are distinctive lifestyle café outlets that strive to revolutionize the way individuals dine, work, and handling services relatinglive, by providing a conducive environment for everyone to product sales are recognized as fulfillment activities. Shippingrelish the four facets – health and handling expenses were $0wellness, fitness, productivity, and $183,138 for the ninerecreation all under one roof.

In recent months ended September 30, 2020 and 2019, respectively. Shipping and handling expenses were $0 and $56,438 for the three months ended September 30, 2020 and 2019, respectively. Shipping and handling costs paid by the Company are includedincorporated two new subsidiaries Shenzhen Leyouyou Catering Management Co., Ltd. and Dongguan Leyouyou Catering Management Co., Ltd. in generalthe People’s Republic of China. Both companies will be principally engaged in the food and administrative expenses. 

F-17
Other Businesses
Mutual Fund Management Service Income
Revenue is recognized when (or as)beverage business in Mainland China.

Additionally, through its subsidiary MOC HK Limited, the Company performs services to its customersis focusing on operating café business in amounts that reflect the consideration to which the Company expects to be entitled to in exchange for those services, which occurs when (or as) the Company satisfies its contractual obligations and performs services to its customers. 

The Company generates revenue from providing management services for mutual fund customers. In respect to the provision of services, the agreements are less than one year with a cancellable clause and customers are typically billed on a monthly basis. 
During the three months ended September 30, 2020 and 2019, the Company recognized revenue of $0 and $8,495, respectively. During the nine months ended September 30, 2020 and 2019, the Company recognized revenue of $0 and $28,350, respectively.
Remaining performance obligations
Hong Kong.

Remaining performance obligations

As of SeptemberJune 30, 20202023 and December 31, 2019,2022, there were no remaining performance obligations or continuing involvement, as all service obligations within the other business activities segment have been completed.

Advertising
Costs incurred

Stock-Based Compensation

The Company accounts for advertisingstock-based compensation to employees in accordance with ASC 718, “Compensation-Stock Compensation”. ASC 718 requires companies to measure the cost of employee services received in exchange for an award of equity instruments, including stock options, based on the grant date fair value of the award and to recognize it as compensation expense over the period the employee is required to provide service in exchange for the award, usually the vesting period. Stock option forfeitures are recognized at the date of employee termination. Effective January 1, 2019, the Company are charged to operations as incurred. Advertising expensesadopted ASU 2018-07 for the nineaccounting of share-based payments granted to non-employees for goods and services. During the three and six months ended Septemberon June 30, 20202023 and 2019 were $136,253 and $156,822, respectively. Advertising expenses for2022, the three months ended September 30, 2020 and 2019 were $74,062 and $28,289, respectively. 

Company recorded $0 as stock-based compensation expense.

Foreign currency

Functional and reporting currency

Items included in the financial statements of each entity in the Company are measured using the currency of the primary economic environment in which the entity operates (“functional currency”). The financial statements of the Company are presented in U.S. dollars (the “reporting currency”).

The functional and reporting currency of the Company is the United States dollar (“U.S. dollar”). The financial records of the Company’s subsidiaries located in Singapore, Hong Kong, Australia and South Korea are maintained in their local currencies, the Singapore Dollar (S$), Hong Kong Dollar (HK$), Australian Dollar (“AUD”) and, South Korean Won (“KRW”) and Chinese Yuan (CN¥), which are also the functional currencies of these entities.

Transactions in foreign currencies

Transactions in currencies other than the functional currency during the yearperiods are converted into functional currency at the applicable rates of exchange prevailing when the transactions occurred. Transaction gains and losses are recognized in the statement of operations.

The majority of the Company’s foreign currency transaction gains or losses come from the effects of foreign exchange rate changes on the intercompany loans between Singapore entities and U.S. entities. The Company recorded $960,268 gain on foreign exchange during the nine months ended on September 30, 2020gain of $1,150,830 and a $438,608 gain during the nine months ended on September 30, 2019. The Company recorded foreign exchange loss of $415,203 and $757,068 gain$2,077,709 during the three months ended on SeptemberJune 30, 20202023 and 2019,2022, respectively. The Company recorded foreign exchange gain of $362,528 and $2,485,804 during the six months ended on June 30, 2023 and 2022, respectively. The foreign currency transactional gains and losses are recorded in operations.

F-18
F-18

Translation of consolidated entities’ financial statements

Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency at the rates of exchange ruling at the balance sheet date. The Company’s entities with functional currency of Singapore Dollar, Hong Kong Dollar,S$, HK$, AUD, KRW and KRW,CN¥, translate their operating results and financial positions into the U.S. dollar, the Company’s reporting currency. Assets and liabilities are translated using the exchange rates in effect on the balance sheet date. Revenue, expense, gains and losses are translated using the average rate for the year. Translation adjustments are reported as cumulative translation adjustments and are shown as a separate component of comprehensive income (loss).

For the nine months ended on September 30, 2020, the

The Company recorded other comprehensive loss of $2,183,883from foreign currency translation of $585,085, and a $325,518 loss infor the ninethree months ended SeptemberJune 30, 2019,2023 and $3,514,595 loss for the three months ended June 30, 2022, in accumulated other comprehensive loss. The Company recorded other comprehensive gainloss of $1,087,940 from foreign currency translation of $462,064 and $584,561 loss infor the threesix months ended SeptemberJune 30, 20202023 and 2019, respectively. 

Earnings (loss) per share
The Company presents basic and diluted earnings (loss) per share data for its ordinary shares. Basic earnings (loss) per share is calculated by dividing the profit or$ 4,163,735 loss attributable to ordinary shareholders of the Company by the weighted-average number of ordinary shares outstanding during the year, adjusted for treasury shares held by the Company.
Diluted earnings (loss) per share is determined by adjusting the profit or loss attributable to ordinary shareholders and the weighted-average number of ordinary shares outstanding, adjusted for treasury shares held, for the effects of all dilutive potential ordinary shares, which comprise convertible securities, such as stock options, convertible bonds and warrants. Due to the limited operations of the Company, there are no potentially dilutive securities outstanding on Septembersix months ended June 30, 2020 and 2019. 
Fair Value Measurements
ASC 820, Fair Value Measurement and Disclosures, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price)2022, in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. This topic also establishes a fair value hierarchy which requires classification based on observable and unobservable inputs when measuring fair value. There are three levels of inputs that may be used to measure fair value:
Level 1: Observable inputs such as quoted prices (unadjusted) in an active market for identical assets or liabilities.
Level 2: Inputsaccumulated other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.
Level 3: Unobservable inputs that are supported by little or no market activity; therefore, the inputs are developed by the Company using estimates and assumptions that the Company expects a market participant would use, including pricing models, discounted cash flow methodologies, or similar techniques.
The carrying value of the Company’s financial instruments, including cash and cash equivalents, accounts receivable and accounts payable and accrued expenses approximate fair value because of the short-term maturity of these financial instruments. The liabilities in connection with the conversion and make-whole features included within certain of the Company’s convertible notes payable and warrants are each classified as a level 3 liability.
F-19
comprehensive loss.

Non-controlling interests

Non-controlling interests represent the equity in subsidiary not attributable, directly or indirectly, to owners of the Company, and are presented separately in the condensed consolidated statements of operation and comprehensive income, and within equity in the Condensed Consolidated Balance Sheets, separately from equity attributable to owners of the Company.

On SeptemberJune 30, 20202023 and December 31, 2019,2022, the aggregate non-controlling interests in the Company were $41,672,434$10,363,141 and $6,975,459$11,009,149, respectively.

Capitalized Financing Costs

Financing costs, such as loan origination fee, administration fee, interests, and other related financing costs should be capitalized and recorded on the balance sheet, if these financing activities are directly associated with the development of real estate.

Capitalized financing costs are allocated to lots sold based on the total expected development and interest costs of the completed project and allocating a percentage of those costs based on the selling price of the sold lot compared to the expected sales values of all lots in the project. If the allocation of capitalized financing costs based on the projection and relative expected sales value is impracticable, those costs could also be allocated based on an area method, which uses the size of the lots compared to the total project area and allocates costs based on their size.

As of June 30, 2023 and December 31, 2022, the capitalized financing costs were $1,225,739 and $3,247,739, respectively.

Beneficial Conversion Features

The Company evaluates the conversion feature for whether it was beneficial as described in ASC 470-30. The intrinsic value of a beneficial conversion feature inherent to a convertible note payable, which is not bifurcated and accounted for separately from the convertible note payable and may not be settled in cash upon conversion, is treated as a discount to the convertible note payable. This discount is amortized over the period from the date of issuance to the date the note is due using the effective interest method. If the note payable is retired prior to the end of its contractual term, the unamortized discount is expensed in the period of retirement to interest expense. In general, the beneficial conversion feature is measured by comparing the effective conversion price, after considering the relative fair value of detachable instruments included in the financing transaction, if any, to the fair value of the shares of common stock at the commitment date to be received upon conversion.

F-19

Recent Accounting Pronouncements

Accounting pronouncement adopted

In February 2016,October 2021, the FASB issued ASU No. 2016-02, Leases2021-08, “Business Combinations (Topic 842) (“805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers.” ASU 2016-02”) which supersedes ASC Topic 840, Leases. ASU 2016-022021-08 requires lesseesthe company acquiring contract assets and contract liabilities obtained in a business combination to recognize a right-of-use asset and a lease liability on their balance sheets for allmeasure them in accordance with ASC 606, “Revenue from Contracts with Customers”. At the leases with terms greater than twelve months. Based on certain criteria, leases will be classifiedacquisition date, the company acquiring the business should record related revenue, as either financing or operating, with classification affectingif it had originated the pattern of expense recognitioncontract. Before the update such amounts were recognized by the acquiring company at fair value. The amendments in the income statement. For leases with a term of twelve months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and lease liabilities. If a lessee makes this election, it should recognize lease expense for such leases generally on a straight-line basis over the lease term. ASU 2016-02 isupdate are effective for fiscal years beginning after December 15, 2019 for emerging growth companies, and interim periods within those years, with early adoption permitted. In transition, lessees and lessors are required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach. In July 2018, the FASB issued ASU No. 2018-11, “Leases (Topic 842): Targeted Improvements” that allows entities to apply the provisions of the new standard at the effective date (e.g. January 1, 2019), as opposed to the earliest period presented under the modified retrospective transition approach (January 1, 2017) and recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. The modified retrospective approach includes a number of optional practical expedients primarily focused on leases that commenced before the effective date of Topic 842,2022, including continuing to account for leases that commence before the effective date in accordance with previous guidance, unless the lease is modified. The new leasing standard presents dramatic changes to the balance sheets of lessees. Lessor accounting is updated to align with certain changes in the lessee model and the new revenue recognition standard. The standard had a material impact on the Company’s condensed consolidated balance sheets, but did not have an impact on its condensed consolidated statements of operations. The most significant impact was the recognition of right-of-use assets and lease liabilities for operating leases. As a lessor of one home, this standard does not have material impact on the Company. The balances of operating lease right-of-use assets and operating lease liabilities as of September 30, 2020 were $546,519 and $541,887, respectively. Operating lease right-of-use assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As our leases do not provide a readily determinable implicit rate, we estimate our incremental borrowing rate to discount the lease payments based on information available at lease commencement. The operating lease right-of-use asset also includes any lease payments made and excludes lease incentives and initial direct costs incurred. The lease term includes options to extend or terminate when we are reasonably certain the option will be exercised. In general, we are not reasonably certain to exercise such options. We recognize lease expense for minimum lease payments on a straight-line basis over the lease term. We elected the practical expedient to not recognize operating lease right-of-use assets and operating lease liabilities for lease agreements with terms less than 12 months.

In July 2017, the FASB issued ASU No. 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception (“ASU 2017-11”). ASU 2017-11 is intended to simplify the accounting for financial instruments with characteristics of liabilities and equity. Among the issues addressed are: (i) determining whether an instrument (or embedded feature) is indexed to an entity’s own stock; (ii) distinguishing liabilities from equity for mandatorily redeemable financial instruments of certain nonpublic entities; and (iii) identifying mandatorily redeemable noncontrolling interests. The Company adopted ASU 2017-11 on January 1, 2019 and determined that this ASU does not have a material impact on the condensed consolidated financial statements. 
F-20
In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework: Changes to the Disclosure Requirements for Fair Value Measurement (“ASU 2018-13”). ASU 2018-13 is intended to improve the effectiveness of fair value measurement disclosures. ASU 2018-13 is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Early adoption is permitted.permitted, including in interim periods, for any financial statements that have not yet been issued. The Company determined that ASU 2018-13 did not have a material impactadopted these requirements prospectively, effective on its consolidated financial statements.
In response to the COVID-19 pandemic, the Coronavirus Aid, Relief and Economic Security Act (“CARES Act”) was signed into law in March 2020. The CARES Act lifts certain deduction limitations originally imposed by the Tax Cuts and Jobs Act of 2017 (“2017 Tax Act”). Corporate taxpayers may carryback net operating losses (NOLs) originating between 2018 and 2020 for up to five years, which was not previously allowed under the 2017 Tax Act. The CARES Act also eliminates the 80% of taxable income limitations by allowing corporate entities to fully utilize NOL carryforwards to offset taxable income in 2018, 2019 or 2020. Taxpayers may generally deduct interest up to the sum of 50% of adjusted taxable income plus business interest income (30% limit under the 2017 Tax Act) for 2019 and 2020. The CARES Act allows taxpayers with alternative minimum tax credits to claim a refund in 2020 for the entire amountfirst day of the credits instead of recoveringyear 2023.

In June 2016, the credits through refunds over a period of years, as originally enacted by the 2017 Tax Act.

In addition, the CARES Act raises the corporate charitable deduction limit to 25% of taxable income and makes qualified improvement property generally eligible for 15-year cost-recovery and 100% bonus depreciation. The enactment of the CARES Act did not result in any material adjustments to our income tax provision for the nine months ended September 30, 2020.
Accounting pronouncement not yet adopted
In December 2019, The FASB issued ASU 2019-12, Income TaxesNo. 2016-13, “Financial Instruments - Credit Losses (Topic 740)326): SimplifyingMeasurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). ASU 2016-13 requires financial assets measured at amortized cost to be presented at the Accounting for Income Taxes.net amount expected to be collected. The amendmentsmeasurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amounts. An entity must use judgment in this Update simplifydetermining the accounting for income taxes by removing certain exceptions to the general principlesrelevant information and estimation methods that are appropriate in Topic 740. The amendments also improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. For public business entities, the amendments in this Update areits circumstances. ASU 2016-13 is effective for fiscal years, andannual reporting periods beginning after December 15, 2019, including interim periods within those fiscal years, and a modified retrospective approach is required, with a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. In November of 2019, the FASB issued ASU 2019-10, which delayed the implementation of ASU 2016-13 to fiscal years beginning after December 15, 2020.2022 for smaller reporting companies. The Company is currently evaluatingadopted these requirements prospectively, effective on the impactfirst day of ASU 2020-04 on its future consolidated financial statements.
the year 2023.

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of Reference Rate Reform on Financial Reporting. The amendments in this Updateupdate provide optional expedients and exceptions for applying generally accepted accounting principles (GAAP) to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments in this Updateupdate apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The Company’s line of credit agreement provides procedures for determining a replacement or alternative rate in the event that LIBOR is unavailable. The amendments in this Updateupdate are effective for all entities as of March 12, 2020 through December 31, 2022.2024. The Company does not believe that ASU 2020-04 will have significant impact on its future consolidated financial statements.

Accounting pronouncement not yet adopted

In August 2020, the FASB issued ASU 2020-06, Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40) which simplifies the accounting for convertible instruments. The guidance removes certain accounting models which separate the embedded conversion features from the host contract for convertible instruments. Either a modified retrospective method of transition or a fully retrospective method of transition is permissible for the adoption of this standard. Update No. 2020-06 is effective for fiscal years beginning after December 15, 2023 for smaller reporting companies, including interim periods within those fiscal years. Early adoption is permitted no earlier than the fiscal year beginning after December 15, 2020. The Company is currently evaluating the impact of ASU 2020-042020-06 on its future consolidated financial statements.

3. CONCENTRATIONS

The Company maintains cash balances at various financial institutions in different countries. These balances are usually secured by the central banks’ insurance companies. At times, these balances may exceed the insurance limits. As of June 30, 2023 and December 31, 2022, uninsured cash and restricted cash balances were $26,119,471 and $15,723,599, respectively.

For the three months ended June 30, 2023, three customers accounted for approximately 37%, 36% and 27% of the Company’s property development revenue. For the three months ended June 30, 2022, two customers accounted for approximately 85%, and 15% of the Company’s property development revenue. For the six months ended June 30, 2023, three customers accounted for approximately 37%, 36%, and 27% of the Company’s property development revenue. For the six months ended June 30, 2022, three customers accounted for approximately 42%, 49% and 9% of the Company’s property development revenue.

F-20
3.SEGMENTS

4. SEGMENTS

Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision–making group, in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision-maker is the CEO. The Company operates in and reports four business segments: property development,real estate, digital transformation technology, biohealth, and other business activities. The Company’s reportable segments are determined based on the services they perform and the products they sell, not on the geographic area in which they operate. The Company’s chief operating decision maker evaluates segment performance based on segment revenue. Costs excluded from segment income (loss) before taxes and reported as “Other” consist of corporate general and administrative activities which are not allocable to the four reportable segments.

F-21

The following table summarizes the Company’s segment information for the following balance sheet dates presented, and for the ninesix months ended SeptemberJune 30, 20202023 and 2019:

2022:

SCHEDULE OF SEGMENT INFORMATION

  Real Estate  Digital Transformation Technology  Biohealth Business  Other  Total 
                
Six Months Ended on June 30, 2023                    
Revenue $19,515,728  $28,074  $12,786  $524,196  $20,080,784 
Cost of Sales  (12,168,470)  (9,139)  (109,657)  (140,508)  (12,427,774)
Gross Margin  7,347,258   18,935   (96,871)  383,688   7,653,010 
Operating Expenses  (992,201)  (202,430)  (477,917)  (2,960,696)  (4,633,244)
Operating Loss  6,355,057   (183,495)  (574,788)  (2,577,008)  3,019,766 
Other Income (Expense)  215,306   (1,091,514)  835,888   (13,116,034)  (13,156,354)
Net Loss Before Income Tax $6,570,363  $(1,275,009) $261,100  $(15,693,042) $(10,136,588)

  Real Estate  Digital Transformation Technology  Biohealth Business  Other  Total 
                
Six Months Ended on June 30, 2022                    
Revenue $1,924,916  $7,701  $749,693  $196,267  $2,878,577 
Cost of Sales  (1,625,942)  (2,792)  (11,985)  (24,508)  (1,665,227)
Gross Margin  298,974   4,909   737,708   171,759   1,213,350 
Operating Expenses  (1,320,957)  (159,976)  (910,246)  (2,129,974)  (4,521,153)
Operating (Loss) Income  (1,021,983)  (155,067)  (172,538)  (1,958,215)  (3,307,803)
Other Expense  209   (764,968)  (3,039,097)  (10,579,541)  (14,383,397)
Other Income (Expense)  209   (764,968)  (3,039,097)  (10,579,541)  (14,383,397)
Net Loss Before Income Tax $(1,021,774) $(920,035) $(3,211,635) $(12,537,756) $(17,691,200)
                     
June 30, 2023                    
Cash and Restricted Cash $2,209,538  $461,704  $991,986  $25,828,907  $29,492,135 
Total Assets  61,091,436   3,516,613   5,136,085   98,697,677   168,441,811 
                     
December 31, 2022                    
Cash and Restricted Cash $2,592,577  $514,260  $1,338,404  $14,076,662  $18,521,903 
Total Assets  57,951,324   3,184,416   4,861,615   87,492,981   153,490,336 

 
 
Property Development
 
 
Digital Transformation Technology
 
 
Biohealth Business
 
 
Other
 
 
Discontinued Operations
 
 
Total
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Nine Months Ended September 30, 2020
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue
 $7,148,786 
 $- 
 $31,133 
 $- 
 $- 
 $7,179,919 
Cost of Sales
  (5,603,164)
  - 
  (6,139)
  - 
  - 
  (5,609,303)
Gross Margin
  1,545,622 
  - 
  24,994 
  - 
  - 
  1,570,616 
Operating Expenses
  (634,254)
  (87,972)
  (388,083)
  (3,086,630)
  (416,950)
  (4,613,889)
Operating Income (Loss)
  911,368 
  (87,972)
  (363,089)
  (3,086,630)
  (416,968)
  (3,043,273)
Other Income (Expense)
  (2,646)
  115 
  (10,211,916)
  11,123 
  (488)
  (10,203,812)
Net Income (Loss) Before Income Tax
  908,722 
  (87,857)
  (10,575,005)
  (3,075,507)
  (417,438)
  (13,247,085)
 
 
Property Development
 
 
Digital Transformation Technology
 
 
Biohealth Business
 
 
Other
 
 
Discontinued Operations
 
 
Total
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Nine Months ended September 30, 2019
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue
 $21,509,197 
 $- 
 $1,406,951 
 $28,350 
 $- 
 $22,944,498 
Cost of Sales
  (18,819,865)
  - 
  (357,935)
  - 
  - 
  (19,177,800)
Gross Margin
  2,689,332 
  - 
  1,049,016 
  28,350 
  - 
  3,766,698 
Operating Expenses
  (4,598,112)
  (193,959)
  (1,780,026)
  (1,697,423)
  (358,534)
  (8,628,054)
Operating Income (Loss)
  (1,908,780)
  (193,959)
  (731,010)
  (1,669,073)
  (358,534)
  (4,861,356)
Other Income (Expense)
  34,433 
  296,726 
  31,151 
  (4,874)
  (30,397)
  327,039 
Net Income (Loss) Before Income Tax
  (1,874,347)
  102,767 
  (699,859)
  (1,673,947)
  (388,931)
  (4,534,317)
 
    
    
    
    
    
    
 
    
    
    
    
    
    
September 30, 2020
    
    
    
    
    
    
Cash and Restricted Cash
 $5,079,010 
 $62,422 
 $1,386,513 
 $6,461,531 
 $- 
 $12,989,476 
Total Assets
  30,540,913 
  162,524 
  61,572,898 
  9,197,695 
  - 
  101,474,030 
 
    
    
    
    
    
    
December 31, 2019
    
    
    
    
    
    
Cash and Restricted Cash
 $5,439,318 
 $55,752 
 $388,670 
 $1,338,525 
 $108,731 
 $7,330,996 
Total Assets
  29,857,615 
  155,854 
  948,931 
  4,770,949 
  139,431 
  35,872,780 
F-21
4.REAL ESTATE ASSETS

5. REAL ESTATE ASSETS

As of SeptemberJune 30, 20202023 and December 31, 2019,2022, real estate assets consisted of the following:

 
 
September 30,
2020
 
 
December 31,
2019
 
 
 
 
 
 
 
 
Construction in Progress
 $12,298,889 
 $9,601,364 
Land Held for Development
  12,691,477 
  14,283,340 
   Total Real Estate Assets
 $24,990,366 
 $23,884,704 
 
    
    
5.PROPERTY AND EQUIPMENT

SCHEDULE OF REAL ESTATE ASSETS

  June 30, 2023  December 31, 2022 
       
Construction in Progress $4,660,812  $15,506,572 
Land Held for Development  3,395,701   7,943,126 
Rental Properties, net  31,388,691   31,169,031 
Total Real Estate Assets $39,445,204  $54,618,729 

Single family residential properties

As of SeptemberJune 30, 20202023 and December 31, 2019, property2022, the Company owned 132 Single Family Residential Properties (“SFRs”). The Company’s aggregate investment in those SFRs was $31 million. Depreciation expense was $276,125 and equipment consisted of the following:

 
 
September 30,
2020
 
 
December 31,
2019
 
 
 
 
 
 
 
 
Computer Equipment
 $181,559 
 $175,992 
Furniture and Fixtures
  62,328 
  52,798 
Vehicles
  90,929 
  90,929 
 Subtotal
  334,816 
  319,719 
Accumulated Depreciation
  (257,153)
  (239,434)
 Total
 $77,663 
 $80,285 
The Company recorded depreciation expense of $17,719 and $20,697 during the nine months ended September 30, 2020 and 2019, respectively. The Company recorded depreciation expense of $4,657 and $7,080 during$173,119 in the three months ended SeptemberJune 30, 20202023 and 2019,2022, respectively.
F-22
6.BUILDER DEPOSITS
Depreciation expense was $519,827 and $318,743 in the six months ended June 30, 2023 and 2022, respectively. These homes are located in Montgomery and Harris Counties, Texas.

The following table presents the summary of our SRFs as of June 30, 2023:

SUMMARY OF SINGLE FAMILY RESIDENTIAL PROPERTIES

  

Number of

Homes

  

Aggregate

investment

  

Average Investment

per Home

 
SFRs  132  $31,388,691  $237,793 

6. BUILDER DEPOSITS

In November 2015, SeD Maryland Development, LLC (“SeD Maryland”) entered into lot purchase agreements with NVR, Inc. (“NVR”) relating to the sale of single-family home and townhome lots to NVR in the Ballenger Run Project. The purchase agreements were amended three times thereafter. Based on the agreements, NVR iswas entitled to purchase 479 lots for a price of approximately $64,000,000,$64,000,000, which escalatesescalated 3% annually after June 1, 2018.

As part of the agreements, NVR was required to give a deposit in the amount of $5,600,000.$5,600,000. Upon the sale of lots to NVR, 9.9%9.9% of the purchase price is taken as payback of the deposit. A violation of the agreements by NVR would cause NVR to forfeit the deposit. On January 3, 2019 and April 28, 2020, NVR gave SeD Maryland two more deposits in the amounts of $100,000$100,000 and $220,000,$220,000, respectively, based on the 3rd Amendment to the Lot Purchase Agreement. On September June 30, 20202023 and December 31, 2019,2022, there were $1,808,747 and $2,445,269was $0 held on deposit, respectively.

7.NOTES PAYABLE
deposit. Remaining balance of $31,553 was repaid during 2022.

7. NOTES PAYABLE

As of SeptemberJune 30, 20202023 and December 31, 2019,2022, notes payable consisted of the following:

SCHEDULE OF NOTES PAYABLE

  

June 30,

2023

  

December 31,

2022

 
Motor Vehicle Loans $167,898  $181,846 
Total notes payable $167,898  $181,846 

F-22
 
 
September 30,
2020
 
 
December 31,
2019
 
Union Bank Loan
  - 
  - 
M&T Bank Loan, Net of Debt Discount
  619,329 
  - 
PPP Loan
  68,502 
  - 
Australia Loan
  159,966 
  157,105 
Total notes payable
 $847,797 
 $157,105 
Union Bank Loan
On November 23, 2015, SeD Maryland entered into a Revolving Credit Note with the Union Bank in the original principal amount of $8,000,000 (the “Revolving Credit Note”). During the term of the loan, cumulative loan advances may not exceed $26,000,000. The line of credit bears interest at LIBOR plus 3.8% with a floor rate of 4.5%. The interest rate at December 31, 2018 was 6.125%. Beginning December 1, 2015, interest only payments were due on the outstanding principal balance. The entire unpaid principal and interest sum was due and payable on November 22, 2018, with the option of one twelve-month extension period. The loan is secured by a deed of trust on the property, $2,600,000 of collateral cash, and a Limited Guaranty Agreement with SeD Ballenger. The Company also had an $800,000 letter of credit from the Union Bank. The letter of credit was due on November 22, 2018 and bore interest at 15%. In September 2017, SeD Maryland Development LLC and the Union Bank modified the Revolving Credit Note, which increased the original principal amount from $8,000,000 to $11,000,000 and extended the maturity date of the loan and letter of credit to December 31, 2019. Accordingly, this change in terms of the Union Bank Loan was accounted for as a modification in accordance withASC 470 – Debt.
On April 17, 2019, the Union Bank Loan was paid off and SeD Maryland Development LLC and Union Bank terminated the Revolving Credit Note. After termination, the collateral cash was released and all L/Cs were transferred to the M&T Bank L/C Facility. 
F-23

M&T Bank Loan

On April 17, 2019, SeD Maryland Development LLC entered into a Development Loan Agreement with Manufacturers and Traders Trust Company (“M&T Bank”) in the principal amount not to exceed at any one time outstanding the sum of $8,000,000,$8,000,000, with a cumulative loan advance amount of $18,500,000.$18,500,000. The line of credit bears interest rate onof LIBOR plus 375 basis points. SeD Maryland Development LLC was also provided with a Letter of Credit (“L/C”) Facility in an aggregate amount of up to $900,000.$900,000. The L/C commission will be 1.5%1.5% per annum on the face amount of the L/C. Other standard lender fees will apply in the event the L/C is drawn down. The loan is a revolving line of credit. The L/C Facility is not a revolving loan, and amounts advanced and repaid may not be re-borrowed. Repayment of the Loan Agreement is secured by $2,600,000$2,600,000 collateral fund and a Deed of Trust issued to the Lender on the property owned by SeD Maryland. As of SeptemberJune 30, 2020,2023, the outstanding balance of the revolving loan was $0. $0. As part of the transaction, the Company incurred loan origination fees and closing fees in the amount of $381,823$381,823 and capitalized it into construction in process.

On June 18, 2020, Alset iHome Inc. (“Alset iHome”), a wholly-owned subsidiaryMarch 15, 2022, approximately $2,300,000 was released from collateral, leaving approximately $300,000 as collateral for outstanding letters of LiquidValue Development Inc., entered into a Loan Agreement with Manufacturers and Traders Trust Company, (the “Lender”).
Pursuant to the Loan Agreement, the Lender provided a non-revolving loan to Alset iHome in an aggregate amount of up to $2,990,000 (the “Loan”). The line of credit bears interest rate on LIBOR plus 375 basis points. Repayment of the Loan is secured by a Deed of Trust issued to the Lender on the property owned by certain subsidiaries of Alset iHome. The maturity date of this Loan is July 1, 2022. LiquidValue Development Inc. and one of its subsidiaries are guarantors of this Loan.
As of September 30, 2020, the loan balance was $670,281. As part of the transaction, the Company incurred loan origination fees and closing fees in the amount of $61,679 which was recorded as loan discount and is amortized over the term of the loan. As of September 30, 2020 and December 31, 2019, the balance of unamortized loan discount was $50,952 and $0, respectively.
credit.

Paycheck Protection Program Loan

On April 6, 2020,February 11, 2021, the Company entered into a termfive year note with M&T Bank with a principal amount of $68,502$68,502 pursuant to the Paycheck Protection Program (“PPP Term Note”) under the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). The PPP Loan iswas evidenced by a promissory note. The PPP Term Note bears interest athad a fixed annual rate of 1.00%1.00%, with the first tensixteen months of principal and interest deferred.deferred until we applied for loan forgiveness. The PPP Term Note was subject to acceleration upon the occurrence of an event of default.

The PPP Term Note was unsecured and guaranteed by the United States Small Business Administration. The Company applied to M&T Bank for forgiveness of the PPP loan.

Term Note, with the amount which may be forgiven equal to at least 60% of payroll costs and other eligible payments incurred by the Company, calculated in accordance with the terms of the CARES Act. In April 2022 the Company received confirmation that the PPP Loan was fully forgiven.

Australia Loan

On January 7, 2017, SeD Perth Pty Ltd (“SeD Perth”) entered into a loan agreement with National Australian Bank Limited (the “Australia Loan”) for the purpose of funding land development. The loan facility provides SeD Perth with access to funding of up to approximately $460,000$460,000 and matures on December 31, 2018.2018. The Australia Loan is secured by both the land under development and a pledged deposit of $35,276.$36,059. This loan is denominated in AUD. Personal guarantees amounting to approximately $500,000$500,000 have been provided by our CEO, Chan Heng Fai and by Rajen Manicka, the CEO of Holista CollTech and Co-founder of iGalen Inc. The interest rate on the Australia Loan is based on the weighted average interest rates applicable to each of the business markets facility components as defined within the loan agreement, ranging from 4.36%4.12% to 5.57%4.86% per annum for the nine months ended September 30, 2020 and from 5.97% to 6.64% per annum for the nine months ended September 30, 2019.2021. On September 7, 2017 the Australia Loan was amended to reduce the maximum borrowing capacity to approximately $179,000.$179,000. During 2020, the terms of the Australia Loan were amended to reflect an extended maturity date of December 31, 2020.April 30, 2022. This was accounted for as a debt modification. The Company did not pay fees to the National Australian Bank Limited for the modification of the loan agreement.

F-24
8.RELATED PARTY TRANSACTIONS
Personal Guarantees by Directors
As of both September 30, 2020 and December 31, 2019, a director of In February 2022, SeD Perth repaid the Company had provided personal guarantees amounting to approximately $5,500,000 to secure external loans from financial institutions for HFE and the consolidated entities.
Sale of HotApp Blockchain to DSS Asia
loan.

Motor Vehicle Loans

On October 25, 2018, HIP, a wholly-owned subsidiary of HotApp Blockchain, Inc.,May 17, 2021, Alset International Limited entered into an agreement with Hong Leong Finance Limited to purchase a car for business. The total purchase price of the car, including associated charges, was approximately $184,596. Alset International paid an initial deposit of $78,640, and would make monthly instalment of approximately $1,300, including interest of 1.88% per annum, for the 84 months.

On September 22, 2022 Alset International entered into an agreement with United Overseas Bank Limited to purchase additional car for business. The total purchase price of the car, including associated charges, was approximately $182,430. Alset International paid an initial deposit of $66,020 and would make monthly installments of approximately $1,472, including interest of 1.88% per annum, for the 84 months.

Future minimum principal payments under existing motor vehicle loans at June 30, 2023 in each calendar year through the end of their terms are as follows:

SCHEDULE OF FUTURE MINIMUM PAYMENTS 

      
2024  $29,959 
2025   29,959 
2026   29,959 
2027   29,959 
2028   27,680 
Thereafter   20,382 
Total Future Receipts  $167,898 

F-23

8. RELATED PARTY TRANSACTIONS

Purchase of Shares and Warrants from NECV

On July 17, 2020, the Company purchased 122,039,000 shares, approximately 9.99% ownership, and warrants to purchase 1,220,390,000 shares with an exercise price of $0.0001 per share, from NECV, for an aggregate purchase price of $122,039. We value the NECV warrants under level 3 category through a Black Scholes option pricing model and the fair value of the NECV warrants were $860,342 as of July 17, 2020, the purchase date, $47,115 as of June 30, 2023 and $327,565 as of December 31, 2022. The difference of $945,769 of fair value of stock and warrants, total $1,067,808 and the purchase price $122,039, was recorded as additional paid in capital at December 31, 2021, as it was a related party transaction.

Purchase and Sale of Stock in True Partners Capital Holding Limited

On March 12, 2021, the Company purchased 62,122,908 ordinary shares of True Partners Capital Holding Limited for $6,729,629 from a related party. The fair market value of such stock on the acquisition date was $10,003,689. The difference between the purchase price and the fair market value of $3,274,060 was recorded as an equity transaction on Company’s condensed consolidated statement of stockholders’ equity at December 31, 2021. Pursuant to a Stock Purchase Agreement from February 2022, the Company sold 62,122,908 shares of True Partner to DSS Inc. (through the transfer of subsidiary and otherwise), for a purchase agreement (the “HotAppsprice of 17,570,948 shares of common stock of DSS. DSS shareholders approved the Stock Purchase Agreement”) with DSS Asia, a Hong Kong subsidiaryAgreement on May 17, 2022 (which is deemed to be the effective date of this transaction). The transaction loss of $446,104, which is the difference between the fair value of True Partner stock and fair value of DSS stock at the agreement’s effective date, was recorded as other expense in the Company’s Statement of Operations.

SHRG Shares Dividend Received from DSS

On May 4, 2023, DSS distributed approximately 280 million shares of Sharing Services Global Corporation (“SHRG”) beneficially held by DSS and its subsidiaries in the form of a dividend to the shareholders of DSS common stock. As a result of this distribution, the Company directly received 70,426,832 shares of SHRG, and through its majority-owned subsidiary Alset International pursuant to which HIP agreed to sell to DSS Asia allLimited, and certain subsidiaries of Alset International Limited, indirectly received additional 55,197,696 shares of SHRG. The Company and its majority-owned subsidiaries now collectively own 125,624,528 shares of SHRG, representing 33.4% of the issued and outstanding shares of HotApps Information Technology Co. Ltd., also known as Guangzhou HotApps, a wholly-owned subsidiary of HIP. Guangzhou HotApps is primarily engaged in engineering work for software development, as well as, aSHRG Common Stock (such number of outsourcing projects related to real estateSHRG shares held and lighting.ownership percentage do not include any shares held by affiliates of the Company which we do not hold a majority interest in). Additionally, our founder, Chairman and Chief Executive Officer, Chan Heng Fai, is the CEO of DSS Asiadirectly and DSS International. For further details on this transaction, refer to Note 11 – Discontinued Operations. 

Sale of 18% of LiquidValue Asset Management Pte. Ltd.
On May 8, 2019, SeD Capital Pte. Ltd. entered into a sale and purchase agreement to sell 522,000 ordinary shares (representing approximately 18% of the ownership) in LiquidValue Asset Management Pte. Ltd. to LiquidValue Development Pte. Ltd. (“LVD”) for a cash of $46,190. Chan Heng Faiindirectly is the owner of LVD.
Salean additional 37,947,756 shares of Impact BiomedicalSHRG and is a beneficial owner of approximately 43.5% of SHRG shares (including those shares owned by Alset Inc. and its majority-owned subsidiaries).

Consolidation of Alset Capital Acquisition Corp.

On May 1, 2023, Alset Capital Acquisition Corp. (“Alset Capital”) held a Special Meeting of Stockholders. In connection with the Special Meeting and certain amendments to DSS

On April 27, 2020, Global BioMedical Pte Ltd (“GBM”), oneAlset Capital’s Amended and Restated Certificate of our subsidiaries, entered into a share exchange agreement with DSS BioHealth Security, Inc. (“DBHS”), a wholly owned subsidiaryIncorporation, 6,648,964 shares of Document Securities Systems Inc. (“DSS”), pursuant to which, DBHS agreed to acquire all Alset Capital’s Class A Common Stock were rendered for redemption. Following the redemption, 2,449,786 shares of Class A Common Stock of Alset Capital remained issued and outstanding, including 473,750 shares held by the Company. The Company also owns 2,156,250 shares of Alset Capital’s Class B Common Stock. Following the redemptions, Company’s ownership in Alset Capital has increased from 23.4% of the outstanding capital stock of Impact BioMedical Inc., a wholly owned subsidiary of GBM, through a share exchange. It was agreed that the aggregate consideration to be issued to GBM for the Impact BioMedical shares would be the following: (i) 483,334 newly issued shares of DSS common stock; and (ii) 46,868 newly issued shares of a new series of DSS perpetual convertible preferred stock with a stated value of $46,868,000, or $1,000 per share. The convertible preferred stock can be convertible into shares of DSS common stock at a conversion price of $6.48 of preferred stock stated value per share of common stock, subject to a 19.9% beneficial ownership conversion limitation (a so-called “blocker”) based on the total issued outstanding shares of common stock of DSS beneficially owned by GBM. Holders to 57.1% of the convertible preferred stock will have no voting rights, except as required by applicable law or regulation, and no dividends will accrue or be payable on the convertible preferred stock. The holderstotal number of convertible preferred stock will be entitled to a liquidation preference of $1,000 per share, and DSS will have the right to redeem all or any portion of the then outstanding shares of convertible preferred stock, pro rata among all holders, at a redemption price per share equal to such liquidation value per share.
Under ASU 2014-08, a disposal transaction meets the definitiontwo classes. The Company recognized $21,657,036 loss on the consolidation of a discontinued operation if allAlset Capital. The loss is included in Finance Costs on the Company’s Consolidated Statement of Operations for the three and six months ended June 30, 2023.

Purchase of Hapi Travel Ltd. Stock

On June 14, 2023, one of the following criteria are met:

1.
The disposal group constitutesCompany’s subsidiaries acquired Hapi Travel Ltd. from Business Mobile Intelligence Ltd., a component of an entity or a group of components of an entity
2.
The component of an entity (or group of components of an entity) meets the held-for-sale classification criteria, is disposed ofcompany 100% owed by sale, or is disposed of other than by sale (e.g., “by abandonment, in an exchange measured based on the recorded amount of the nonmonetary asset relinquished, or in a distribution to owners in a spinoff”).
3.
The disposal of a component of an entity (or group of components of an entity) “represents a strategic shift that has (or will have) a major effect on an entity’s operationsour CEO and financial results”.
F-25
Impact Biomedical Inc. is a group of subsidiaries of HFE and operates independently with its own financial reporting. The transaction is a disposal by sale and has a major effect on HFE’s financial results. Since it meets all above test criteria, we treated this disposal transaction as a discontinued operation in our financial statements.
On August 21, 2020, the transaction closed and Impact BioMedical Inc became a direct wholly owned subsidiary of DBHS. GBM received 483,334 shares of DSS common stock and 46,868 shares of DSS preferred stock, which preferred shares could be converted to 7,232,716 common shares (however, any conversion will be subject to the blocker GBM has agreed to, as described above). After this transaction, we hold 500,001 shares of the common stock of DSS, representing 9.7% of the outstanding common stock of DSS. Our CEO,majority stockholder, Chan Heng Fai, owns an additional 12.8%for consideration of the common stock of DSS (not including any common or preferred shares we hold) and is the executive Chairman of the Board of Directors of DSS. The Company has elected the fair value option for the DSS common stock that would otherwise be accounted for under the equity method of accounting. ASC 820, Fair Value Measurement and Disclosures, defines the fair value of the financial assets. We value DSS common stock under level 1 category through quoted prices and preferred stock under level 3 category through a Monte Carlo valuation model. The quoted price of DSS common stock was $6.95 as of August 21, 2020. The total fair value of DSS common and preferred stocks GBM received as consideration for the disposal of Impact BioMedical was $67,208,173. As of August 21, 2020, the net asset value of Impact BioMedical was $57,143. The difference of $67,151,030 was recorded as additional paid in capital. We did not recognize gain or loss from this transaction as it was a related party transaction. For further details on this transaction, refer to Note 11 – Discontinued Operations. 
$214,993. On October 16, 2020, GBM converted 4,293 shares of DSS Series A Preferred Stock having a par value of $0.02 per share in exchange for 662,500 restricted shares of DSS common stock based upon a liquidation value of $1,000 and a conversion price of $6.48 per share. Our ownership with DSS was 8.6% before conversion and 19.9% after the conversion.
Notes Payable
During the year ended on December 31, 2017, a director of the Company lent non-interest loans of $7,156,680, for the general operations of the Company. The loans are interest free, not tradable, unsecured, and repayable on demand. On October 15, 2018, a formal lending agreement between the Alset International andNovember 17, 2021, Chan Heng Fai was executed. Underhad acquired Hapi Travel Ltd. (formerly known as Travel Panda Ltd.) from Chan Hei Wai, an individual unaffiliated with the agreement, Chan Heng Fai provides a lending credit limit of approximately $10 million for Alset International with interest rate 6% per annum for the outstanding borrowed amount, which commenced retroactively from January 1, 2018. The loans are still not tradable, unsecured and repayable on demand. As of September 30, 2020 and December 31, 2019 the outstanding principal balance of the loan is $0 and $4,246,604, respectively. Interest started to accrue on January 1, 2018 at 6% per annum. During the nine months ended on September 30, 2020 and 2019, the interest expenses were $129,566 and $268,847, respectively. During the three months ended on September 30, 2020 and 2019, the interest expenses were $6,334 and $68,482, respectively. As of September 30, 2020 and December 31, 2019, the accrued interest total was $0 and $822,405, respectively.Company.

F-24

Notes Payable

Chan Heng Fai provided an interest-free, due on demand advance to HFESeD Perth Pty. Ltd. for theits general operations. On September As of June 30, 20202023 and December 31, 2019,2022, the outstanding balance was $178,400.

On August 20, 2020, the Company acquired 30,000,000 common shares from $12,343 and $12,668, respectively.

Chan Heng Fai in exchangeprovided an interest-free, due on demand advance to Hapi Metaverse Inc. for a two-year non-interest bearing note of $1,333,429. On September 30, 2020 the amount outstanding was $1,333,429.

On May 1, 2018, Rajen Manicka, CEO and one of the directors of iGalen International Inc., which holds 100% of iGalen Inc., provided a loan of approximately $367,246 to iGalen Inc. (the “2018 Rajen Manicka Loan”). The term of 2018 Rajen Manicka Loan is ten years. The 2018 Rajen Manicka Loan has an interest rate of 4.7% per annum. On March 8, March 27 and April 23, 2019, iGalen borrowed additional monies of $150,000, $30,000 and $50,000, respectively, from Rajen Manicka, total $230,000 (the “2019 Rajen Manicka Loan”). The 2019 Rajen Manicka Loan is interest free, not tradable, unsecured, and repayable on demand.its general operations. As of SeptemberJune 30, 20202023 and December 31, 2019,2022, the total outstanding principal balance of the loans was $531,030$4,138 and $546,397, respectively, and was included in the Notes Payable – Related Parties balance on the Company’s Condensed Consolidated Balance Sheets. During the nine months ended September 30, 2020 and 2019, the Company incurred $13,185 and $8,084 of interest expense,$4,158, respectively. During the three months ended September 30, 2020 and 2019, the Company incurred $4,411 and $0 of interest expense, respectively. The Company accrued interest of $0 and $0 at September 30, 2020 and December 31, 2019, respectively
F-26
On August 13, 2019, iGalen International Inc., which holds 100% of iGalen Inc., borrowed $250,000 from Decentralized Sharing Services, Inc., a company whose sole shareholder and director is Chan Heng Fai, our CEO. The term of the loan is 12 months, with an interest rate of 10% per annum. In addition, Decentralized Sharing Services, Inc. received the right to receive 3% of any revenue received by iGalen International Inc. for 99 years.  During the nine months ended September 30, 2020 the Company incurred $9,729 of interest expense and $0 from the right to receive 3% of revenue. During the three months ended September 30, 2020 the Company incurred $0 of interest expense and $0 from the right to receive 3% of revenue. During the three months ended September 30, 2019 the Company incurred $0 of interest expense and $0 from the right to receive 3% of revenue. The amount outstanding on the loan as of September 30, 2020 and December 31, 2019 was $0 and $250,000, respectively. The accrued interest was $19,318 and $9,589 as of September 30, 2020 and December 31, 2019. The principal of $250,000 was paid off in June 2020.
On November 3, 2019, iGalen Inc. borrowed $160,000 from iGalen Funding Inc., a company whose directors and shareholders include two members of the Board of iGalen Inc. The term of the loan is 6 months, with an interest rate of 10% per annum. During the nine months ended September 30, 2020 the Company incurred $11,967 of interest expense. During the three months ended September 30, 2020 the Company incurred $3,989 of interest expense. The amount outstanding on the loan as of September 30, 2020 and December 31, 2019 was $160,000 and $160,000, respectively. The accrued interest was $14,510 and $2,542 as of September 30, 2020 and December 31, 2019. The expiration date was extended to November 3, 2021 after 6 months.
Shares issued in exchange agreement with Chairman and CEO
Hengfai International Pte. Ltd
On October 1, 2018, 100% of the ownership interest in Hengfai International Pte. Ltd. (“Hengfai International”) was transferred from Chan Heng Fai, our founder, Chairman and CEO to HF Enterprises Inc. in exchange for 8.5 million shares of the Company. Hengfai International holds 100% of Hengfai Business Development Pte. Ltd. (“Hengfai Business Development”), which holds 761,185,294 shares of Alset International and 359,834,471 warrants. Both Hengfai International and Hengfai Business Development are holding companies without any business operations. 
Heng Fai Enterprises Pte. Ltd.
On October 1, 2018, 100% of the ownership interest in Heng Fai Enterprises Pte. Ltd. (“Heng Fai Enterprises”) was transferred from Chan Heng Fai, our founder, Chairman and CEO to HF Enterprises Inc. in exchange for 500,000 shares of the Company. Heng Fai Enterprises holds 2,730,000 shares (13.1% as of September 30, 2020 and December 31, 2019) of Vivacitas Oncology Inc., a U.S.-based biopharmaceutical company. Heng Fai Enterprises cost to purchase these Vivacitas shares was $200,128, which is recorded at cost by the Company because it does not have a readily determinable fair value as it is a private US company. Heng Fai Enterprises is a holding company without any business operations.
Global eHealth Limited
On October 1, 2018, 100% of Global eHealth Limited (“Global eHealth”) was transferred from Chan Heng Fai, a director of the Company, to the Company in exchange for 1,000,000 shares of the Company. There was no other consideration exchange in conjunction with this transaction. Global eHealth holds 46,226,673 shares (16.8%) of Holista CollTech Limited, a public Australian company that produces natural food ingredients. Global eHealth is a holding company without any business operations. 
F-27

Management Fees

MacKenzie Equity Partners, LLC, an entity owned by Charles MacKenzie, a Directorthe Chief Development Officer of the Company's subsidiary LiquidValue Development,Company, has had a consulting agreement with a majority-owned subsidiary of the Company since 2015. PerPursuant to the terms of the agreement, as amended on January 1, 2018, the Company pays a monthly fee of $15,000 with an additional $5,000 per month due upon the close of the sale to Houston LD, LLC. Since January of 2019, the Company hasCompany’s subsidiary paid a monthly fee of $20,000$20,000 for these consulting services. Pursuant to an agreement entered into in June of 2022, the Company’s subsidiary has paid $25,000 per month for consulting services, effective as of January 2022.

In addition, MacKenzie Equity Partners will be paid certain bonuses, including (i) a sum of $50,000 on June 30, 2022; (ii) a sum of $50,000 upon the successful financing of 100 homes owned by American Housing REIT Inc. with an entity not affiliated with SeD Development Management LLC (a subsidiary of the Company); and (iii) a sum of $50,000 upon the successful leasing of 30 homes in the Alset of Black Oak development.

The Company incurred expenses of $180,000$75,000 and $180,000 for$150,000 in the ninethree and six months ended SeptemberJune 30, 20202023, respectively, and 2019,$140,000 and $200,000 in the three and six months ended June 30, 2022, respectively, which were capitalized as part of Real Estate on the Company’s Consolidated Balance Sheetbalance sheet as the services relate to property and project management. The Company incurred expenses of $60,000 and $60,000 for the three months ended SeptemberIn June 2022, MacKenzie Equity Partners was paid $50,000 bonus payment (as described above). On June 30, 2020 and 2019, respectively. As of September 30, 2020,2023 and December 31, 2019 2022, the Company owed $20,000 and $0, respectively, to this entity. 

Consulting Services
A law firm owned by Conn Flanigan, a Director of LiquidValue Development, performs consulting services for LiquidValue Development and some subsidiaries of the Company. The Company incurred expenses of $12,645 and $46,510 for the nine months ended September 30, 2020 and 2019, respectively. The Company incurred expenses of $12,645 and $3,153 for the three months ended September 30, 2020 and 2019, respectively. As of September 30, 2020, and December 31, 2019 there was no outstanding balance due to this entity. 
Rajen Manicka, the CEO of Holista CollTech and Co-founder of iGalen International Inc., performs consulting services for iGalen Inc. iGalen Inc. incurred expenses of $0 and $180,000 for the nine months ended September 30, 2020 and 2019, respectively. The Company incurred expenses of $0 and $60,000 for the three months ended September 30, 2020 and 2019, respectively. On both, September 30, 2020 and December 31, 2019, iGalen owed this related party fees for consulting services in the amount of $591,403. The Consulting service with Rajen Manicka was terminated on December 31, 2019.
Chan Tung Moe, the consultant engaged with the Company through Pop Motion Consulting Pte. Ltd.$25,000 and $25,000, is the son of Chan Heng Fai, a director and the CEO of the Company. In August of 2020 this consulting agreement was terminated, and Chan Tung Moe became an employee of Alset International as Chief Development Officer. The Company incurred expense of $140,758 for the nine months ended September 20, 2020 and 2019, respectively. The Company incurred expense of $22,470 for the three months ended September 30, 2020 and 2019, respectively. As of September 30, 2020 and December 2019, the Company owed Pop Motion consulting fee of $0 and $118,288, respectively.
iGalen Inc. Affiliates
iGalen Philippines and iGalen SDN are related party entities which are owned by Dr. Rajen Manicka and are not owned by the Company. iGalen Inc. provides use of its platform to collect sale revenue and payment of expenses for these entities without service fees. On September 30, 2020 and December 31, 2019, iGalen owed $364,377 and $342,695 to iGalen Philippines, respectively.
iGalen SDN had a consulting agreement to provide accounting, administration and other logistic services to iGalen with a monthly fee $4,000. This agreement was terminated on December 31, 2019. The Company incurred expenses of $0 and 36,000 for the nine months ended September 30, 2020 and 2019, respectively. The Company incurred expenses of $0 and $12,000 for the three months ended September 30, 2020 and 2019, respectively. As of September 30, 2020, iGalen owed $87,756 to iGalen SDN. As of December 31, 2019, iGalen SDN owed iGalen $74,331.
During the nine months ended September 30, 2020, iGalen SDN provided a $710,524 advance to iGalen for its operations. The advance is interest free, no security requirement and no payment term. The repayment depends on the demand and the future financial situation of iGalen.
Medi Botanics Sdn Bhd, a subsidiary of Holista CollTech, is only raw material and product suppliers of iGalen. Dr. Rajen Manicka is the controlling shareholder and a director of both Medi Botanics Sdn Bhd and Holista CollTech. Medi Botanics Sdn Bhd supplied $0 and $372,594 raw materials and products to iGalen in the nine months ended September 30, 2020 and 2019, respectively. During three months ended on September 30, 2020 and 2019, Medi Botanics Sdn Bhd supplied $0 and $85,787 raw materials and products to iGalen. On September 30, 2020 and December 31, 2019, iGalen owed $698,198 and $956,300 to this entity, respectively. 
F-28
Investment in the Global Opportunity Fund
On February 1, 2017, the Company invested $300,000 in Global Opportunity Fund (“Fund”), a mutual fund registered in the Cayman Islands and Chan Heng Fai is one of the directors of this fund. This Fund was closed during November 2019 and is being liquidated. LiquidValue Asset Management Pte. Ltd., one of the subsidiaries of the Company, is the investment manager of the Fund and receives a management fee from the Fund at 2% per annum of the aggregated net asset value of the investments and a performance fee of 20%. As of December 31, 2019, the Company recorded a receivable $307,944 from the Global Opportunity Fund. In the nine months ended on September 30, 2020 and 2019, the management fee and performance fee charged to the Fund were $0 and $4,425, respectively. In the three months ended on September 30, 2020 and 2019, the management fee and performance fee charged to the Fund were $0 and $1,386, respectively. On September 30, 2020 and December 31, 2019, the Fund owed accrued management and performance fee receivable $0 and $15,484 respectively.  On January 23, 2020, the Company received $307,944 as a result of the liquidation of Global Opportunity Fund.
Note

Notes Receivable from a related party company

Related Party

On March 2, 2020 and on October 29, 2021, LiquidValue Asset Management Pte. Ltd. (“LiquidValue”) received a $200,000two $200,000 Promissory Notes and on October 29, 2021 Alset International received $8,350,000 Promissory Note from American Medical REIT Inc. (“AMRE”), a company which is 36.1%15.8% owned by LiquidValue.LiquidValue as of September 30, 2022. Chan Heng Fai and Chan Tung Moe and Alan Lui from Alset International are directors of American Medical REIT Inc. The note carries interestsnotes carry interest rates of 8% and isare payable in two, years.three years and 25 months, respectively. LiquidValue also received warrants to purchase AMRE shares at the Exercise Price $5.00exercise price of $5.00 per share. The amount of the warrants equals to the note principleprincipal divided by the Exercise Price.exercise price. If AMRE goes to IPO in the future and IPO price is less than $10.00 per share, the Exerciseexercise price shall be adjusted downward to fifty percent (50%) of the IPO price. In March 2022 the Company converted two $200,000 loans, together with associated warrants into 167,938 common shares of AMRE, and increased its ownership in AMRE from 3.4% to 15.8%. On July 12, 2022, pursuant to Assignment and Assumption Agreement from February 25, 2022, as amended on July 12, 2022, the Company sold the $8,350,000 loan, together with accrued interest, to DSS for a purchase price of 21,366,177 shares of DSS’s common stock. The loss from this transaction of $1,089,675 was calculated as the difference between the face value of promissory note together with accrued interest and the fair value of DSS stock on July 12, 2022, and was recorded under Other Expense in Statement of Operations.

F-25

As of SeptemberJune 30, 2020,2023 and December 31, 2022, the Company provided advances for operation of $236,699 to HWH World Co., a direct sales company in Thailand of which the Company holds approximately 19% ownership.

In the first quarter of 2022, a subsidiary of the Company made a non-interest bearing advance in the amount of $476,250 on behalf of Alset Investment Pte. Ltd., a company 100% owned by one of our directors. Such advance was made in connection with a private placement into Alset Capital Acquisition Corp. by its sponsor, Alset Acquisition Sponsor, LLC. During 2022, Alset Investment repaid all balance due of $476,250.

In June 2022, Alset International Limited, a subsidiary of the Company, entered into a stock purchase agreement with one of our directors and paid $1,746,279 to one of our directors as the consideration for purchase of 7,276,163 common shares of Value Exchange International. This transaction was terminated under the agreement of both parties thereafter. On October 17, 2022 the Company purchased 7,276,163 common shares of Value Exchange International for an aggregate purchase price of $1,743,734. After the transaction the Company owns approximately 38.3% of Value Exchange International.

On July 28, 2022 Hapi Café Inc. entered into binding term sheet (the “First Term Sheet”) with Ketomei Pte Ltd and Tong Leok Siong Constant, pursuant to which Hapi Café lent Ketomei $41,750. This loan has a 0% interest rate for the first 60 days and an interest rate of 8% per annum afterwards. On August 4, 2022 the same parties entered into another binding term sheet (the “Second Term Sheet”) pursuant to which Hapi Café agreed to lend Ketomei up to S$360,000 Singapore Dollars (equal to approximately $250,500 US Dollars) pursuant to a convertible loan, with a term of 12 months. After the initial 12 months, the interest on such loan will be 8%. In addition, pursuant to the Second Term Sheet, the July 28, 2022 loan was modified to include conversion rights. In August 2022, Ketomei drew $29,922 from the loan. As of June 30, 2023 and December 31, 2022, Ketomei owed $260,961 and $198,162 to Hapi Café, respectively.

On October 13, 2021 BMI Capital Partners International Limited (“BMI”) entered into loan agreement with Liquid Value Asset Management Limited (“LVAML”), a subsidiary of DSS, pursuant to which BMI agreed to lend $3,000,000 to LVAML. The loan has variable interest rate and matures on January 12, 2023, with automatic three-month extension. The purpose of the loan is to purchase a portfolio of trading securities by LVAM. BMI participates in the losses and gains from portfolio based on the calculations included in the loan agreement. As of June 30, 2023 and December 31, 2022 LVAML owes the Company $516,165 and $3,042,811, respectively.

On January 27, 2023, the Company’s subsidiary Hapi Metaverse Inc. and New Electric CV Corp. (“NECV,” and together with Hapi Metaverse Inc., the “Lenders”) entered into a Convertible Credit Agreement (the “Credit Agreement”) with Value Exchange International, Inc. (“Value Exchange”), a Nevada corporation. The Credit Agreement provides Value Exchange with a maximum credit line of $1,500,000 (“Maximum Credit Line”) with simple interest accrued on any advances of the money under the Credit Agreement at 8%. The principal amount of any advance of money under the Credit Agreement (each being referred to as an “Advance”) is due in a lump sum, balloon payment on the third annual anniversary of the date of the Advance (“Advance Maturity Date”). Accrued and unpaid interest on any Advance is due and payable on a semi-annual basis with interest payments due on the last business day of June and last business day of December of each year. A Lender may demand that any portion or all of the unpaid principal amount of any Advance as well as accrued and unpaid interest thereon may be paid by shares of Value Exchange Common Stock in lieu of cash payment. As of June 30, 2023, $1,400,000 of credit was used, and interest income of $27,923 and $38,970 is included in interest income in the three and six months ended June 30, 2023, respectively.

F-26

9. GOODWILL

The Company and its subsidiaries continually evaluate potential acquisitions that align with the Company’s plans. Starting an F&B business in Hong Kong, China, and Taiwan can be an excellent opportunity due to the large consumer market, diverse food culture, high demand for international cuisine, favorable business environment, skilled labor force, and opportunities for growth.

On October 4, 2022, the Company completed its first F&B business acquisition of MOC HK Limited (“MOC”), a F&B business started in Hong Kong. The accompanying consolidated financial statements include the operations of the acquired entity from its acquisition date. The acquisition has been accounted for as a business combination. Accordingly, consideration paid by the Company to complete the acquisition is initially allocated to the acquired assets and liabilities assumed based upon their estimated acquisition date fair values. The recorded amounts for assets acquired and liabilities assumed are provisional and subject to change during the measurement period, which is up to 12 months from the acquisition date.

As a result of the acquisition of MOC, goodwill of $60,363 generated in a business combination represents the purchase price of $70,523 in excess of identifiable tangible and intangible assets. Goodwill and intangible assets that have an indefinite useful life are not amortized. Instead, they are reviewed periodically for impairment.

On June 14, 2023, the Company completed acquisition of Hapi Travel Limited (“HTL”), an online travel business started in Hong Kong. The accompanying consolidated financial statements include the operations of the acquired entity from its acquisition date. The acquisition has been accounted for as a business combination. Accordingly, consideration paid by the Company to complete the acquisition is initially allocated to the acquired assets and liabilities assumed based upon their estimated acquisition date fair values. The recorded amounts for assets acquired and liabilities assumed are provisional and subject to change during the measurement period, which is up to 12 months from the acquisition date.

As a result of the acquisition of HTL, goodwill of $214,174 generated in a business combination represents the purchase price of $214,993 in excess of identifiable tangible and intangible assets. Goodwill and intangible assets that have an indefinite useful life are not amortized. Instead, they are reviewed periodically for impairment.

The Company evaluates goodwill on an annual basis in the fourth quarter or more frequently, if management believes indicators of impairment exist. Such indicators could include, but are not limited to (1) a significant adverse change in legal factors or in business climate, (2) unanticipated competition, or (3) an adverse action or assessment by a regulator. The Company first assesses qualitative factors to determine whether it is more likely than not that the fair marketvalue of a reporting unit is less than its carrying amount, including goodwill. If management concludes that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, management conducts a quantitative goodwill impairment test. The impairment test involves comparing the fair value of the warrantsapplicable reporting unit with its carrying value. The Company estimates the fair values of its reporting units using a combination of the income, or discounted cash flows, approach and the market approach, which utilizes comparable companies’ data. If the carrying amount of a reporting unit exceeds the reporting unit’s fair value, an impairment loss is recognized in an amount equal to that excess, limited to the total amount of goodwill allocated to that reporting unit. The Company’s evaluation of goodwill completed during the period resulted in no impairment losses.

The table below reflects the Company’s estimates of the acquisition date fair value of the assets acquired and liabilities assumed for the 2022 and 2023 acquisition:

SCHEDULE OF ESTIMATES OF ACQUISITION FAIR VALUE

  MOC  HTL 
Acquisition Date   October 4, 2022   June 14, 2023  
         
Purchase Price        
Cash $70,523  $214,993 
Total purchase consideration  70,523   214,993 
         
Purchase Price Allocation        
Assets acquired        
Current assets  32,700   15,098 
Property and Equipment, net  11,266   1,485 
Operating lease right-of-use assets, net  114,232   16,516 
Total assets acquired  158,198   33,099 
         
Liabilities assumed:        
Current liabilities  (33,437)  (20,885)
Operating lease liability  (114,232)  (11,395)
Accrued taxes  (349)  - 
Total liabilities assumed  (148,018)  (32,280)
         
Net assets acquired  10,180   819 
Goodwill  60,343   214,174 
Total purchase consideration $70,523  $214,993 

The following table summarizes changes in the carrying amount of goodwill at June 30, 2023 and December 31, 2022

SCHEDULE OF GOODWILL

  June 30, 2023  December 31, 2022 
       
Balance at beginning of the period/year $60,343  $- 
Acquisitions  214,174   60,343 
Foreign currency exchange adjustment  (283)    
Balance as of end of the period/year $274,234  $60,343 

F-27

10. EQUITY

On June 14, 2021, the Company filed an amendment (the “Amendment”) to its Third Amended and Restated Certificate of Incorporation, as amended, to increase the Company’s authorized share capital. The Amendment increased the Company’s authorized share capital to 250,000,000 common shares and 25,000,000 preferred shares, from 20,000,000 common shares and 5,000,000 preferred shares, respectively.

The Company has designated 6,380 preferred shares as Series A Preferred Stock and 2,132 as Series B Preferred Stock.

On December 6, 2022 the Company filed a certificate of Amendment to the Company’s Certificate of Formation with the Texas Secretary of State to effect a 1-for-20 reverse stock split. The reverse stock split was $0.effective as of December 28, 2022.

Holders of the Series A Preferred Stock shall be entitled to receive dividends equal, on an as-if-converted basis, to and in the same form as dividends actually paid on shares of the Company’s common stock, par value $0.001 per share (“Common Stock”) when, as and if paid on shares of Common Stock. Each holder of outstanding Series A Preferred Stock is entitled to vote equal to the number of whole shares of Common Stock into which each share of the Series A Preferred Stock is convertible. Holders of Series A Preferred Stock are entitled, upon liquidation of the Company, to receive the same amount that a holder of Series A Preferred Stock would receive if the Series A Preferred Stock were fully converted into Common Stock.

Holders of the Series B Preferred Stock shall be entitled to receive dividends equal, on an as-if-converted basis, to and in the same form as dividends actually paid on shares of the Company’s common stock par value $0.001 per share (“Common Stock”) when, as and if paid on shares of Common Stock. Each holder of outstanding Series B Preferred Stock is entitled to vote equal to the number of whole shares of Common Stock into which each share of the Series B Preferred Stock is convertible. Holders of Series B Preferred Stock are entitled, upon liquidation of the Company, to receive the same amount that a holder of Series B Preferred Stock would receive if the Series B Preferred Stock were fully converted into Common Stock.

The Company analyzed the Preferred stock and the embedded conversion option for derivative accounting consideration under ASC 815-15 “Derivatives and Hedging” and determined that the conversion option should be classified as equity.

On February 6, 2023, the Company entered into an Underwriting Agreement (the “Underwriting Agreement”) in connection with an offering (the “Offering”) of its common stock, par value $0.001 per share (the “Common Stock”), with Aegis Capital Corp. (the “Underwriter”) as the underwriter, relating to an underwritten public offering of 1,727,273 shares of Common Stock at a public offering price of $2.20 per share. The Underwriting Agreement provides the Underwriter a 45-day option to purchase up to an additional 212,863 shares of Common Stock to cover over-allotments, if any.

F-28
Warrants Exercised

The net proceeds to the Company from the Offering were approximately $3.4 million, after deducting underwriting discounts and the payment of other offering expenses associated with the Offering that are payable by DSS

the Company.

The Offering closed on February 8, 2023. The Common Stock was being offered pursuant to an effective registration statement on Form S-3 (File No. 333-264234), as well as a prospectus supplement in connection with the Offering filed with the Securities and Exchange Commission.

On June 30, 2020, we received deposit $1,419,605 from Document Security Systems, Inc. for a warrant exercise to acquire 44,005,182 shares of Alset International at a price approximately $0.03 per share. The transaction was closed in July 2020. After this exercise, DSS holds 127,179,311 shares of Alset International’s common stock, approximately 9.3%. Fai Heng Chan, our CEO, Chairman of our Board and controlling shareholder, is also Chairman of the Board of Document Security Systems, Inc. and a significant shareholder of Document Security Systems, Inc.

9.EQUITY
The Company is authorized to issue 20,000,000 common shares and 5,000,000 preferred shares, both at a par value $0.001 per share. At December 31, 2019,2023, there were 10,001,0009,235,119 common shares issued and outstanding.
Pursuant

The following table summarizes the warrant activity for the six months ended June 30, 2023.

SCHEDULE OF WARRANT ACTIVITY

  

Warrant for

Common

Shares

  

Weighted

Average

Exercise Price

  

Remaining Contractual

Term

(Years)

  

Aggregate

Intrinsic

Value

 
Warrants Outstanding as of December 31, 2022  634,488  $80.32   3.23  $- 
Warrants Vested and exercisable at December 31, 2022  634,488  $80.32   3.23  $- 
Granted  -   -         
Exercised  -   -         
Forfeited, cancelled, expired  -   -         
Warrants Outstanding as of June 30, 2023  634,488  $80.32   2.74  $- 
Warrants Vested and exercisable at June 30, 2023  634,488  $80.32   2.74  $- 

Changes of Ownership of Alset International

In the year ended December 31, 2022 the Company purchased 6,670,200 shares of Alset International from the market.

On January 17, 2022 the Company entered into a securities purchase agreement with Chan Heng Fai, pursuant to an agreement on June 24, 2020 with our stockholders HFE Holdings Limitedwhich the Company agreed to purchase from Chan Heng Fai 293,428,200 ordinary shares of Alset International for a purchase price of 29,468,977 newly issued shares of the Company’s common stock. On February 28, 2022, the Company and Chan Heng Fai HFE Holdings Limited surrendered 3,600,000entered into an amendment to this securities purchase agreement pursuant to which the Company shall purchase these 293,428,200 ordinary shares of ourAlset International for a purchase price of 35,319,290 newly issued shares of the Company’s common stock to the treasurystock. The closing of our company, andthis transaction with Chan Heng Fai surrendered 1,000was subject to approval of the Nasdaq and the Company’s stockholders. These 293,428,200 ordinary shares of our common stock to the treasury of our company, and all such shares were cancelled. No consideration was exchanged in connection with the surrenderAlset International represent approximately 8.4% of the shares. As a result, the3,492,713,362 total number ofissued and outstanding shares of our common stock at September 30, 2020 was reduced to 6,400,000 shares from 10,001,000 shares.

HotApp Blockchain, Inc. Sale of Shares
From January to September, 2020, the Company sold 207,300 shares of HotApp Blockchain to international investors with the amount of $177,300, which was booked as addition paid-in capital.Alset International. The Company held 505,976,376 shareshad a Special Meeting of the total outstanding shares 506,898,576 before the sale. After the sale, the Company still owns approximately 99% of HotApp Blockchain’s total outstanding shares. 
From JanuaryStockholders to September, 2019, the Company sold 361,500 shares of HotApp Blockchain to international investors with the amount of $229,500, which was booked as addition paid-in capital. The Company held 506,262,076 shares of the total outstanding shares 506,898,576 before the sale. After the sale, the Company still owns approximately 99% of HotApp Blockchain’s total outstanding shares.
F-29
Distribution to Minority Shareholder
From January to September, 2020, SeD Maryland Development LLC Board approved the payment distribution plan to members and paid $197,400 in distribution to the minority shareholder. From January to September, 2019, SeD Maryland Development LLC Board approved the payment distribution plan to members and paid $740,250 in distribution to the minority shareholder.
Change in Minority Interest
From January 1 to September 30, 2020, Alset International issued 343,197,062 common shares through warrants exercise with exercise price approximately $0.03 per share and received $10,764,837 cash. On May 27, 2020, the Alset International granted 7,500,000 common shares to its employees in the performance share award plan. The fair value $146,853 of these shares was basedvote on the market priceapproval of this transaction on the granted day and was recorded as both compensation expense and equity in the financial statements. On June 5, 2020,6, 2022.

Due to these transactions the shareholder meeting approved 35,278,600 shares granted to the directors. The fair value $1,417,523 was based the June 5, 2020, the grant day, market price and was recorded as both compensation expense and equity in the financial statements. During the three and nine months ended September 30, 2020, the stock-based compensation expense was $0 and $1,573,623, respectively. On August 20, 2020, the Company acquired 30,000,000 common shares from Chan Heng Fai in exchange for a two-year non-interest bearing note of $1,333,429. The Company’s ownership of Alset International changed from 65.4%76.8% as of December 31, 20192021 to 51.04%85.4% as of September June 30, 2020.

During2023 and December 31, 2022.

Promissory Note Converted into Shares

On December 13, 2021 the threeCompany entered into a Securities Purchase Agreement with Chan Heng Fai for the issuance and nine months ended September 30, 2020sale of a convertible promissory note in favor of Chan Heng Fai, in the principal amount of $6,250,000. The note bears interest of 3% per annum and 2019,was due on the salesearlier of HotApp Blockchain’s December 31, 2024 or when declared due and payable by Chan Heng Fai. The note could be converted in part or whole into common shares of the Company at the conversion price of $0.625 or into cash. The loan closed on January 26, 2022 after all closing conditions were met. Chan Heng Fai opted to convert all of the amount of such note into 10,000,000 shares of the Company’s common stock, which shares were de minimis comparedissued on January 27, 2022.

F-29

Registration Statement on Form S-3

On April 11, 2022 the Company filed a Registration Statement on Form S-3 using a “shelf” registration or continuous offering process. Under this shelf registration process, the Company may, from time to its outstanding shares and did not changetime, sell any combination of the minority interest.

Changessecurities (common stock, preferred stock, warrants, rights, units) described in the filed prospectus in one or more offerings up to a total aggregate offering price of Ownership Percentage$75,000,000.

Class A Common Stock of Alset International

On July 13, 2020, dueCapital Acquisition Corp. Subject to share grantsPossible Redemption

The Company accounts for its, and warrant exercises,its subsidiaries’ common stock subject to possible redemption in accordance with the guidance enumerated in ASC 480 “Distinguishing Liabilities from Equity”. Common stock subject to possible redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable common stock (including shares of common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s ownership percentagecontrol) are classified as temporary equity. At all other times, shares of common stock are classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered by the Company to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at June 30, 2023, the Class A common stock of Alset International fell below 50% andCapital Acquisition Corp. subject to possible redemption in the entityamount of $20,075,127, are presented as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheets.

On May 1, 2023, after the redemptions (for further details on this transaction refer to Note 8. – Related Party Transactions, Consolidation of Alset Capital Acquisition Corp.), the Company consolidated Alset Capital. As of June 30, 2023, non-controlling interest of $(658,292) was deconsolidatedrecorded as temporary equity, since these non-controlling interests are considered redeemable noncontrolling interests in accordance with ASC 810-10-45-5. A gain810-10 and ASC 480-10-S99-3A.

11. LEASE INCOME

The Company generally rents its SFRs under lease agreements with a term of approximately $53 million was recordedone or two years. Future minimum rental revenue under existing leases on our properties at June 30, 2023 in each calendar year through the end of their terms are as a resultfollows:

SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS

2023 1,082,873 
2024  623,105 
Total Future Receipts $1,705,978 

Property Management Agreements

The Company has entered into property management agreement with the property managers under which the property managers generally oversee and direct the leasing, management and advertising of the deconsolidation.

Upon deconsolidationproperties in our portfolio, including collecting rents and acting as liaison with the tenants. The Company elected to applypays its property managers a monthly property management fee for each property unit and a leasing fee. For the Fair Value Option under ASU 2016-01 tothree months ended June 30, 2023 and 2022, property management fees incurred by the investment in Alset International asproperty managers were $34,650 and $20,990, respectively. For the Company still retained significant influence ofsix months ended June 30, 2023 and 2022, property management fees incurred by the subsidiary.
On August 20, 2020,property managers were $66,600 and $32,015, respectively. For the Company acquired 30,000,000 common shares from Chan Heng Fai in exchange for a two-year non-interest bearing note of $1,333,429. After that transaction,three months ended June 30, 2023 and 2022, leasing fees incurred by the Company’s ownership was 51.04%property managers were $41,745 and $87,035, at which point Alset International was required to be consolidated. Upon reconsolidation a loss of approximately $22 million was recorded.
Duringrespectively. For the period thatsix months ended June 30, 2023 and 2022, leasing fees incurred by the investment in Alset International was accounted for under ASU 2016-01, the Company recorded an unrealized loss on the fair value of the investment of approximately $31 million.
As of September 30, 2020, the Company’s ownership of Alset International is 51.04%.
As of December 29, 2020, Alset International has outstanding warrantsproperty managers were $66,755 and options to purchase 1,982,286,206 and 1,061,333 shares,$112,825, respectively. Of the warrants outstanding, HF Enterprises Inc. holds warrants to purchase 359,834,471 shares, Chan Heng Fai, our founder and CEO, holds warrants to purchase 1,590,925,000 shares, and warrants to purchase 31,526,735 shares are held by third parties. All of the outstanding options to purchase 1,061,333 shares are owned by Chan Heng Fai. Due to this, the Company does not expect to own less than 50% of Alset International moving forward.
F-30
10.ACCUMULATED OTHER COMPREHENSIVE INCOME

12. ACCUMULATED OTHER COMPREHENSIVE INCOME

Following is a summary of the changes in the balances of accumulated other comprehensive income, net of tax:

 
 
Unrealized Gains and Losses on Security Investment
 
 
Foreign Currency Translations
 
 
Change in Minority Interest
 
 
Total
 
Balance at January 1, 2020
 $(59,888)
 $1,613,125 
 $(84,968)
 $1,468,269 
 
    
    
    
    
Other Comprehensive Income
  (8,240)
  (1,094,810)
  - 
  (1,103,050)
 
    
    
    
    
Balance at March 31, 2020
 $(68,128)
 $518,315 
 $(84,968)
 $365,219 
 
    
    
    
    
Other Comprehensive Income
  8,147 
  389,413 
  (18,317)
  379,243 
 
    
    
    
    
Balance at June 30, 2020
 $(59,981)
 $907,728 
 $(103,285)
 $744,462 
 
    
    
    
    
Other Comprehensive Income
  14,865 
  235,837 
  50,420 
  301,122 
 
    
    
    
    
Balance at September 30, 2020
 $(45,116)
 $1,143,565 
 $(52,865)
 $1,045,584 
 
 
Unrealized Gains and Losses on Security Investment
 
 
Foreign Currency Translations
 
 
Total
 
Balance at January 1, 2019
 $(23,779)
 $1,606,567 
 $1,582,788 
 
    
    
    
Other Comprehensive Income
  11,681 
  74,262 
  85,943 
 
    
    
    
Balance at June 30, 2019
 $(12,098)
 $1,680,829 
 $1,668,731 
 
    
    
    
Other Comprehensive Income
  22 
  104,762 
  104,784 
 
    
    
    
Balance at June 30, 2019
 $(12,076)
 $1,785,591 
 $1,773,515 
 
    
    
    
Other Comprehensive Income
  (37,099)
  (403,990)
  (441,089)
 
    
    
    
Balance at September 30, 2019
 $(49,175)
 $1,381,601 
 $1,332,426 

SCHEDULE OF CHANGES IN ACCUMULATED OTHER COMPREHENSIVE INCOME, NET OF TAX

  Unrealized Gains and Losses on Security Investment  Foreign Currency Translations  Change in Minority Interest  Total 
Balance at January 1, 2023 $(54,921) $121,272  $3,769,712  $3,836,063 
                 
Other Comprehensive Income  -   936,265   -   936,265 
                 
Balance at March 31, 2023 $(54,921) $1,057,537  $3,769,712  $4,772,328 
                 
Other Comprehensive Loss  -   (1,849,049)  -   (1,849,049)
                 
Balance at June 30, 2023 $(54,921) $(791,512) $3,769,712  $2,923,279 

  Unrealized Gains and Losses on Security Investment  Foreign Currency Translations  Change in Minority Interest  Total 
Balance at January 1, 2022 $(90,031) $(367,895) $799,572  $341,646 
Balance $(90,031) $(367,895) $799,572  $341,646 
                 
Other Comprehensive Income  (7,027)  (499,967)  459,069   (47,925)
                 
Balance at March 31, 2022 $(97,058) $(867,862) $1,258,641  $293,721 
Balance $(97,058) $(867,862) $1,258,641  $293,721 
                 
Other Comprehensive Income  (505)  (3,002,167)  3,266,996   264,324 
                 
Balance at June 30, 2022 $(97,563) $(3,870,029) $4,525,637  $558,045 
Balance $(97,563) $(3,870,029) $4,525,637  $558,045 
                 

11.DISCONTINUED OPERATIONSF-30
HotApps Information Technology Co. Ltd.
On October 25, 2018, HotApps International Pte. Ltd. (“HIP”) entered into an Equity Purchase Agreement with DSS Asia Limited (“DSS Asia”), a Hong Kong subsidiary of DSS International Inc. (“DSS International”), pursuant to which HIP agreed to sell to DSS Asia all of the issued and outstanding shares of HotApps Information Technology Co. Ltd., also known as Guangzhou HotApps Technology Ltd. (“Guangzhou HotApps”). Guangzhou HotApps was a wholly owned subsidiary of HIP, which was primarily engaged in engineering work for software development, mainly voice over internet protocol. Guangzhou HotApps was also involved in a number of outsourcing projects, including projects related to real estate and lighting. 
The parties to the Equity Purchase Agreement agreed that the purchase price for this transaction would be $100,000, which would be paid in the form of a two-year, interest free, unsecured, demand promissory note in the principal amount of $100,000, and that such note would be due and payable in full in two years. As of September 30, 2020 and December 31, 2019, the outstanding receivable of this promissory note was $100,000. The closing of the Equity Purchase Agreement was subject to certain conditions; these conditions were met and the transaction closed on January 14, 2019.
F-31
The composition of assets and liabilities included in discontinued operations was as follows:
 
September 30,
2020
December 31,
2019
Assets
Current Assets
   Cash
$-
$-
   Deposit and other receivable
-
-
      Total Current Assets
-
-
   Fixed assets, net
-
-
      Total Assets
$-
$-
Liabilities
Current Liabilities
   Accounts payable and accrued expenses
$-
$-
      Total Current Liabilities
-
-
      Total Liabilities
$-
$-
 The aggregate financial results of discontinued operations were as follows:
Three Months Ended September 30, 2020
Three Months Ended September 30, 2019
Nine Months Ended September 30, 2020
Nine Months Ended September 30, 2019
Revenues:
Project fee-others
$-
$-
$-
$-
-
-
-
-
Cost of revenues
-
-
-
-
Gross profit
$-
$-
$-
$-
Operating expenses:
Depreciation
-
-
-
48
General and administrative
-
-
-
3,662
Total operating expenses
-
-
-
3,710
(Loss) from operations
-
-
-
(3,710)
Other income (expenses):
Other sundry income
-
-
-
-
Foreign exchange (loss)
-
-
-
(2)
Total other (expenses) income
-
-
-
(2)
Loss from discontinued operations
$-
$-
$-
$(3,712)

F-32
The cash flows attributable to the discontinued operations are as follows:
Nine Months Ended September 30, 2020
Nine Months Ended September 30, 2019
Operating
$-
$24,493
Investing
-
-
Financing
-
-
Net Change in Cash
$-
$24,493
Impact BioMedical Inc.
On April 27, 2020, Global BioMedical Pte Ltd (“GBM”), one of our subsidiaries, entered into a share exchange agreement with DSS BioHealth Security, Inc. (“DBHS”), a wholly owned subsidiary of Document Securities Systems Inc. (“DSS”), pursuant to which, DBHS will acquire all of the outstanding capital stock of Impact BioMedical Inc., wholly owned subsidiary of GBM, through a share exchange. The aggregate consideration to be issued to GBM for the Impact BioMedical shares will be the following: (i) 483,334 newly issued shares of DSS common stock; and (ii) 46,868 newly issued shares of a new series of DSS perpetual convertible preferred stock with a stated value of $46,868,000, or $1,000 per share. The convertible preferred stock can be convertible into shares of DSS common stock at a conversion price of $6.48 of preferred stock stated value per share of common stock, subject to a 19.9% beneficial ownership conversion limitation (a so-called “blocker”) based on the total issued outstanding shares of common stock of DSS beneficially owned by GBM. Holders of the convertible preferred stock will have no voting rights, except as required by applicable law or regulation, and no dividends will accrue or be payable on the convertible preferred stock. The holders of convertible preferred stock will be entitled to a liquidation preference of $1,000 per share, and DSS will have the right to redeem all or any portion of the then outstanding shares of convertible preferred stock, pro rata among all holders, at a redemption price per share equal to such liquidation value per share.
Under ASU 2014-08, a disposal transaction meets the definition of a discontinued operation if all of the following criteria are met:
1.
The disposal group constitutes a component of an entity or a group of components of an entity
2.
The component of an entity (or group of components of an entity) meets the held-for-sale classification criteria, is disposed of by sale, or is disposed of other than by sale (e.g., “by abandonment, in an exchange measured based on the recorded amount of the nonmonetary asset relinquished, or in a distribution to owners in a spinoff”).
3.
The disposal of a component of an entity (or group of components of an entity) “represents a strategic shift that has (or will have) a major effect on an entity’s operations and financial results”.
Impact Biomedical Inc. is a group of subsidiaries of HFE and operates independently with its own financial reporting. The transaction is a disposal by sale and has a major effect on HFE’s financial results. Since it meets all above test criteria, we treated this disposal transaction as a discontinued operation in our financial statements.
On August 21, 2020, the transaction closed and Impact BioMedical Inc became a direct wholly owned subsidiary of DBHS. GBM received 483,334 shares of DSS common stock and 46,868 shares of DSS preferred stock, which preferred shares could be converted to 7,232,716 common shares (however, any conversion will be subject to the blocker GBM has agreed to, as described above). After this transaction, we hold 500,001 shares of the common stock of DSS, representing 9.7% of the outstanding common stock of DSS. Our CEO, Chan Heng Fai owns an additional 14.5% of the common stock of DSS (not including any common or preferred shares we hold) and is the executive chairman of the board of directors of DSS. The Company has elected the fair value option for the DSS common stock that would otherwise be accounted for under the equity method of accounting. ASC 820, Fair Value Measurement and Disclosures, defines fair value of the financial assets. We value DSS common stock under level 1 category through quoted prices and preferred stock under level 3 category through a Monte Carlo valuation model. Under the “blocker” term in the agreement, the Company could convert 4,293 shares Convertible Preferred Stock into 662,500 shares of the common stock of DSS as of September 30, 2020. The quoted price of DSS common stock was $6.95 as of August 21, 2020. The total fair value of DSS common and preferred stocks GBM received as consideration for the disposal of Impact BioMedical was $67,208,173. As of August 21, 2020, the net asset value of Impact BioMedical was $57,143. The difference of $67,151,030 was recorded as additional paid in capital. We did not recognize gain or loss from this transaction as it was a related party transaction.
F-33
The composition of assets and liabilities included in discontinued operations is as follows:
 
 
September 30,
 
 
December 31,
 
 
 
2020
 
 
2019
 
Assets
      Cash
 
 
 
 
 
 
Assets
      Cash
 $- 
 $108,731 
      Prepaid Expense
  - 
  30,700 
           Total Asset
 $- 
 $139,431 
 
    
    
Liabilities
    
    
      Accounts Payable
 $- 
 $7,021 
           Total Liabilities
 $- 
 $7,021 
The financial results of discontinued operations are as follows:
 
 
Three Months Ended September 30,
 
 
Nine Months Ended September 30,
 
 
 
2020
 
 
2019
 
 
2020
 
 
2019
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue
 $- 
 $- 
 $- 
 $- 
 
    
    
    
    
Operating Expense
    
    
    
    
      Research & Development
  45,617 
  79,457 
  246,915 
  260,671 
      General & Administration
  10,280 
  31,648 
  170,035 
  94,153 
             Total Operating Expense
  55,897 
  111,105 
  416,950 
  354,824 
 
    
    
    
    
Other Expense
  138 
  17,449 
  488 
  30,395 
 
    
    
    
    
Loss from Discontinued Operations
 $(56,053)
 $(128,554)
 $(417,438)
 $(385,219)
The cash flows attributable to the discontinued operation are as follows:
 
 
Nine Months Ended on September 30, 2020
 
 
Nine Months Ended on September 30, 2019
 
 
 
 
 
 
 
 
Operating
 $(522,435)
 $(470,902)
Investing
  - 
  (36,000)
Financing
  - 
  - 
Net Change in Cash
 $(522,435)
 $(506,902)
F-34
 12. INVESTMENTS MEASURED AT FAIR VALUE

13. INVESTMENTS MEASURED AT FAIR VALUE

Financial assets measured at fair value on a recurring basis are summarized below and disclosed on the condensed consolidated balance sheet as of SeptemberJune 30, 20202023 and December 31, 2019:

 
   
 
Fair Value Measurement Using
 
   
 
 
Amount at Cost
 
 
Level 1
 
 
Level 2
 
 
Level 3
 
 
Amount at Fair Value
 
September 30, 2020
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assets
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investment securities- Fair Value Option
 $3,457,056 
 $4,787,454 
 $- 
 $- 
 $4,787,454 
Investment securities- Trading
  16,016 
  15,758 
  - 
  - 
  15,758 
Convertible preferred stock
  63,849,002 
  - 
  - 
  54,864,632 
  54,864,632 
Convertible note receivable
  50,000 
  - 
  - 
  77,477 
  77,477 
Warrants - American Premium Water
  - 
  - 
  - 
  - 
  - 
Warrants - AMRE
  - 
  - 
  - 
  - 
  - 
Stock Options - Vivacitas
  - 
  - 
  - 
  - 
  - 
Total Investment in securities at Fair Value
 $67,372,074 
 $4,803,212 
 $- 
 $54,942,109 
 $59,745,321 
 
   
 
Fair Value Measurement Using
 
   
 
 
Amount at Cost
 
 
Level 1
 
 
Level 2
 
 
Level 3
 
 
Amount at Fair Value
 
December 31, 2019
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assets
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investment securities- Fair Value Option
 $3,457,056 
 $2,973,582 
 $- 
 $- 
 $2,973,582 
Investment securities- Trading
  16,016 
  15,907 
  - 
  - 
  15,907 
Convertible note receivable
  50,000 
  - 
  - 
  26,209 
  26,209 
Stock Option - Vivacitas
  - 
  - 
  - 
  - 
  - 
Total Investment in securities at Fair Value
 $3,523,072 
 $2,989,489 
 $- 
 $26,209 
 $3,015,698 
Unrealized2022:

SCHEDULE OF FINANCIAL ASSETS MEASURED AT FAIR VALUE ON A RECURRING BASIS

  Fair Value Measurement Using  Amount at 
  Level 1  Level 2  Level 3  Fair Value 
June 30, 2023                
Assets                
Investment Securities- Fair Value $287,818  $-  $-  $287,818 
Investment Securities- Fair Value - Related Party  24,757,622   -   -   24,757,622 
Investment Securities- Trading  6,319,406   -   -   6,319,406 
Convertible Note Receivable  -   -   88,599   88,599 
Warrants - New Electric CV Corp.  -   -   47,115   47,115 
                 
Total Investment in securities at Fair Value $31,364,846  $-  $135,714  $31,500,560 

  Fair Value Measurement Using  Amount at 
  Level 1  Level 2  Level 3  Fair Value 
December 31, 2022                
Assets                
Investment Securities- Fair Value $884,432  $-  $-  $884,432 
Investment Securities- Fair Value - Related Party  12,865,525   -   -   12,865,525 
Investment Securities- Trading  5,315,204   -   -   5,315,204 
Convertible Note Receivable  -   -   88,599   88,599 
Warrants - New Electric CV Corp.  -   -   327,565   327,565 
                 
Total Investment in securities at Fair Value $19,065,161  $-  $416,164  $19,481,325 

Realized loss on investment securities for the ninesix months ended September June 30, 20202023 was $10,688,542 and 2019 was $42,169,116 and $146,470, respectively. Unrealizedrealized loss on investment securities for threethe six months ended September June 30, 20202022 was $43,761,763$6,355,451. Unrealized loss on securities investment was $17,652,880 and unrealized gain on investment securities for$10,766,390 in the threesix months ended September June 30, 2019 2023 and 2022, respectively. These gains and losses were recorded directly to net loss. The change in fair value of the convertible note receivable in the six months ended June 30, 2023 and 2022 was $507,727.
$0 and $9,123, respectively, and was recorded in condensed consolidated statements of stockholders’ equity.

F-31

For U.S. trading stocks, we use Bloomberg Market stock prices as the share prices to calculate fair value. For overseas stock, we use the stock price from the local stock exchange to calculate fair value. The following chart shows details of the fair value of equity security investment at September June 30,, 2020 2023 and December 31, 2019,2022, respectively.

SCHEDULE OF FAIR VALUE OF EQUITY SECURITY INVESTMENT

  Share price     Market Value   
  6/30/2023  Shares  6/30/2023  Valuation
            
DSS (Related Party) $0.359   62,812,264  $22,549,603  Investment in Securities at Fair Value
               
AMBS (Related Party) $0.001   20,000,000  $16,000  Investment in Securities at Fair Value
               
Holista (Related Party) $0.007   40,927,621  $271,818  Investment in Securities at Fair Value
               
New Electric CV (Related Party) $0.001   354,039,000  $70,808  Investment in Securities at Fair Value
               
Value Exchange (Related Party) $0.100   13,834,643  $1,383,464  Investment in Securities at Fair Value
               
Sharing Services (Related Party) $0.006   125,624,528  $753,747  Investment in Securities at Fair Value
               
Trading Stocks         $6,319,406  Investment in Securities at Fair Value
               
   Total Level 1 Equity Securities  $31,364,846   
Nervotec  N/A   1,666  $37,631  Investment in Securities at Cost
HWH World Co.  N/A   3,800  $42,562  Investment in Securities at Cost
UBeauty  N/A   3,600  $19,609  Investment in Securities at Cost
   Total Equity Securities  $31,464,648   

  Share price     Market Value   
  12/31/2022  Shares  12/31/2022  Valuation
            
DSS (Related Party) $0.164   62,812,264  $10,301,211  Investment in Securities at Fair Value
               
AMBS (Related Party) $0.002   20,000,000  $34,000  Investment in Securities at Fair Value
               
Holista (Related Party) $0.020   42,999,621  $850,432  Investment in Securities at Fair Value
               
New Electric CV (Related Party) $0.001   354,039,000  $212,423  Investment in Securities at Fair Value
               
Value Exchange (Related Party) $0.170   13,834,643  $2,351,889  Investment in Securities at Fair Value
               
Trading Stocks         $5,315,204  Investment in Securities at Fair Value
               
Total Level 1 Equity Securities    $19,065,161   
               
Nervotec  N/A   1,666  $35,958  Investment in Securities at Cost
HWH World Co.  N/A   3,800  $42,562  Investment in Securities at Cost
UBeauty  N/A   3,600  $19,609  Investment in Securities at Cost
Total Equity Securities  $19,163,290   

F-32
 
 
Share price
 
   
 
Market Value
 
 
 
 
9/30/2020
 
 
Shares
 
 
9/30/2020
 
Valuation
 
 
 
 
 
 
 
 
 
 
 
DSS (Related Party)
 $4.560 
  500,001*
 $2,280,005 
    Investment in Securities at Fair Value
 
    
    
    
 
AMBS (Related Party)
 $0.011 
  20,000,000 
 $222,000 
    Investment in Securities at Fair Value
 
    
    
    
 
Holista (Related Party)
 $0.043 
  46,226,673 
 $1,980,350 
    Investment in Securities at Fair Value
 
    
    
    
 
American Premium Water (Related Party)
 $0.003 
  122,039,000 
 $305,100 
    Investment in Securities at Fair Value
 
    
    
    
 
Others
    
    
 $15,758 
    Investment in Securities at Fair Value
 
    
    
    
 
 
  Total Level 1 Equity Securities 
 $4,803,213 
 
 
    
    
    
 
Vivacitas (Related Party)
  N/A 
  2,480,000 
 $200,128 
    Investment in Securities at Cost
Nervotech
  N/A 
  1,666 
 $36,628 
    Investment in Securities at Cost
 
    
    
    
 
 
  Total Equity Securities 
 $5,039,969 
 
* Ratio

Sharing Services Convertible Note

The fair value of 1-for-30 (the “Reverse Split”) was effective at 5:01 p.m. Eastern Time on May 7, 2020 (the “Effective Time”)

F-35
 
 
Share price
 
   
 
Market Value
 
 
 
 
12/31/2019
 
 
Shares
 
 
12/31/2019
 
Valuation
 
 
 
 
 
 
 
 
 
 
 
DSS (Related Party)
 $0.301 
  500,000 
 $150,500 
    Investment in Securities at Fair Value
 
    
    
    
 
AMBS (Related Party)
 $0.013 
  20,000,000 
 $262,000 
    Investment in Securities at Fair Value
 
    
    
    
 
Holista (Related Party)
 $0.055 
  46,226,673 
 $2,561,082 
    Investment in Securities at Fair Value
 
    
    
    
 
Others
    
    
 $15,907 
    Investment in Securities at Fair Value
 
    
    
    
 
 
  Total Level 1 Equity Securities 
 $2,989,489 
 
 
    
    
    
 
Vivacitas (Related Party)
  N/A 
  2,480,000 
 $200,128 
    Investment in Securities at Cost
 
    
    
    
 
 
  Total Equity Securities 
 $3,189,617 
 
The DSS convertible preferred stockthe Sharing Services Convertible Note under level 3 category was valued through calculated using a Monte Carlo simulationBlack-Scholes valuation model. As

We assumed dividend yield rate of September 30, 2020, the Company held 46,848 shares of DSS convertible preferred stock, which could convert to 7,232,716 common shares, with fair market value $54,864,632.0.00% in Sharing Services. The Monte Carlo model uses certain assumptions. The significant inputs and assumptions utilized are as follows:

 
 
As of September 30,
 
 
As of August 21,
 
 
 
2020
 
 
2020
 
Stock price
 $4.52 
 $6.88 
Risk-free rate
  0.16%
  0.16%
Annualized volatility
  60.00%
  60.00%
Forecast horizon in years
  3.00 
  3.00 
Trading steps per year
  52.00 
  52.00 
Probability of call (annual)
  10.00%
  10.00%
The selected stock prices represent the close market bid price of DSSvolatility was based on the valuation date.Risk - freehistorical volatility of the Sharing Services’ common stock. Risk-free interest rates were obtained from U.S. Treasury rates for the applicable periods.

The volatility is based on the historical volatility of the DSS common stock. We assumed a three-year life for the preferred stock and assumed that after three-years the Company would desire to begin receiving a return on this investment – either through a conversion or liquidation. The Company has the right to call the preferred stock at any point. We believed that this is not a probable scenario but did apply a 10% annual probability of a call occurring.

The fair value of the Sharing Services Convertible Note under level 3 category as of September 30, 2020 and December 31, 2019 was calculated using a Black-Scholes valuation model valued with the following weighted average assumptions:
 
 
September 30,
2020
 
 
December 31,
2019
 
 
 
 
 
 
 
 
Dividend yield
  0.00%
  0.00%
Expected volatility
  221.69%
  159.88%
Risk free interest rate
  0.13%
  1.61%
Contractual term (in years)
  2.01 
  2.76 
Exercise price
 $0.15 
 $0.15 
We assumed dividend yield rate is 0.00%redeemed in Sharing Services. The volatility is based on the historical volatility of the Sharing Services’ common stock. Risk -free interest rates were obtained from U.S. Treasury rates for the applicable periods.

July 2022. 

Changes in the observable input values would likely cause material changes in the fair value of the Company’s Level 3 financial instruments. A significant increase (decrease) in this likelihood would result in a higher (lower) fair value measurement.

F-36

The table below provides a summary of the changes in fair value which are recorded as other comprehensive income (loss), including net transfers in and/or out of all financial assets measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the ninethree and six months ended SeptemberJune 30, 20202023 and 2019:

Total
Balance at January 1, 2020
$26,209
Total losses
(12,599)
Balance at March 31, 2020
$13,610
Total gain
13,115
Balance at June 30, 2020
$26,725
Gain during deconsolidation
21,628
Net losses
(8,955,246)
Acquisition of DSS Preferred Stock
63,849,002
Balance at September 30, 2020
$54,942,109
Total
Balance at January 1, 2019
$78,723
Total losses
(5,439)
Balance at March 31, 2019
$73,284
Total losses
(18,497)
Balance at June 30, 2019
$54,787
Total losses
(14,041)
Balance at September 30, 2019
$40,746
2022:

SCHEDULE OF CHANGE IN FAIR VALUE

  Total 
Balance at January 1, 2023 $327,565 
Total gains  62,348 
Balance at March 31, 2023 $389,913 
Total losses  (342,798)
Balance at June 30, 2023 $47,115 
     
   Total 
Balance at January 1, 2022 $1,108,252 
Total losses  (203,463)
Balance at March 31, 2022 $904,789 
Total losses  (591)
Balance at June 30, 2022 $904,198 

Vector Com Convertible Bond

On February 26, 2021, the Company invested approximately $88,599 in the convertible bond of Vector Com Co., Ltd (“Vector Com”), a private company in South Korea. The interest rate is 2% per annum and maturity is two years. The conversion price is approximately $21.26, per common share of Vector Com. As of June 30, 2023, the management estimated that the fair value of this note remained unchanged from its initial purchase price.

Warrants

On March 2, 2020 and October 29, 2021, the Company received warrants to purchase shares of AMRE, a related party private startup company, in conjunction with the Company lending a $200,000two $200,000 promissory note.notes. For further details on this transaction, refer to Note 8 - Related Party Transactions, Note Receivable from a Related Party Company. The Company holds a stock option to purchase 250,000 shares of Vivacitas common stock at $1 per share at any time prior to the date of public offering.. As of September 30, 20202022 and December 31, 2019, both2021, AMRE and Vivacitas werewas a private companies.company. Based the management’s analysis, the fair value of the warrants and the stock option were $0was $0 as of September 30, 2020 and December 31, 2019.2021. All warrants were converted into common shares in March 2022.

F-33

On July 17, 2020, the Company purchased 122,039,000 shares, approximately 9.99% ownership, and 122,039,0001,220,390,000 warrants with an exercise price of $0.0001$0.0001 per share, from APW,NECV, for an aggregated purchase price of $122,039. Based on$122,039. During 2021, the management’s analysis,Company exercised 232,000,000 of the warrants to purchase 232,000,000 shares of NECV for the total consideration of $232,000, leaving the balance of outstanding warrants of 988,390,000 at December 31, 2021 and 2022. The Company did not exercise any warrants during six months ended June 30, 2023. We value NECV warrants under level 3 category through a Black Scholes option pricing model and the fair value of the warrants from APWNECV was $0$47,115 as of SeptemberJune 30, 2020.

13.COMMITMENTS AND CONTINGENCIES
2023 and $327,565 as of December 31, 2022.

The fair value of the NECV warrants under level 3 category as of June 30, 2023 and December 31, 2022 was calculated using a Black-Scholes valuation model valued with the following weighted average assumptions:

SCHEDULE OF SIGNIFICANT INPUTS AND ASSUMPTIONS

  

June 30,

2023

  

December 31,

2022

 
       
Stock Price $0.0002  $0.0006 
Exercise price  0.001   0.001 
Risk free interest rate  3.96%  3.95%
Annualized volatility  250.4%  186.1%
Dividend Yield  0.00   0.00 
Year to maturity  7.07   7.56 

14. COMMITMENTS AND CONTINGENCIES

Lots Sales Agreement

On November 23, 2015, SeD Maryland Development LLC completed the $15,700,000$15,700,000 acquisition of Ballenger Run, a 197-acre197-acre land sub-division development located in Frederick County, Maryland. Previously, on May 28, 2014, the RBG Family, LLC entered into a $15,000,000$15,000,000 assignable real estate sales contract with NVR, by which RBG Family, LLC would facilitate the sale of the 197 acres of Ballenger Run to NVR. On December 10, 2014, NVR assigned this contract to SeD Maryland Development, LLC through execution of an assignment and assumption agreement and entered into a series of lot purchase agreements by which NVR would purchase 443 subdivided residential lots from SeD Maryland Development, LLC. Through December 31, 2019, NVR has purchased 123 lots. In the nine months ended on September 30, 2020, NVR purchased 72 additional lots. 

On July 20, 2016, SeD Maryland entered into a lot purchase agreement with Orchard Development Corporation relating to the sale of 210 multifamily units in the Ballenger Run Project for a total purchase price of $5,250,000, which closed on August 7, 2018. 
F-37
On February 19, 2018, SeD Maryland entered into a contract to sell the Continuing Care Retirement Community Assisted Independent Living parcel to Orchard Development Corporation. It was agreed that the purchase price for the 5.9 acre lot would be $2,900,000 with a $50,000 deposit. It was also agreed that Orchard Development Corporation would have the right to terminate the transaction during the feasibility study period, which would last through May 30, 2018, and receive a refund of its deposit. On April 13, 2018, Orchard Development Corporation indicated that it would not be proceeding with the purchase of the CCRC parcel. On December 31, 2018, SeD Maryland entered into the Third Amendment to the Lot Purchase Agreement for Ballenger Run with NVR. Pursuant to the Third Amendment, SeD Maryland will convert the 5.9 acre CCRC parcel to 36 lots (the 28 feet wide villa lot) and sell to NVR. SeD Maryland pursued the required zoning approval to change the number of such lots from 85 to 121, which was approved in July 2019. Subsequently, SeD Maryland Development signed Fourth Amendment to the Lot Purchase Agreement, pursuant to which NVR agreed to purchase all of the new 121 lots.

During the three months ended on June 30, 2023 and 2022, NVR purchased 0 lots. During the six months ended on June 30, 2023 and 2022, NVR purchased 0 and 3 lots, respectively. Through June 30, 2023 and December 31, 2022, NVR had purchased a total of 479 lots.

Certain arrangements for the sale of buildable lots to NVR require the Company to credit NVR with an amount equal to one year of the FFB assessment. Under ASC 606, the credits to NVR are not in exchange for a distinct good or service and accordingly, the amount of the credit was recognized as the reduction of revenue. As of June 30, 2023 and December 31, 2022, the accrued balance due to NVR was $189,475.

Leases

The Company leases offices in Bethesda, Maryland, Magnolia, Texas, Singapore, Hong Kong, South Korea and China through leased spaces aggregating approximately 30,000 square feet, under leases expiring on various dates from November 2023 to March 2027. The leases have rental rates ranging from $1,401 to $23,020 per month. Our total rent expense under these office leases was $266,103 and $156,575 in the three months ended June 30, 2023 and 2022, respectively. Our total rent expense under these office leases was $525,781 and $313,150 in the six months ended June 30, 2023 and 2022, respectively. The following table outlines the details of lease terms:

SCHEDULE OF OPERATING AND RENEWED LEASE TERMS RENTAL

Office LocationLease Term as of December 31, 2021
Singapore - AIJune 2023 to May 2026
Singapore – F&BOctober 2021 to October 2024
Singapore – Four Seasons ParkJuly 2022 to July 2024
Singapore – Hapi CafeJuly 2022 to June 2024
Singapore - PLQDecember 2022 to July 2024
Hong Kong - OfficeOctober 2022 to October 2024
Hong Kong - WarehouseNovember 2022 to October 2024
Hong Kong - ShopOctober 2022 to September 2024
South Korea – Hapi CafeAugust 2022 to August 2025
South Korea – HWH WorldAugust 2022 to July 2025
Magnolia, TexasMay 2022 – January 2023
Bethesda, MarylandJanuary 2021 to March 2024
China - CafeDecember 2022 - November 2023
China - OfficeMarch 2023 – March 2027

F-34

The Company adopted ASU No. 2016-02, Leases (Topic 842) (“ASU 2016-02”) to recognize a right-of-use asset and a lease liability for all the leases with terms greater than twelve months. We elected the practical expedient to not recognize operating lease right-of-use assets and operating lease liabilities for lease agreements with terms less than 12 months. Operating lease right-of-use assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As our leases do not provide a readily determinable implicit rates, we estimate our incremental borrowing rates to discount the lease payments based on information available at lease commencement. Our incremental borrowings rates are at a range from 0.35% to 3.9% in 2023 and 2022, which were used as the discount rates. The balances of operating lease right-of-use assets and operating lease liabilities as of June 30, 2023 were $1,805,482 and $1,834,289 respectively. The balances of operating lease right-of-use assets and operating lease liabilities as of December 31, 2022 were $1,614,159 and $1,628,039, respectively.

The table below summarizes future payments due under these leases as of June 30, 2023.

For the Years Ended June 30:

SCHEDULE OF LEASE PAYMENTS

     
2024 $1,064,127 
2025  589,037 
2026  220,887 
2027  29,433 
Total Minimum Lease Payments $1,903,485 
Less: Effect of Discounting  (69,196)
Present Value of Future Minimum Lease Payments  1,834,289 
Less: Current Obligations under Leases  (186,380)
Long-term Lease Obligations $1,647,909 

Agreement to Sell 189 Lots

On July 3, 2018,March 17, 2023, 150 CCM Black Oak (the “Seller”) entered into a Purchase andContract of Sale Agreement(the “Contract of Sale”) with Houston LD,Davidson Homes, LLC, for the sale of 124 lots located at its Black Oak project.an Alabama limited liability company (“Davidson Homes”). Pursuant to the Purchase andterms of the Contract of Sale, Agreement, it was agreed that 124 lots would be sold for a range of prices based on the lot type. In addition, Houston LD, LLCSeller has agreed to contribute a “communitysell approximately 189 single-family detached residential lots comprising an additional section of the Lakes at Black Oak. The price of the lots and certain community enhancement fee” for each lot, collectively totaling $310,000, which is currently held in escrow. 150 CCM Black Oakfees the Seller will apply these funds exclusively towardsbe entitled to receive are anticipated to equal an amenity package on the property. aggregate of $10,022,500.

The closing of the transactions contemplated bydescribed in the PurchaseContract of Sale depends on the satisfaction of certain conditions set forth therein. There can be no assurance that such closings will be completed on the terms outlined herein or at all. Davidson Homes has agreed to purchase the lots in stages, comprising an initial closing of 94 lots, the remaining lots to be purchased on or before December 29, 2023. Commencing on March 17, 2023, Davidson Homes had a thirty (30) day inspection period in which to inspect the properties and Sale Agreementdetermine their suitability; during such inspection period, Davidson Homes was subjectentitled to Houston LD, LLC completing due diligencedecline to proceed with the closing of these transactions. Davidson Homes did not exercise its satisfaction. On October 12, 2018, 150 CCM Black Oak Ltd entered into an Amendedright to decline, and Restated Purchase and Sale Agreement (the “Amended and Restated Purchase and Sale Agreement”) for these 124 lots. Pursuantpursuant to the Amended and Restated Purchase andContract of Sale, Agreement,has made an additional deposit in escrow. Through the purchase price remained $6,175,000, 150 CCM Black Oak Ltd was required to meet certain closing conditions and the timing for the closing was extended.

date hereof, Davidson Homes has deposited $1,425,000 in escrow. On January 18, 2019,May 30, 2023 the sale of 12494 lots closed and the Company received approximately $5 million.

The Seller shall be required to complete certain improvements at the property at the Seller’s cost prior to the closing of the remaining lots.

Security Deposits

Our rental-home lease agreements require tenants to provide a one-month security deposits. The property management company collects all security deposits and maintains them in Magnolia, Texas was completed.

Royalty Fees
a trust account. The Company also has royalty commitments for the license and sale rights of certain nutraceutical products that include both fixed and variable royalty payments through 2022. The fixed royalty commitments are $15,000 per month. Variable royalty payments vary from $1.00 per unit soldobligation to $0.20 per unit sold depending on sales volume. The Exclusive Sublicensing Agreement was terminated on January 8, 2019.
Litigation with Gara Group
On September 27, 2019, iGalen International Inc., one of our majority-owned subsidiaries, and iGalen Inc., its wholly-owned subsidiary, filed a complaint in the Superior Court of the State of California, County of San Diego, Central Division, against Gara Group, Inc., a Delaware corporation, and certain affiliated or related entities, including the Chief Executive Officer of the Gara Group (collectivelyrefund these entities are referred to herein as the “Gara Group”). A similar complaint had been filed in Utah on September 26, 2019, but subsequently re-filed in California. The complaint, as amended on October 24, 2019, enumerates causes of action for breach of contract, breach of covenant of good faith and fair dealing and intentional interference with economic relations.
iGalen Inc. and Gara Group are parties to a Specialized Services Agreement, dated March 29, 2017 (the “Specialized Services Agreement”). iGalen Inc. contracted with Gara Group to provide for services that include, among other things, (i) product fulfillment; (ii) software development and maintenance of an onsite “Platform,” which includes a company website and interactive portal referred to as the “Back Office”; and (iii) managing iGalen’s social media sites. The Gara Group had previously claimed that iGalen Inc. owed Gara Group certain amounts, including (i) $125,000 for “Back Office Fees”; (ii) $150,000 for “Speaking Fees”; and (iii) $67,299 for services related to iGalen’s merchant account, back office, and shipping fulfillment, invoiced on August 28 and 31, and September 15, 2019. iGalen Inc.’s amended complaint notes that no provision in the Specialized Services Agreement allows for the particular “Back Office Fees” of $125,000 and that no provision in the Specialized Services Agreement allows for the so-called “Speaking Fees” of $150,000. Gara Group cut off services to iGalen following iGalen’s indication that it was disputing the amounts owed. iGalen’s amended complaint notes that the actions of Gara Group and Mr. Gara have caused, and continue to cause, iGalen to suffer substantial harm by, among other things, making it so iGalen was unable to communicate with distributors via its website and Back Office, fulfill orders made by distributors, or pay commission to distributors. iGalen is seeking damages.
F-38
On October 10, 2019, Gara Group filed a complaint in the Superior Court of the State of California, County of San Diego, Central Division against iGalen International Inc., iGalen Inc., Alset International, Chan Heng Fai, Dr. Rajen Manicka and David Price, an executive of iGalen Inc. Gara Group’s complaint for damages asserts that the Gara Group is entitled to general damages of $9,000,000 and liquidated damages of $50,000,000. iGalen Inc. intends to vigorously contest this matter. No trial date has been set. The Company is unable to assess the risk of loss at this time, but does not believe the outcome will have a material effect on our financial statements.
In addition, from time to time, during the normal course of our businesses, we may be subject to various litigation claims and legal disputes, including in the area of intellectual property (e.g., trademarks, copyrights and patents). Our intellectual property rights extend to our technology, business processes and the content on our website. We use the intellectual property of third parties in marketing and providing our services through contractual and other rights. Despite our efforts, from time to time, third parties may allege that we have violated their intellectual property rights.
Although the results of claims, lawsuits and proceedings in which we may be involved cannot be predicted with certainty, we do not currently believe that the final outcome of the matters discussed above will have a material adverse effect on our business, financial condition or results of operations. However, defending and prosecuting any such claims is costly and may impose a significant burden on our management and employees. In addition, we may receive unfavorable preliminary or interim rulings in the course of litigation, and there can be no assurances that favorable final outcomes will be obtained. With regard to intellectual property matters which may arise, if we are unable to obtain an outcome which sufficiently protects our rights, successfully defends our use or allows us time to develop non-infringing technology and content or to otherwise alter our business practices on a timely basis in responsedeposits to the claims against us, our business, prospects and competitive position may be adversely affected.
Promissory Note from Azure
Pursuant to a Secured Promissory Note dated as of August 13, 2018, on October 13, 2019 Azure Holdings, LLC, was obligated to pay our subsidiary, 150 CCM Black Oak Ltd, $140,000 in principal, plus accrued interestrenters at the ratetime of 2.5% per annum through October 13, 2019. Azure Holdings, LLC failed to pay the amount due. Effective as of October 13, 2019, the interest rate increased to a default rate of 18% per annum. The Company has subsequently had numerous communications with Azure Holdings, LLC regarding the payment of this Secured Promissory Note, and attempts to set a schedule for Azure Holdings, LLC to repay the amount due. We have not yet commenced litigation against either Azure Holdings, LLC or the guarantor of this Secured Promissory Note, but may do so in the immediate future.  Based on current situation, the management has not believed that the collection from Azure is probable.lease termination. As of SeptemberJune 30, 20202023 and December 31, 2019, $169,1662022, the security deposits held in the trust account were $305,255 and $149,697 were due to 150 CCM Black Oak Ltd,$271,480, respectively.

F-35
14.DIRECTORS AND EMPLOYEES’ BENEFITS

15. DIRECTORS AND EMPLOYEES’ BENEFITS

AEI Stock Option plans HFE

The Company reserves 500,000

Under our 2018 Incentive Compensation Plan (the “Plan”), adopted by our board of directors and holders of a majority of our outstanding shares of common stock in September 2018, 25,000 shares of common stock (subject to certain adjustments) were reserved for issuance upon exercise of stock options and grants of other equity awards. No options or other equity awards have been granted under the Plan. The reservation of shares under the Incentive Compensation Plan for high-quality executives and other employees, officers, directors, consultants and other persons who provide services to the Company or its related entities. This plan is meant to enable such persons to acquire or increase a proprietary interestwas cancelled in the Company in order to strengthen the mutuality of interests between such persons and the Company’s shareholders, and providing such persons with performance incentives to expand their maximum efforts in the creation of shareholder value. As of September 30, 2020 and December 31, 2019, there have been no options granted. 

May 2021.

Alset International Stock Option plans

On November 20, 2013, Alset International approved a Stock Option Plan (the “2013 Plan”). Employees, executive directors, and non-executive directors (including the independent directors) are eligible to participate in the 2013 Plan.

F-39

The following tables summarize stock option activity under the 2013 Plan for the ninethree months ended SeptemberJune 30, 2020:

2023:

SCHEDULE OF OPTION ACTIVITY

  Options for Common Shares  Exercise Price  Remaining Contractual Term (Years)  Aggregate Intrinsic Value 
Outstanding as of January 1, 2022  1,061,333  $0.09   2.00  $- 
Vested and exercisable at January 1, 2022  1,061,333  $0.09   2.00  $- 
Granted  -   -         
Exercised  -   -         
Forfeited, cancelled, expired  -   -         
Outstanding as of December 31, 2022  1,061,333  $0.09   1.00  $- 
Vested and exercisable at December 31, 2022  1,061,333  $0.09   1.00  $- 
Granted  -   -         
Exercised  -   -         
Forfeited, cancelled, expired  -   -         
Outstanding as of June 30, 2023  1,061,333  $0.09   0.50  $- 
Vested and exercisable at June 30, 2023  1,061,333  $0.09   0.50  $- 

16. SUBSEQUENT EVENTS

On August 1, 2023, Alset Capital held a Special Meeting of Stockholders. In connection with this Special Meeting, Alset Capital’s business combination with HWH International Inc. was approved by its stockholders and certain amendments to Alset Capital’s Amended and Restated Certification of Incorporation were also approved. The business combination is planned to close during the third quarter of 2023, subject to the completion of certain closing conditions.

 
 
Options
for 
 
 
 
 
 
Remaining
Contractual
 
 
 Aggregate
 
 
 
Common
Shares 
 
 
Exercise
Price 
 
 
Term
(Years)
 
 
 Intrinsic
Value
 
Outstanding as of December 31, 2019 
  1,061,333 
 $0.09 
  4.00 
 $- 
Granted
  - 
  - 
    
    
Exercised
  - 
  - 
    
    
Forfeited, cancelled, expired
  - 
  - 
    
    
Outstanding as of September 30, 2020
  1,061,333 
 $0.09 
  3.25 
 $- 
Vested and exercisable at September 30, 2020
  1,061,333 
 $0.09 
  3.25 
 $- 
F-36
15.SUBSEQUENT EVENTS
The Company evaluated the events and transactions subsequent to September 30, 2020, the balance sheet date, through October 15, 2020, the date the consolidated financial statements were available to be issued. 
COVID-19
Since the beginning of 2020 there is an outbreak of the novel strain of coronavirus (“COVID-19”), which has spread to over 200 countries, including United States. COVID-19 was declared a global pandemic in March, 2020 and worldwide mitigation and measures were recommended.  The impact of the outbreak is evolving and is adversely affecting global economic activities and contributes to significant instability in financial markets. While the impact related to current situation cannot be estimated at this time, it is possible that changes in the fair values of various investments could materially adversely affect our future financial statements.
Forgiveness of PPP Loan
On November 26, 2020, the amount of $64,502 from the PPP Loan was forgiven by the United States Small Business Administration and was recorded as other income. At such date, the PPP loan balance was $4,000.
Initial Public Offering
On November 23, 2020, the Company entered into an underwriting agreement (the “Underwriting Agreement”) with Aegis Capital Corp., as representative of the underwriters (“Aegis”), pursuant to which the Company agreed to sell to the underwriters in a firm commitment underwritten public offering (the “Offering”) an aggregate of 2,160,000 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at an initial public offering price of $7.00 per share. Aegis has a 60-day over-allotment option to purchase up to an additional 324,000 shares of Common Stock at $6.475 per share. The Offering closed on November 27, 2020.
The Offering was the Company’s initial public offering and the shares began trading on The Nasdaq Capital Market on November 24, 2020 under the symbol “HFEN.” The shares were offered by the Company pursuant to a registration statement on Form S-1, as amended (File No. 333-235693), filed with the Securities and Exchange Commission (the “Commission”), which was declared effective by the Commission on November 12, 2020 (the “Registration Statement”). Aegis acted as lead book-running manager for the Offering and Westpark Capital, Inc. acted as co-manager.
The net proceeds to the Company from the Offering, after deducting the underwriting discount, underwriters’ fees and expenses and other expenses of the offering, were approximately $12.7 million. The Company anticipates using the net proceeds from the Offering primarily to fund possible acquisitions of new companies and properties, and for working capital and other general corporate purposes.
Also, under the terms of the Underwriting Agreement, the Company, upon closing of the Offering, issued to Aegis a warrant (the “Representative’s Warrant”) to purchase an aggregate of 108,000 shares of common stock (5% of the total shares issued in the Offering). The Representative’s Warrant is exercisable at a per share price of $9.80 (equal to 140% of the initial public offering price of the Common Stock) and is exercisable at any time and from time to time, in whole or in part, during the four-year period commencing from the date of issuance.
DSS Shares Exercise 
On October 16, 2020, GBM converted 4,293 shares of the DSS Series A Convertible Preferred Stock into 662,500 shares of the common stock of DSS. As the time of conversion, we owned approximately 19.9% of the common stock of DSS, and our CEO, Chan Heng Fai, owns an additional 12.8% of the common stock of DSS (not including any common or preferred shares we held).
F-40

Item 2. Management’sManagement’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

This Form 10-Q contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. For this purpose, any statements contained in this Form 10-Q that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, words such as “may”, “will”, “expect”, “believe”, “anticipate”, “estimate” or “continue” or comparable terminology are intended to identify forward-looking statements. These statements by their nature involve substantial risks and uncertainties, and actual results may differ materially depending on a variety of factors, many of which are not within our control. These factors include by are not limited to economic conditions generally and in the industries in which we may participate, competition within our chosen industry, including competition from much larger competitors, technological advances and failure to successfully develop business relationships.

Business Overview

We are a diversified holding company principally engaged through our subsidiaries in propertythe development of EHome communities and other real estate, financial services, digital transformation technologytechnologies, biohealth activities and biohealth activitiesconsumer products with operations in the United States, Singapore, Hong Kong, Australia and South Korea. We manage a significant portion of our three principal businesses primarily through our 85.4% owned subsidiary, Alset International Limited, (“Alset International”), which is a public company traded on the Singapore Stock Exchange and in which we own a 51.04% equity interest.Exchange. Through this subsidiary (and indirectly, through other public and private U.S. and Asian subsidiaries), we are actively developing two significant real estate projects near Houston, Texas and in Frederick, Maryland, in our property developmentreal estate segment. We have designed applications for enterprise messaging and e-commerce software platforms in the United States and Asia inIn our digital transformation technology business unit.segment, we focus on serving business-to-business (B2B) needs in e-commerce, collaboration and social networking functions. Our recent foray into the biohealth segment includes research to treat neurological and immune-related diseases, nutritional chemistry to create a natural sugar alternative, research regarding innovative products to slow the spreadsale of disease, and natural foods and supplements.

We opportunistically identify global businesses for acquisition, incubation and corporate advisory services, primarily related to our existing operating business segments. consumer products.

We also have ownership interests outside of Alset International, including a 36.9% equity interest in American Pacific Bancorp Inc., an indirect 16.8%14.7% equity interest in Holista CollTech Limited, a 44.8% equity interest in DSS Inc. (“DSS”), a 38.3% equity interest in Value Exchange International, Inc., a 0.5% equity interest in New Electric CV Corporation (“NECV” formerly known as “American Premium Mining Corporation” or “APM,” and earlier known as “American Premium Water Corp.”), and 33.4% equity interest in Sharing Services Global Corp. (“SHRG”). American Pacific Bancorp Inc. is a financial network holding company. Holista CollTech Limited is a public Australian company that produces natural food ingredients (ASX: HCT). DSS is a multinational company operating businesses within nine divisions: product packaging, biotechnology, consumer marketing, commercial lending, securities and an indirect 13.1% equity interest in Vivacitas Oncologyinvestment management, alternative trading, secure living, and alternative energy. DSS Inc., is listed on the NYSE American (NYSE: DSS). Value Exchange International, Inc. is a U.S.-based biopharmaceuticalprovider of information technology services for businesses, and is traded on the OTCQB (OTCQB: VEII). NECV is a publicly traded consumer products company but neither of which company has material asset value relative to our principal businesses. Under(OTCPK: HIPH). SHRG markets and distributes health and wellness products, as well as member-based travel services, using a direct selling business model. SHRG is traded on the guidance of Chan Heng Fai, our founder, Chairman and Chief Executive Officer, who is also our largest stockholder, we have positioned ourselves as a participant in these key markets through a series of strategic transactions. Our growth strategy is both to pursue acquisition opportunities that we can leverage on our global network using our capital and management resources and to accelerate the expansion of our organic businesses.

OTCQB (OTCQB: SHRG).

We generally acquire majority and/or control stakes in innovative and promising businesses that are expected to appreciate in value over time. Our emphasis is on building businesses in industries where our management team has in-depth knowledge and experience, or where our management can provide value by advising on new markets and expansion. We have at times provided a range of global capital and management services to these companies in order to gain access to Asian markets. We have historically favored businesses that improve an individual’s quality of life or that improve the efficiency of businesses through technology in various industries. We believe our capital and management services provide us with a competitive advantage in the selection of strategic acquisitions, which creates and adds value for our company and our stockholders.

3

Recent Developments

Alset Capital Acquisition Corp.

On February 3, 2022 Alset Capital Acquisition Corp. (“Alset Capital”), a special purpose acquisition company sponsored by the Company and certain affiliates, closed its initial public offering of 7,500,000 units at $10 per unit. Each unit consisted of one of Alset Capital’s shares of Class A common stock, one-half of one redeemable warrant and one right to receive one-tenth of one share of Class A common stock upon the consummation of an initial business combination. Each whole warrant entitles the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share. Only whole warrants are exercisable. The underwriters exercised their over-allotment option in full for an additional 1,125,000 units on February 1, 2022, which closed at the time of the closing of the Offering. As a result, the aggregate gross proceeds of this offering, including the over-allotment, were $86,250,000, prior to deducting underwriting discounts, commissions, and other offering expenses.

On February 3, 2022, simultaneously with the consummation of Alset Capital’s initial public offering, Alset Capital consummated the private placement of 473,750 units (the “Private Placement Units”) to the Sponsor, which amount includes 33,750 Private Placement Units purchased by the Sponsor in connection with the underwriters’ exercise of the over-allotment option in full, at a price of $10.00 per Private Placement Unit, generating gross proceeds of approximately $4.7 million (the “Private Placement”) the proceeds of which were placed in the trust account. No underwriting discounts or commissions were paid with respect to the Private Placement. The Private Placement Units are identical to the units sold in the initial public offering, except that (a) the Private Placement Units and their component securities will not be transferable, assignable or saleable until 30 days after the consummation of Alset Capital’s initial business combination except to permitted transferees and (b) the warrants and rights included as a component of the Private Placement Units, so long as they are held by the Sponsor or its permitted transferees, will be entitled to registration rights, respectively.

The Company and its majority-owned subsidiary Alset International together own the sole member of Alset Acquisition Sponsor, LLC, the sponsor of Alset Capital.

On September 9, 2022, Alset Capital entered into an agreement and plan of merger (the “Merger Agreement”) by and among Alset Capital, HWH International Inc., a Nevada corporation (“HWH”) and HWH Merger Sub Inc., a Nevada corporation and a wholly owned subsidiary of Alset Capital (“Merger Sub”). Pursuant to the Merger Agreement, a business combination between Alset Capital and HWH will be effected through the merger of Merger Sub with and into HWH, with HWH surviving the merger as a wholly owned subsidiary of Alset Capital (the “Merger”). HWH is an indirect subsidiary of the Company through its subsidiary Alset International Limited. The Merger has not closed as of the date of this Report and is subject to the receipt of the required approval by the stockholders of Alset Capital, the shareholder of HWH and the satisfaction of certain other customary closing conditions.

On May 1, 2023, Alset Capital amended its Investment Management Trust Agreement with Wilmington Trust, National Association, a national banking association, which was entered into on January 31, 2022. The Trust Agreement is now amended, in part, so that Alset Capital’s ability to complete a business combination may be extended in additional increments of one month up to a total of twenty-one (21) additional months from the closing date of its initial public offering, subject to the payment into the trust account by Alset Capital of one-third of 1% of the funds remaining in the trust account following any redemptions in connection with the approval of the amendment to Alset Capital’s Amended and Restated Certificate of Incorporation.

As approved by its stockholders at the Special Meeting of Stockholders held on May 1, 2023 (the “Alset Capital Special Meeting”), Alset Capital filed an amendment to its Amended and Restated Certificate of Incorporation with the Delaware Secretary of State on May 2, 2023, to (i) give Alset Capital the right to extend the date by which it has to consummate a business combination from May 3, 2023, to November 3, 2023, on a month-to-month basis; and (ii) expand the methods that it may employ to not become subject to the “penny stock” rules of the Securities and Exchange Commission.

4

In connection with the Alset Capital Special Meeting, 6,648,964 shares of the Class A Common Stock of Alset Capital were tendered for redemption. Following this redemption, 2,449,786 shares of the period coveredClass A Common Stock of Alset Capital remained issued and outstanding, including 473,750 shares held by Alset Acquisition Sponsor, LLC and 1,976,036 public shares. Alset Acquisition Sponsor, LLC owns 2,156,250 shares of Class B Common Stock. 

Name Change

During a Special Meeting of Stockholders on June 6, 2022, the stockholders approved the reincorporation of the Company in Texas and the change of the Company’s name to “Alset Inc.” The management believes that such new name will more fully reflect its current business model.

Purchase of Rental Business from Majority-Owned Subsidiary

On December 9, 2022, Alset Inc. entered into an agreement with Alset EHome Inc. and Alset International Limited pursuant to which Alset Inc. agreed to reorganize the ownership of its home rental business. Previously, Alset Inc. and certain majority-owned subsidiaries collectively owned 132 single-family rental homes in Texas. 112 of these rental homes are owned by subsidiaries of American Home REIT Inc. (“AHR”). Alset Inc. owns 85.4% of Alset International Limited, and Alset International Limited indirectly owns approximately 99.9% of Alset EHome Inc.

The closing of the transaction contemplated by this report,agreement was completed on January 13, 2023. Pursuant to this agreement, Alset Inc. has become the direct owner of AHR and its subsidiaries that collectively own these 112 homes, instead of such homes being owned indirectly through Alset International Limited’s subsidiaries.

Alset EHome Inc. sold AHR to Alset Inc. for a total consideration of $26,250,933, including the forgiveness of debt in the amount of $13,900,000, a promissory note in the amount of $11,350,933 and a cash payment of $1,000,000. This purchase price represents the book value of AHR as of November 23, 2020,30, 2022.

The closing of this transaction was approved by the shareholders of Alset International Limited and the transaction was closed on January 13, 2023. Certain members of Alset Inc.’s Board of Directors and management are also members of the Board of Directors and management of each of Alset International Limited and Alset EHome Inc.

Public Offering

On February 6, 2023, we entered into an underwriting agreementUnderwriting Agreement (the “Underwriting Agreement”) in connection with Aegis Capital Corp., as representative of the underwriters (“Aegis”), pursuant to which we agreed to sell to the underwriters in a firm commitment underwritten publican offering (the “Offering”) of an aggregate of 2,160,000 shares of our common stock, par value $0.001 per share (the “Common Stock”), with Aegis Capital Corp. (the “Underwriter”) as the underwriter, relating to an underwritten public offering of 1,727,273 shares of Common Stock at an initiala public offering price of $7.00$2.20 per share. Aegis hasThe Underwriting Agreement provides the Underwriter a 60 day over-allotment45-day option to purchase up to an additional 324,000212,863 shares of Common Stock atto cover over-allotments, if any.

The net proceeds to the initial publicCompany from the Offering were approximately $3.3 million, after deducting underwriting discounts and the payment of other offering price. expenses associated with the Offering that are payable by the Company.

The Offering closed on November 27, 2020.

February 8, 2023. The OfferingCommon Stock was our initial public offering and the shares began trading on The Nasdaq Capital Market on November 24, 2020 under the symbol “HFEN.” The shares werebeing offered by the Company pursuant to aan effective registration statement on Form S-1, as amendedS-3 (File No. 333-235693)333-264234), as well as a prospectus supplement in connection with the Offering filed with the Securities and Exchange Commission.

5

Purchase of Travel Business

On June 14, 2023, Hotapp Blockchain Pte. Ltd., (“Hotapp”) a wholly owned subsidiary of Hapi Metaverse Inc., a majority owned subsidiary of the Company, entered into a Stock Purchase Agreement (the “Stock Purchase Agreement”) in connection with its purchase of all of the outstanding shares of Hapi Travel Limited, a Hong Kong corporation, from Business Mobile Intelligence Inc. (“BMI”) for a total consideration of $214,993 (the “Purchase Price”). In order to facilitate the Stock Purchase Agreement, Hapi Metaverse made a loan (the “Loan”) in an amount equal to the Purchase Price to Hotapp. Chan Heng Fai, the chairman of the Company, is also Chairman of Hotapp and the sole stockholder of BMI, and therefore recused himself from any deliberation or voting regarding the Stock Purchase Agreement and the Loan.

Purchase of Sentinel Brokers Company Inc. Shares

On May 22, 2023 the Company’s indirect subsidiary, SeD Capital Pte Ltd (“SeD Capital”), entered into a Stock Purchase Agreement, pursuant to which was declared effective bySeD Capital purchased 39.8 shares (19.9%) of the Common Stock of Sentinel Brokers Company Inc. (“Sentinel”) for the aggregate purchase price of $279,719. Sentinel is a broker-dealer operating primarily as a fiduciary intermediary, facilitating institutional trading of municipal and corporate bonds as well as preferred stock, and is registered with the Securities and Exchange Commission, on November 12, 2020. Aegis acted as lead book-running manager for the Offering and Westpark Capital, Inc. acted as co-manager.

2
Financial Impactis a member of the COVID-19 Pandemic
Real Estate Projects
Financial Industry Regulatory Authority, Inc. (“FINRA”), and is a member of the Securities Investor Protection Corporation (“SIPC”). The extentCompany has significant influence over Sentinel and its CEO holds a director position on Sentinel’s Board of Directors.

Sale of Certain Lots

Sale of 131 Lots

On October 28, 2022, 150 CCM Black Oak Ltd. (the “Seller”), a Texas Limited Partnership and an indirect, majority-owned subsidiary of the Company, entered into a Contract for Purchase and Sale and Escrow Instructions (the “Agreement”) with Century Land Holdings of Texas, LLC, a Colorado limited liability company (the “Buyer”). Pursuant to the terms of the Agreement, the Seller agreed to sell all of the approximately 242 single-family detached residential lots comprising a residential community in the city of Magnolia, Texas known as the “Lakes at Black Oak.”

On November 28, 2022, the parties to the Agreement entered into an amendment to the Agreement, pursuant to which the COVID-19 pandemic may impact our business will depend on future developments, which are highly uncertain and cannot be predicted. The COVID-19 pandemic’s far-reaching impact on the global economy could negatively affect various aspects of our business, including demand for real estate. From March through September 2020, we continuedSeller agreed to sell approximately 131 lots instead of 242 lots, and the anticipated purchase price was reduced.

On April 13, 2023, the sale of the 131 lots was completed and the Seller received a total consideration of $6,615,500 from the Buyer.

The Seller was required to develop and improve the property at our Ballenger Run project (in Maryland) for the construction of town homesSeller’s cost pursuant to NVR. To date, sales of such town homes by NVR are up in 2020 comparedcertain development plans and government regulations prior to the first nine months of 2019. Such town homes are often soldclosing described above.

Agreement to first-time home buyers, who do not have to worry about selling their existing homes. We believe low interest rates have encouraged home sales. Many buyers opted to see home models at the project virtually. This technology allowed them to ask questions to sales staff and see the town homes.

We have received strong indications that buyers and renters across the country are expressing interest in moving from more densely populated urban areas to the suburbs. We believe that our Ballenger Run project is well suited and positioned to accommodate those buyers. Our latest phase for sale at Ballenger Run, involving single-family homes, has seen a high number of interested potential buyers signing up for additional information and updates on home availability.
The COVID-19 pandemic could impact the ability of our staff and contractors to continue to work, and our ability to conduct our operations in a prompt and efficient manner. To date, we experienced a slowdown in the construction of a clubhouse at the Ballenger Run project, which had been completed behind the original schedule. This delay was caused in part by policies requiring lower numbers of contractors working indoors.
The COVID-19 pandemic may adversely impact the timeliness of local government in granting real estate permits and licenses required for various development projects. Accordingly, the COVID-19 pandemic may cause the completion of important stages in our real estate projects to be delayed.
At ourSell 110 Lots

On March 16, 2023, 150 CCM Black Oak project in Texas, we have strategically redesigned the lots over the past year for smaller “starter home” products that we believe will be more resilient in fluctuating real estate markets. Should we initiate sales at Black Oak, we believe the same implications described above, regarding our Ballenger Run project, may apply to our Black Oak project in the near future (including the general trend of customers’ interest shifting from urban to suburban areas). In addition, Houston and its surrounding areas have been economically impacted by the decline in energy prices in 2020. Unlike our Ballenger Run project, our Black Oak project may include our involvement in single family rental home development.

On April 6, 2020, the Company received a loan in the principal amount of $68,502 pursuant to the Paycheck Protection Program under the Coronavirus Aid, Relief, and Economic Security Act. On November 26, 2020, $64,502 of this loan was forgiven by the United States Small Business Administration.
On June 18, 2020, Alset EHome Inc. (formerly known as Alset iHome Inc.Ltd. (the “Seller”) entered into a loan agreementPurchase and Sale Agreement (the “M&T Loan“Purchase and Sale Agreement”) with M&T Bank.Rausch Coleman Homes Houston, LLC, a Texas limited liability company (“Rausch Coleman”). Pursuant to the M&T Loanterms of the Purchase and Sale Agreement, M&T Bank providedthe Seller has agreed to sell approximately 110 single-family detached residential lots which comprise a non-revolving loansection of the Lakes at Black Oak. The transaction closed on May 15, 2023.

Agreement to Sell 189 Lots

On March 17, 2023, 150 CCM Black Oak Ltd. (the “Seller”) entered into a Purchase and Sale Agreement (the “Purchase and Sale Agreement”) with Davidson Homes, LLC, an Alabama limited liability company (“Davidson”). Pursuant to the terms of the Purchase and Sale Agreement, the Seller has agreed to sell approximately 189 single-family detached residential lots developed within section 2 of Black Oak project. The sale of the first 94 lots closed on May 30, 2023. The sale of remaining lots is estimated to close at the end of the year 2023.

6

Purchase of Value Exchange International, Inc. Shares

On October 17, 2022, our majority-owned subsidiary Hapi Metaverse entered into a Stock Purchase Agreement (the “Stock Purchase Agreement”) with Chan Heng Fai, who is the Chairman of Hapi Metaverse’s Board of Directors and the Chairman, Chief Executive Officer and largest stockholder of Alset EHome Inc. inPursuant to the Stock Purchase Agreement, Hapi Metaverse bought an aggregate amount of up to $2,990,000, as described in “Liquidity and Capital Resources” below. It is intended that this loan will be utilized to commence our residential initiatives.

Our subsidiaries are reviewing plans for potential additional fundraising to fund single family rental operations and the acquisition7,276,163 shares of additional real estate projects.
3
Other Business Activities
The COVID-19 pandemic may adversely impact our potential to expand our business activities in ways that are difficult to assess or predict. The COVID-19 pandemic continues to evolve. The COVID-19 pandemic has impacted, and may continue to impact, the global supply of certain goods and services in ways that may impact the sale of products to consumers that we, or companies we may invest in or partner with, will attempt to make. The COVID-19 pandemic may prevent us from pursuing otherwise attractive opportunities.
Impact on Staff
Most of our U.S. staff works out of our Bethesda, Maryland office. At our office in Texas, we received a 50% rent abatementValue Exchange International Inc. (“VEII”) for the monthfollowing purchase prices: (i) $1,733,079 for 7,221,163 shares, representing a price of May 2020.
Our U.S. staff has shifted to mostly working from home since March 2020, but this has had$0.24 per share; (ii) $2,314 for 10,000 shares, representing a minimal impact on our operations to date. Our staff in Singaporeprice of $0.2314 per share; (iii) $5,015 for 25,000 shares, representing a price of $0.2006 per share; and Hong Kong has been able to work from home when needed with minimal impact on our operations, however our staff’s ability to travel between our Hong Kong and Singapore offices has been significantly limited, and our staff’s travel(iv) $3,326 for 20,000 shares, representing a price of $0.1663 per share. Collectively, these purchases represent an aggregate purchase price of $1,743,734 for 7,276,163 shares of VEII. Such purchase prices were negotiated between the U.S. and non-U.S. offices has been suspended since March 2020. The COVID-19 pandemic has also impacted the frequency with which our management would otherwise travelparties to the Black Oaks project; however, we have a contractor in Texas providing supervisionStock Purchase Agreement.

Mr. Chan and another member of the project. Management continuesBoard of Directors of Hapi Metaverse, Lum Kan Fai Vincent, are both members of the Board of Directors of VEII. In addition to regularly superviseMr. Chan, two other members of the Ballenger Run project. Limitations onBoard of Directors of Alset Inc. are also members of the mobilityBoard of our managementDirectors of VEII (Mr. Wong Shui Yeung and staff may slow down our ability to enter into new transactions and expand existing projects.

We have not reduced our staff in connection with the COVID-19 pandemic. To date, we did not have to expend significant resources related to employee health and safety matters related to the COVID-19 pandemic. We have a small staff, however, and the inability of any significant number of our staff to work due to illness or the illness of a family member could adversely impact our operations.
Mr. Wong Tat Keung).

Matters that May or Are Currently Affecting Our Business

In addition to the matters described above, the primary challenges and trends that could affect or are affecting our financial results include:

● Our ability to improve our revenue through cross-selling and revenue-sharing arrangements among our diverse group of companies;

● Our ability to identify complementary businesses for acquisition, obtain additional financing for these acquisitions, if and when needed, and profitably integrate them into our existing operation;

● Our ability to attract competent, skilled technical and sales personnel for each of our businesses at acceptable compensation levels to manage our overhead; and

● Our ability to control our operating expenses as we expand each of our businesses and product and service offerings.

Results of Operations

Summary of Statements of Operations for the Three and NineSix Months Ended SeptemberJune 30, 20202023 and 20192022

  Three- Months Ended  Six-months Ended 
  

June 30, 2023

  

June 30, 2022

  

June 30, 2023

  

June 30, 2022

 
Revenue $19,153,848  $926,340  $20,080,784  $2,878,577 
Operating Expenses $14,044,352  $2,580,602  $17,061,018  $6,186,380 
Other Expenses $10,922,902  $8,328,599  $13,156,354  $14,383,397 
Net Loss $5,813,406  $9,982,861  $10,136,588  $17,913,314 

7
 
 
Three Months Ended September 30,
 
 
Nine Months Ended September 30,
 
 
 
2020
 
 
2019
 
 
2020
 
 
2019
 
Revenue
 $2,148,923 
 $5,306,863 
 $7,179,919 
 $22,944,498 
Operating Expenses
  2,414,563 
  5,576,162 
  9,806,242 
  27,447,320 
Other Income (Expense)
  (12,946,960)
  1,197,775 
  (10,203,324)
  357,436 
Loss from Discontinued Operations
  (56,053)
  (128,554)
  (417,438)
  (388,931)
Net Loss
 $(13,342,758)
 $799,922 
 $(13,435,844)
 $(4,534,317)
4

Revenue

The following tables setsset forth period-over-period changes in revenue for each of our reporting segments:

 
 
Three Months Ended September 30,
 
 
Change
 
 
 
2020
 
 
2019
 
 
Dollars
 
 
Percentage
 
Property development
 $2,146,992 
 $4,938,017 
 $(2,791,025)
  (57%)
Biohealth
  1,931 
  360,351 
  (358,420)
  (99%)
Digital transformation technology
  - 
  - 
  - 
  - 
Other
  - 
  8,495 
  (8,495)
  (100%)
 Total revenue
 $2,148,923 
 $5,306,863 
 $(3,157,940)
  (60%)
 
 
 Nine Months Ended September 30,
 
 
 Change
 
 
 
 2020
 
 
2019
 
 
 Dollars
 
 
 Percentage
 
Property development
 $7,148,786 
 $21,509,197 
 $(14,360,411)
  (67%)
Biohealth
  31,133 
  1,406,951 
  (1,375,818)
  (98%)
Digital transformation technology
  - 
  - 
  - 
  - 
Other
  - 
  28,350 
  (28,350)
  (100%)
 Total revenue
 $7,179,919 
 $22,944,498 
 $(15,764,579)
  (69%)

  Three-months Ended  Change 
  June 30, 2023  June 30, 2022  Dollars  Percentage 
Real Estate $18,881,917  $650,810  $18,231,107   2,801%
Biohealth  -  132,222   (132,222)  -100%
Digital Transformation Technology  14,034   7,701   6,333   82%
Other  257,897   135,607   122,290   90%
Total Revenue $19,153,848  $926,340  $18,227,508   1,968%

  Six-months Ended  Change 
  June 30, 2023  June 30, 2022  Dollars  Percentage 
Real Estate $19,515,728  $1,924,916  $17,590,812   914%
Biohealth  12,786   749,693   (736,907)  -98%
Digital Transformation Technology  28,074   7,701   20,373   265%
Other  524,196   196,267   327,929   167%
Total Revenue $20,080,784  $2,878,577  $17,202,207   598%

Revenue was $2,148,923$19,153,848 and $5,306,863$926,340 for the three months ended SeptemberJune 30, 20202023 and 2019, respectively, reflecting a decrease of $3,157,940 or 60%.2022, respectively. Revenue was $7,179,919$20,080,784 and $2,878,577 for the ninesix months ended SeptemberJune 30, 2020, compared to $22,944,498 for the nine months ended September 30, 2019, reflecting a decrease of $15,764,579 or 69%. An2023 and 2022, respectively. The increase in property sales from the Ballenger Project and first sale of a section of Black Oak Project in the firstsecond quarter of 20192023 contributed to higher revenue in thatthis period. Pursuant

In late 2022 and early 2023, the Company entered into three contracts with builders to a lot purchase agreement dated July 3, 2018, 150 CCMsell multiple lots from its Black Oak Ltd sold 124project. The sales contemplated by these contracts are contingent on certain conditions which the parties to such contracts will need to meet and are expected to generate approximately $22 million of funds from operations, not including certain expenses that the Company will be required to pay. The sale of 335 lots closed in the first six months of 2023 generating approximately $18.1 million revenue.

The Company plans to continue its near-term focus on lot sales to regional and national builders. Funds from such lot sales will substantially improve the Company’s liquidity, strengthen its financial position and meet is working capital requirements.

In May 2023, the Company entered into lease agreement for its model house located in the Company’sMontgomery County, Texas (AHR Black Oak project to Houston LD, LLC for a total purchase price of $6,175,000Lease Agreement”). The revenue from the lease was $4,200 in January 2019. For ourthe three and six months ending June 30, 2023.

In 2022 the last three homes in the Ballenger Project were sold. In this project, builders arewere required to purchase a minimum number of lots based on their applicable sale agreements. We collectcollected revenue only from the sale of lots to builders. We are not involved in the construction of homes at the present time.

Revenue

Income from our biohealth segment comes primarilythe sale of Front Foot Benefits (“FFBs”), assessed on Ballenger Run project lots, decreased from direct sales by iGalen Inc. (formerly known as iGalen USA, LLC), which is 100% owned by iGalen International Inc., 53% of which is owned by Alset International. During$37,725 in the three months ended on SeptemberJune 30, 20202022 to $0 in the three months ended June 30, 2023. Income from the sale of FFBs decreased from $116,088 in the six months ended June 30, 2022 to $0 in the six months ended June 30, 2023. The decrease is a result of the decreased sale of properties to homebuyers in 2023.

Revenue from rental business was $690,967 and 2019,$403,900 in the three months ended June 30, 2023 and 2022, respectively. Revenue from rental business was $1,324,778 and $636,482 in the six months ended June 30, 2023 and 2022, respectively. The Company expects that the revenue from iGalen was $1,331this business will continue to increase as we acquire more rental houses and $360,351, respectively, reflecting a decrease of $359,020 or almost 100%. During the nine months ended September 30, 2020 and 2019, the revenue from iGalen Inc. was $30,533 and $1,406,951, respectively, reflecting a decrease of $1,376,418 or 98%. The decrease was mainly due to slow sales of current products and delay of the new product’s promotion.successfully rent them.

8

In October 2019,recent years, the Company expanded its biohealth segment to the South Korean market through one of the subsidiaries of Health Wealth Happiness Pte. Ltd.HWH International Inc., HWH World Inc (“HWH World”). HWH World similarly to iGalen Inc., operates based on a direct sale model of health supplements. HWH World is at the beginning stage of operations recognized only approximately $600$0 and $132,222 in revenue in ninethe three months ended SeptemberJune 30, 2020.

2023 and 2022, respectively. HWH World recognized $12,587 and $749,693 in revenue in the six months ended June 30, 2023 and 2022, respectively.

The category described as “Other” includes corporate and financial services, food and beverage business and new venture businesses. "Other"“Other” includes certain costs that are not allocated to the reportable segments, primarily consisting of unallocated corporate overhead costs, including administrative functions not allocated to the reportable segments from global functional expenses.

The financial services, food and beverage businesses and new venture businesses are small and diversified, and accordingly they are not separately addressed as one independent category. In the ninethree months ended SeptemberJune 30, 20202023 and 2019,2022, the revenue from other businesses was $0$258,096 and $28,350, respectively, generated by fund management services.$135,607, respectively. In the threesix months ended SeptemberJune 30, 20202023 and 2019,2022, the revenue from other businesses was $0$524,395 and $8,495, respectively.

5
We currently recognize revenue from the sale$196,267, respectively, generated by Korean and Singaporean café shops and restaurants.

Cost of our subdivision development properties, the sale of our biohealth productsRevenues and the rendering of digital transformation technology services through consulting fees. Sales of real properties accounted for approximately 99% of our total revenue in the first nine months of 2020 and sales of biohealth products accounted for approximately 1%. Sales of properties accounted for approximately 94% of our total revenue in first nine months of 2019 and sales of biohealth products accounted for approximately 6%.

From a geographical perspective, we recognized 100%, and 98% of our total revenue in the first nine months of 2020 and 2019, respectively, in the United States.
We believe that, on an ongoing basis, revenue generated from our property development business will decline as a percentage of our total revenue as we expect to experience greater revenue contributions from our digital transformation technology, biohealth businesses and future business acquisitions.
Operating Expenses

The following tables sets forth period-over-period changes in cost of salesrevenues for each of our reporting segments:

 
 
Three Months Ended September 30,
 
 
Change
 
 
 
2020
 
 
2019
 
 
Dollars
 
 
Percentage
 
Property development
 $1,610,238 
 $4,090,759 
 $(2,480,521)
  (61%)
Biohealth
  6,139 
  39,725 
  (33,586)
�� (85%)
Digital transformation technology
  - 
  - 
  - 
  - 
Other
  - 
  - 
  - 
  - 
 Total Cost of Sales
 $1,616,377 
 $4,130,484 
 $(2,514,107)
  (61%)
  
 
Nine Months Ended September 30,
 
 
 Change
 
 
 
2020
 
 
2019
 
 
Dollars
 
 
Percentage
 
Property development
 $5,603,164 
 $18,819,865 
 $(13,216,701)
  (70%)
Biohealth
  6,139 
  357,935 
  (351,796)
  (98%)
Digital transformation technology
  - 
  - 
  - 
  - 
Other
  - 
  - 
  - 
  - 
 Total cost of sales
 $5,609,303 
 $19,177,800 
 $(13,568,497)
  (71%)

  Three-months Ended  Change 
  June 30, 2023  June 30, 2022  Dollars  Percentage 
Real Estate $11,566,130  $532,233  $11,033,897   2,073%
Biohealth  95,290   (53)  95,343   -179,892%
Digital Transformation Technology  4,571   2,792   1,779   64%
Other  72,502   15,705   56,797   362%
Total Cost of Revenues $11,738,493  $550,677  $11,187,816   2,032%

  Six-months Ended  Change 
  June 30, 2023  June 30, 2022  Dollars  Percentage 
Real Estate $12,168,470  $1,625,942  $10,542,528   648%
Biohealth  109,657   11,985   97,672   815%
Digital Transformation Technology  9,139   2,792   6,347   227%
Other  140,508   24,508   116,000   473%
Total Cost of Revenues $12,427,774  $1,665,227  $10,762,547   646%

Cost of sales decreasedrevenues increased from $4,130,848$550,677 in the three months ended SeptemberJune 30, 20192022 to $1,616,377$11,738,493 in the three months ended SeptemberJune 30, 2020, reflecting a decrease2023. Cost of $2,514,107 or 61%, asrevenues increased from $1,665,227 in the six months ended June 30, 2022 to $12,427,774 in the three months ended June 30, 2023. The increase is a result of the decreaseincrease in sales in the Ballenger Run project. Cost of sales decreased from $19,177,800 in the nine months ended September 30, 2019 to $5,609,303 in the nine months ended September 30, 2020, reflecting a decrease of $13,568,497 or 71%, as a result of the decrease in sales in the Ballenger Run and Black Oak projects.Project. Capitalized construction expenses, finance costs and land costs are allocated to sales. We anticipate the total cost of salesrevenues to increase as revenue increases.

The gross margin decreasedincreased from $1,176,379$375,663 to $532,546$7,415,355 in the three months ended SeptemberJune 30, 20192022 and 2020, respectively, reflecting a decrease of $643,833 or 55%.2023, respectively. The gross margin decreasedincreased from $3,766,698$1,213,350 to $1,570,616$7,653,010 in the ninesix months ended SeptemberJune 30, 20192022 and 2020, respectively, reflecting a decrease of $2,196,082 or 58%.2023, respectively. The decreaseincrease of gross margin was caused by the decrease of gross margin of Ballenger Run project, mostly due to the decreaseincrease in sales in the sales. The gross margin from sale of Black Oak section one lots was approximately $0 after real estate impairment of $1.5 million was recorded in 2018.Project.

9
6

The following tables sets forth period-over-period changes in operating expenses for each of our reporting segments.

 
 
Three Months Ended September 30,
 
 
Change
 
 
 
2020
 
 
2019
 
 
Dollars
 
 
Percentage
 
Property development
 $131,326 
 $170,831 
 $(39,505)
  (23%)
Biohealth
  174,283 
  571,591 
  (397,308)
  (70%)
Digital transformation technology
  (7,289)
  34,969 
  (42,258)
  (121%)
Other
  499,866 
  672,133 
  (172,267)
  (26%)
Discontinued Operations
  55,897 
  111,105 
  (55,208)
  (50%)
 Total operating expenses
 $854,083 
 $1,560,629 
 $(706,860)
  (45%)
 
 
Nine Months Ended September 30,
 
 
Change
 
 
 
2020
 
 
2019
 
 
Dollars
 
 
Percentage
 
Property development
 $634,254 
 $4,598,112 
 $(3,963,858)
  (86%)
Biohealth
  388,083 
  1,780,026 
  (1,391,943)
  (78%)
Digital transformation technology
  87,972 
  193,959 
  (105,987)
  (55%)
Other
  3,086,630 
  1,697,423 
  1,389,207 
  82%
Discontinued Operations
  416,950 
  358,534 
  58,416 
  16%
 Total operating expenses
 $4,613,889 
 $8,628,054 
 $(4,014,165)
  (47%)

  Three-months Ended  Change 
  June 30, 2023  June 30, 2022  Dollars  Percentage 
Real Estate $552,184  $784,192  $(232,008)  -30%
Biohealth  336,627   289,904   46,723   16%
Digital Transformation Technology  62,527   45,713   16,814   37%
Other  1,354,521   910,116   444,405   49%
Total Operating Expenses $2,305,859  $2,029,925  $275,934   14%

  Six-months Ended  Change 
  June 30, 2023  June 30, 2022  Dollars  Percentage 
Real Estate $992,201  $1,320,957  $(328,756)  -25%
Biohealth  477,917   910,246   (432,329)  -47%
Digital Transformation Technology  202,430   159,976   42,454   27%
Other  2,960,696   2,129,974   830,722   39%
Total Operating Expenses $4,633,244  $4,521,153  $112,091   2%

The decrease of operating expenses of property developmentreal estate in 2020the first three and six months of 2023 compared with 2019to the same period of 2022 was mostly caused by the recognition of $3.9 million impairmentdecrease rental related expenses. Increase in the first half of 2019. The decrease of research and development expense in biohealth segment because of the discontinued operations was the main reason of decrease of operating expenses in biohealth segmentour other businesses is mainly caused by the increase in 2020 compared with 2019. The increase expense in other segment was mostly due to the issuance of Alset International’s stock for performance award program at the expense of $1,564,376 in second quarter of 2020.

professional and consulting fees.

Other Income (Expense)

In the three months ended SeptemberJune 30, 2020,2023, the Company had other expense of $12,946,960$10,922,902 compared to other incomeexpenses of $1,197,775$8,328,599 in the three months ended SeptemberJune 30, 2019, reflecting an increase in other expense of $14,144,735 or 1,181%.2022. In the ninesix months ended SeptemberJune 30, 2020,2023, the Company had other expense of $10,203,323$13,156,354 compared to other incomeexpenses of $357,436$14,383,397 in the ninesix months ended SeptemberJune 30, 2019, reflecting an increase in other expense of $10,560,759 or 2,955%.2022. The change in realized and unrealized gain (loss) on securities investmentinvestments and loss on foreign exchange transactionsconsolidation of Alset Capital Acquisition Corp. are the primary reasons for the volatility in these two periods. Unrealized lossgain on securities investment was $42,169,116 and $43,761,763 during nine and$18,840,726 in the three months ended June 30, 2023, compared to $6,867,375 loss in the three months ended June 30, 2022. Unrealized gain on Septembersecurities investment was $17,652,880 in the six months ended June 30, 2020, respectively. Unrealized2023, compared to $10,766,390 loss in the six months ended June 30, 2022. Realized loss on security investment was $146,470 during the nine months ended on September 30, 2019; unrealized gain on security investment was $507,727 during$10,557,229 the three months ended on SeptemberJune 30, 2019. Foreign exchange transaction2023, compared to a loss was $415,203of $2,918,668 in the three months ended SeptemberJune 30, 2020,2022. Realized loss on security investment was $10,688,542 the six months ended June 30, 2023, compared to $757,068 gaina loss of $6,355,451 in the six months ended June 30, 2022. Loss on consolidation was $21,657,036 in the three and six months ended June 30, 2023, compared to loss on consolidation of $0 in the three and six months ended June 30, 2022.

Net Loss

In the three months ended SeptemberJune 30, 2019. Foreign exchange transaction gain was $960,268 in the nine months ended September 30, 2020, compared to $438,608 gain in the nine months ended September 30, 2019.

From July 13, 2020 through August 20, 2020, our ownership of Alset International dropped below 50% and the investment in that company was recorded by Fair Value Option under ASU 2016-01. On August 20, 2020, the Company regained greater than 50% ownership of Alset International and reconsolidated the entity. The final net result of losing and regaining control of Alset International did not significantly affect Other Income (Expense).
7
Discontinued Operations
On October 25, 2018, HotApps International Pte. Ltd. (“HIP”) entered into an Equity Purchase Agreement with DSS Asia Limited (“DSS Asia”), a Hong Kong subsidiary of DSS International Inc., pursuant to which HIP agreed to sell to DSS Asia all of the issued and outstanding shares of HotApps Information Technology Co. Ltd., also known as Guangzhou HotApps Technology Ltd. (“Guangzhou HotApps”). Guangzhou HotApps was a wholly owned subsidiary of HIP, which was primarily engaged in engineering work for software development, mainly voice over internet protocol. Guangzhou HotApps was also involved in a number of outsourcing projects, including projects related to real estate and lighting.
The parties to the Equity Purchase Agreement agreed that the purchase price for this transaction would be $100,000, which would be paid in the form of a two-year, interest free, unsecured, demand promissory note in the principal amount of $100,000, and that such note would be due and payable in full in two years. As of September 30, 2020 and December 31, 2019, the outstanding receivable of this promissory note was $100,000. The closing of the Equity Purchase Agreement was subject to certain conditions; these conditions were met and the transaction closed on January 14, 2019.
During the three months ended September 30, 2020 and 2019, no income or loss from this discontinued operation was recognized. During the nine months ended September 30, 2020, no income or loss from this discontinued operation was recognized. During the nine months ended on September 30, 2019, the discontinued loss was $3,712.
On April 27, 2020, Global BioMedical Pte Ltd (“GBM”), one of our subsidiaries, entered into a share exchange agreement with DSS BioHealth Security, Inc. (“DBHS”), a wholly owned subsidiary of Document Securities Systems Inc. (“DSS”), pursuant to which, DBHS will acquire all of the outstanding capital stock of Impact BioMedical Inc., wholly owned subsidiary of GBM, through a share exchange. The aggregate consideration to be issued to GBM for the Impact BioMedical shares will be the following: (i) 483,334 newly issued shares of DSS common stock; and (ii) 46,868 newly issued shares of a new series of DSS perpetual convertible preferred stock with a stated value of $46,868,000, or $1,000 per share. The convertible preferred stock can be convertible into shares of DSS common stock at a conversion price of $6.48 of preferred stock stated value per share of common stock, subject to a 19.9% beneficial ownership conversion limitation (a so-called “blocker”) based on the total issued outstanding shares of common stock of DSS beneficially owned by GBM. Holders of the convertible preferred stock will have no voting rights, except as required by applicable law or regulation, and no dividends will accrue or be payable on the convertible preferred stock. The holders of convertible preferred stock will be entitled to a liquidation preference of $1,000 per share, and DSS will have the right to redeem all or any portion of the then outstanding shares of convertible preferred stock, pro rata among all holders, at a redemption price per share equal to such liquidation value per share.
On August 21, 2020, the transaction closed and Impact BioMedical Inc became a direct wholly owned subsidiary of DBHS. GBM received 483,334 shares of DSS common stock and 46,868 shares of DSS preferred stock, which preferred shares could be converted to 7,232,716 common shares (however, any conversion will be subject to the blocker GBM has agreed to, as described above). After this transaction, we hold 500,001 shares of the common stock of DSS, representing 9.7% of the outstanding common stock of DSS. Our CEO, Chan Heng Fai owns an additional 14.5% of the common stock of DSS (not including any common or preferred shares we hold) and is the executive chairman of the board of directors of DSS. The Company has elected the fair value option for the DSS common stock that would otherwise be accounted for under the equity method of accounting. ASC 820, Fair Value Measurement and Disclosures, defines fair value of the financial assets. We value DSS common stock under level 1 category through quoted prices and preferred stock under level 3 category through a Monte Carlo valuation model. Under the “blocker” term in the agreement, the Company could convert 4,293 shares Convertible Preferred Stock into 662,500 shares of the common stock of DSS as of September 30, 2020. The quoted price of DSS common stock was $6.95 as of August 21, 2020. The total fair value of DSS common and preferred stocks GBM received as consideration for the disposal of Impact BioMedical was $67,208,173. As of August 21, 2020, the net asset value of Impact BioMedical was $57,143. The difference of $67,151,030 was recorded as additional paid in capital. We did not recognize gain or loss from this transaction as it was a related party transaction.
During the three months ended September 30, 2020 and 2019, the discontinued operation loss from Impact BioMedical Inc was $56,053 and $128,554, respectively. During the nine months ended September 30, 2020, the discontinued operation loss from Impact BioMedical Inc was $417,438 and $385,219, respectively.
On October 16, 2020, GBM converted an aggregate of 4,293 shares of Series A Convertible Preferred Stock into 662,500 shares of the common stock of DSS. We now own approximately 19.9% of the common stock of DSS, and our CEO, Chan Heng Fai, owns an additional 12.8% of the common stock of DSS (not including any common or preferred shares we hold).
8
Net Income (Loss)
In the nine months ended September 30, 2020,2023 the Company had net loss of $13,435,843$5,813,406 compared to net loss of $4,534,317$9,982,861 in the nine months ended September 30, 2019, reflecting an increase of $8,901,526 or 196%. In the three months ended SeptemberJune 30, 20202022. In the six months ended June 30, 2023 the Company had net loss of $13,342,758$10,136,588 compared to net gainloss of $799,922$17,913,314 in the threesix months ended SeptemberJune 30, 2019, reflecting an increase of the net loss of $14,142,680 or 1,768%.
2022.

Liquidity and Capital Resources

Our real estate assets have increaseddecreased to $24,990,366$39,445,204 as of SeptemberJune 30, 20202023 from $23,884,704$54,618,729 as of December 31, 2019.2022. This increasedecrease primarily reflects a higher increasethe sale of properties in the capitalized costs related to the construction in progress and impairment recorded on the Black Oak project than in the cost of sales. project.

Our cash has increased from $2,774,587$17,827,383 as of December 31, 20192022 to $8,754,202$28,827,961 as of SeptemberJune 30, 2020.2023. Our liabilities increased from $13,649,449$4,827,221 at December 31, 20192022 to $14,499,650$8,152,468 at SeptemberJune 30, 2020.2023. Our total assets have increased to $101,474,030$168,441,811 as of SeptemberJune 30, 20202023 from $35,872,780$153,490,336 as of December 31, 20192022 mainly due to the increase in cash and investmentsheld in securities.

On April 17, 2019, SeD Maryland Development LLC entered into a Development Loan Agreement with Manufacturers and Traders Trust Company (“M&T Bank”) inAccount after the principal amount not to exceed at any one time outstanding the sum of $8,000,000, with a cumulative loan advance amount of $18,500,000. The line of credit bears interest rate on LIBOR plus 375 basis points. SeD Maryland Development LLC was also provided with a Letter of Credit (“L/C”) Facility in an aggregate amount of up to $900,000. The L/C commission will be 1.5% per annum on the face amount of the L/C. Other standard lender fees will apply in the event the L/C is drawn down. The loan is a revolving line of credit. The L/C Facility is not a revolving loan, and amounts advanced and repaid may not be re-borrowed. Repayment of the Loan Agreement is secured by a $2,600,000 collateral fund and a Deed of Trust issued to the Lender on the property owned by SeD Maryland.
On June 18, 2020, Alset EHome Inc. (previously known as Alset iHome Inc.), entered into the M&T Loan Agreement. Pursuant to the M&T Loan Agreement, M&T Bank provided a non-revolving loan to Alset EHome Inc. in an aggregate amount of up to $2,990,000. Repayment of this loan is secured by a deed of trust issued to the Lender on the property owned by certain subsidiariesconsolidation of Alset EHome Inc. Capital Acquisition Corp.

10

The maturity date of this loan is May 1, 2022. Certain subsidiaries ofmanagement believes that the available cash in bank accounts and favorable cash revenue from real estate projects are sufficient to fund our company areoperations for at least the guarantors of this loan.

Currently the Black Oak project does not have any financing from third parties. On July 20, 2018, 150 CCM Black Oak Ltd. was reimbursed $4,592,079 from the Harris County Improvement District No. 17 for previous expenses incurred by 150 CCM Black Oak Ltd. in the development and installation of infrastructure within the Black Oak project. The future development timeline of Black Oak project is based on multiple limiting conditions, such as the amount of the funds raised from capital market, the loans from third party financial institutions, and the government reimbursements. The development proceed in stages and expenses will be contingent on the amount of funding we will receive.
On November 29, 2016, Alset EHome Inc. entered into three $500,000 loans for a total of $1.5 million that were to incur annual interest at 8%. The principal was paid in full on November 29, 2019.
On April 6, 2020, the Company entered into a term note with M&T Bank with a principal amount of $68,502 pursuant to the Paycheck Protection Program (“PPP Term Note”) under the Coronavirus Aid, Relief, and Economic Security Act. The PPP Loan is evidenced by a promissory note. The PPP Term Note bears interest at a fixed annual rate of 1.00%, with the first ten months of principal and interest deferred. On November 26, 2020, $64,502 of this loan was forgiven by the United States Small Business Administration and $64,502 was recorded as other income.
9
During the year ended on December 31, 2017, Chan Heng Fai provided non-interest loans in the aggregate amount of $7,156,680 for the general operations of the Company. The loans are interest free, not tradable, unsecured, and repayable on demand. On October 15, 2018, a formal lending agreement between Alset International and Chan Heng Fai was executed. Under the agreement, Chan Heng Fai provided a lending credit limit of approximately $10 million for Alset International with an interest rate of 6% per annum for the outstanding amount of the loan, which commenced retroactively from January 1, 2018. The loans are still not tradable, unsecured and repayable on demand. As of September 30, 2020 and December 31, 2019, the outstanding principal balance of the Related Party Loan was $0 and $4,246,604, respectively. Interest started to accrue on January 1, 2018 at 6% per annum. During the nine months ended September 30, 2020 and 2019, the interest expenses were $129,566 and $268,847, respectively. During the three months ended on September 30, 2020 and 2019, the interest expenses were $6,334 and $68,482, respectively. As of September 30, 2020 and December 31, 2019, the accrued interest total was $0 and $822,405, respectively.
Chan Heng Fai provided an interest-free, due on demand, advance to the Company for the Company’s general operations. On September 30, 2020 and December 31, 2019, the outstanding balance was $178,400.
On August 20, 2020, our wholly-owned subsidiary Hengfai Business Development Pte. Ltd. purchased 30,000,000 shares of Alset International from our founder, Chairman, and Chief Executive Officer, Chan Heng Fai, for S$1,860,000 Singapore Dollars ($1,333,429 U.S. Dollars). The Company issued a two-year interest bearing note.
              On May 1, 2018, Rajen Manicka, CEO and one of the directors of iGalen International Inc., which holds 100% of iGalen Inc., provided a loan of approximately $367,246 to iGalen Inc. (the “2018 Rajen Manicka Loan”). The term of this loan is ten years. The 2018 Rajen Manicka Loan has an interest rate of 4.7% per annum. On March 8, March 27 and April 23, 2019, iGalen borrowed additional monies of $150,000, $30,000 and $50,000, respectively, from Rajen Manicka, total $230,000 (the “2019 Rajen Manicka Loan”). The 2019 Rajen Manicka Loan is interest free, not tradable, unsecured, and repayable on demand. As of September 30, 2020 and December 31, 2019, the total outstanding principal balance of the 2018 Rajen Manicka Loan and 2019 Rajen Manicka Loan was $531,030 and $546,397, respectively, and was included in the Notes Payable – Related Parties balance on the Company’s Condensed Consolidated Balance Sheets. During the nine months ended September 30, 2020 and 2019, the Company incurred $13,185 and $8,084 of interest expense on the 2018 Rajen Manicka Loan and 2019 Rajen Manicka Loan, respectively. During the three months ended September 30, 2020 and 2019, the Company incurred $4,411 and $0 of interest expense on the 2018 Rajen Manicka Loan and 2019 Rajen Manicka Loan, respectively.
On August 13, 2019, iGalen International Inc., which holds 100% of iGalen Inc., borrowed $250,000 from Decentralized Sharing Services, Inc., a company whose sole shareholder and director is Chan Heng Fai, our CEO. The term of the loan isnext 12 months, with an interest rate of 10% per annum. In addition, Decentralized Sharing Services, Inc. received the right to receive 3% of any revenue received by iGalen International Inc. for 99 years. During the nine months ended September 30, 2020, the Company incurred $9,729 of interest expense and $0 from the right to receive 3% of revenue. During the three months ended September 30, 2020 the Company incurred $0 of interest expense and $0 from the right to receive 3% of revenue. The amount outstanding on the loan as of September 30, 2020 and December 31, 2019 was $0 and $250,000, respectively. The accrued interest was $19,318 and $9,589 as of September 30, 2020 and December 31, 2019. The principal of $250,000 was paid off in June 2020.
On November 3, 2019, iGalen Inc. borrowed $160,000 (“iGalen Loan”) from iGalen Funding Inc., a company whose directors and shareholders include two members of the Board of iGalen Inc. The term of the iGalen Loan was 6 months, with an interest rate of 10% per annum. During the nine months ended September 30, 2020, the Company incurred $11,967 of interest expense on the iGalen Loan. During the three months ended September 30, 2020 the Company incurred $3,989 of interest expense on the iGalen Loan. The amount outstanding on the iGalen Loan as of September 30, 2020 and December 31, 2019 was $160,000 and $160,000, respectively. The accrued interest was $14,510 and $2,542 as of September 30, 2020 and December 31, 2019, respectively. The expiration date of the iGalen Loan was extended to November 3, 2021 after 6 months.
During the nine months ended September 30, 2020 the Company sold 207,300 shares of HotApp Blockchain to international investors for a total of $177,300. From January to September, 2019, the Company sold 361,500 shares of HotApp Blockchain to international investors for a total of $229,500.
10

Summary of Cash Flows for the NineThree Months Ended SeptemberJune 30, 20202023 and 2019 

 
 
Nine Months Ended September 30,
 
 
 
2020
 
 
2019
 
Net cash provided by (used in) operating activities
 $(1,011,440)
 $8,964,900 
Net cash used in investing activities
 $(66,824)
 $(36,000)
Net cash provided by (used in) financing activities
 $6,700,886 
 $(3,032,489)
2022

  Six-months Ended 
  2023  2022 
Net cash provided by (used in) operating activities $7,409,770  $(16,125,804)
Net cash used in investing activities $(606,983) $(8,308,426)
Net cash provided by financing activities $3,416,971  $6,041,139 

Cash Flows from Operating Activities

Net cash provided by operating activities was $7,409,770 in the first six months of 2023, as compared to net cash used in operating activities was $1,011,440of $16,125,804 in the first nine monthssame period of 2020, as compared to net2022. Property sales from the Black Oak project in 2023 were the main reason for the cash provided by operating activities of $8,964,900 in the same period of 2019, reflecting an increase in the cash used of $9,976,340 or 111%. The lower sales and more property development expenses explained the increased cash flow used in operating activities. We received approximately $9.2 million from sales in the Ballenger Run project and invested approximately $2.4 million in land development projects of both Ballenger Run and Black Oak during the nine months ended September 30, 2020.

2023.

Cash Flows from Investing Activities

Net cash used in investing activities was $66,824$606,983 in the first ninesix months of 2020,2023, as compared to net cash used in investing activities of $36,000$8,308,426 in the same period of 2019, reflecting an increase of $30,824 or 86%.2022. In the ninesix months ended SeptemberJune 30, 2020,2023 we invested $907,212 in marketable securities, issued $1,628,010 in loans to related parties and received $301,976$2,674,653 from the liquidationrepayment of Global Opportunity Fund. We also invested $200,000 in a promissory note of a related party notes receivable. In the six months ended June 30, 2022 we invested $6,662,017 in marketable securities, invested $722,817 to purchase real estate properties and spent $158,667 on purchase of investments.

$602,161 in real estate improvements.

Cash Flows from Financing Activities

Net cash provided by financing activities was $6,700,886$3,416,971 in the ninesix months ended SeptemberJune 30, 2020, comparing2023, compared to $3,032,489 net cash used in the nine months ended September 30, 2019, reflecting an increase in cash provided of $9,733,375 or 321%. Such increase$6,041,139 in the six months ended June 30, 2022. The cash provided by financing activities in the first six months of 2023 is primarily caused by the increase in cash receivedproceeds from the exercisestock issuance of subsidiary warrants.$3,433,921. During the ninesix months ended SeptemberJune 30, 2020,2022, we received cash proceeds of $10,764,837$6,213,000 from the exercise of subsidiary warrants, $177,300 from the sale of our HotApp shares to individual investors and $738,783 from a loan. The Company also distributed $197,400 to one minority interest investor and repaid $4,450,572 of promissory note held by related parties and $250,000 held by third party. During the nine months ended September 30, 2019, we received cash proceeds of $229,500 from the sale of our HotApp shares to individual investors, distributed $740,250 to one minority interest investor, repaid the remaining $13,899 back to the Union Bank loan and repaid approximately $2.5 millionconversion of related party loans.

Real Property Financing Arrangements
Through Alset International, we have three property development projects. Ballenger Run and Black Oak projects are the major projects. The following tables show our forecasts of the phases of the developments and costs for each phase of development:
 Ballenger Run
  Estimated Construction Costs
      Expected Completion Date
Phase 1
$13,786,000
Completed
Phase 2
10,210,000
Completed
Phase 3
10,170,000
Completed
Phase 4
3,460,000
December 2021
Phase 5
1,690,000
June 2022
Total
$39,316,000
11
Black Oak
  Estimated Construction Costs
     Expected Completion Date
Phase 1
$7,080,000
Completed
Phase 2
330,671
November 2022
Phase 3
422,331
November 2022
Phase 4
142,788
November 2022
Phase 5
3,293,000
April 2022
Total
$11,268,790
The timing set forth above reflects our current plan for the development of our Black Oak project; however, we are presently exploring alternate plans for Black Oak, which could leadnote payable to an expansion of the depth and breadth of our involvement in this project, depending on market interest, the outcome of discussions with potential partners and the availability of capital. Should we expand or otherwise alter our plans at the Black Oak project, the later stages of such project may have different time frames and costs. We cannot provide any assurance that we will complete each phase of the Black Oak project as expected.
Our Perth project in Australia is relatively small, representing approximately 2% of our total projects included in the estimated property costs and forecasted revenue, and the development plan of this project is contingent on the local market. We have been monitoring the local market, which has seen no significant improvement to date,common stock and we will consider such development once we are more confident in the market.
Black Oak
Black Oak is a 162-acre land infrastructure and subdivision project situated in Magnolia, Texas, northrepaid $171,861 of Houston. This project is owned by certain subsidiaries of Alset International.
On July 20, 2018, 150 CCM Black Oak, Ltd. received $4,592,079 in reimbursement for previous construction costs incurred in the land development. Of this amount, $1,650,000 will remain on deposit in the District's Capital Projects Fund for the benefit of 150 CCM Black Oak Ltd and will be released upon receipt of the evidence of (a) execution of a purchase agreement between 150 CCM Black Oak Ltd and a home builder with respect to the Black Oak development and (b) completion, finishing and making ready for home construction of at least 105 unfinished lots in the Black Oak development. In 2019, $1,112,861 was released to reimburse the construction costs leaving a balance of $90,394 in the deposit account at District’s Capital Projects Fund at December 31, 2019. In the first nine months of 2020, the entire remaining balance was released, leaving $0 in the deposit account at District’s Capital Projects Fund at September 30, 2020.
Ballenger Run
In November 2015, through LiquidValue Development, we completed the $15.7 million acquisition of Ballenger Run, a 197-acre land subdivision development located in Frederick County, Maryland. Previously, on May 28, 2014, the RBG Family, LLC entered into the Assignable Real Estate Sales Contract with NVR, Inc. (“NVR”) by which RBG Family, LLC would sell the 197 acres for $15 million to NVR. On December 10, 2014, NVR assigned this contract to SeD Maryland Development, LLC pursuant to an Assignment and Assumption Agreement and entered into a series of Lot Purchase Agreements by which NVR would purchase subdivided lots from SeD Maryland Development, LLC.
On November 23, 2015, SeD Maryland Development, LLC and Union Bank (formerly Xenith Bank and The Bank of Hampton Roads) entered into a Construction Loan Agreement, as amended by the Loan Modification Commitment Letter, as further amended by the Loan Modification Commitment Letter, dated as of August 30, 2017 and as further amended by the Third Loan Modification Agreement, dated as of September 18, 2017 (collectively as amended, the “Union Bank Revolving Loan”). The Union Bank Revolving Loan closed simultaneously with the settlement on the land on November 23, 2015, and provided a loan with the following terms: (i) a maximum of $11 million of the principal amount outstanding; (ii) maturity date on December 31, 2019; and (iii) an $800,000 letter of credit facility, with an annual rate of 15% on all issued letters of credit. On September 30, 2020 and December 31, 2019, the principal balance on the Union Bank Revolving Loan was $0 and $0, respectively. As part of the transaction, we incurred loan origination fees and closing fees, totaling $480,947, which were recorded as debt discount and were amortized over the life of the Union Bank Revolving Loan. The unamortized debt discounts were $0 on both September 30, 2020 and December 31, 2019.
12
                The Union Bank Revolving Loan was secured by a deed of trust on the property, a minimum $2,600,000 of cash collateral, and a Limited Guaranty Agreement with SeD Ballenger. In September 2017, SeD Maryland Development, LLC and the Union Bank modified the note related to this loan, increasing the original principal amount from $8,000,000 to $11,000,000 and extending the maturity date of the loan and letter of credit to December 31, 2019.
The Union Bank Revolving Loan was intended to fund the development of the first 276 lots of the multi-family parcel and senior living parcel, the amenities associated with these phases, and certain road improvements. The Union Bank Revolving Loan was repaid in January 2019. On April 17, 2019, SeD Maryland Development LLC and Union Bank terminated the agreement.
On April 17, 2019, SeD Maryland Development LLC entered into a Development Loan Agreement with Manufacturers and Traders Trust Company (“M&T Bank”) in the principal amount not to exceed at any one time outstanding the sum of $8,000,000, with a cumulative loan advance amount of $18,500,000. The line of credit bears interest of LIBOR plus 375 basis points. SeD Maryland Development LLC was also provided with a Letter of Credit (“L/C”) Facility in an aggregate amount of $900,000. The L/C commission is 1.5% per annum on the face amount of the L/C. Other standard lender fees will apply in the event the L/C is drawn down. The L/C Facility is not a revolving loan, and amounts advanced and repaid may not be re-borrowed. Repayment of the Loan Agreement is secured by $2.6 million collateral fund and a Deed of Trust issued to the Lender on the property owned by SeD Maryland.
LIBOR is expected to be unavailable for the public after the end of 2021. Our line of credit agreement provides procedures for determining a replacement or alternative rate in the event that LIBOR is unavailable. However, there can be no assurances as to whether such replacement or alternative rate will be more or less favorable than LIBOR. We intend to monitor the developments with respect to the potential phasing out of LIBOR after 2021 and will work with our lenders to ensure any transition away from LIBOR will have minimal impact on our financial condition. We, however, can provide no assurances regarding the impact of the discontinuation of LIBOR on the interest rate that we would be required to pay or on our financial condition.
As of September 30, 2020 and December 31, 2019, the principal balance of the loan from M&T Bank was $0. During 2019, as part of the transaction, the Company incurred loan origination fees and closing fees in the amount of $381,823 and capitalized them into construction in process.
debt.

Impact of Inflation

We believe that inflation has not had a material impact on our results of operations for the ninethree months ended SeptemberJune 30, 20202023 or the year ended December 31, 2019.2022. We cannot assure you that future inflation will not have an adverse impact on our operating results and financial condition.

Impact of Foreign Exchange Rates

The effect of foreign exchange rate changes on the intercompany loans (under ASC 830), which mostly consist of loans from our corporate entities in Singapore to the ones in the United States and which were approximately $36.2$37 million and $41.1$51 million on SeptemberJune 30, 20202023 and December 31, 2019,2022, respectively, are the reason for the significant fluctuation of foreign currency transaction Gain or Loss on the Condensed Consolidated Statements of Operations and Other Comprehensive Income.Loss. Because the intercompany loan balances between our companies in Singapore and United States will remain at approximately $40$37 million over the next year, we expect this fluctuation of foreign exchange rates to still significantly impact the results of operations in 2020,2023, especially given that the foreign exchange rate may and is expected to be volatile. If the amount of intercompany loan is lowered in the future, the effect will also be reduced. However, at this moment, we do not expect to repay the intercompany loans in the short term.

13

Emerging Growth Company Status

We are an “emerging growth company,” as defined in the JOBS Act, and we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies.” Section 107 of the JOBS Act provides that an “emerging growth company” can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an “emerging growth company” can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to take advantage of these exemptions until we are no longer an emerging growth company or until we affirmatively and irrevocably opt out of this exemption.

11

Seasonality

The real estate business is subject to seasonal shifts in costs as certain work is more likely to be performed at certain times of the year. This may impact the expenses of our subsidiary Alset EHome Inc. from time to time. In addition, should we commence building homes, we are likely to experience periodic spikes in sales as we commence the sales process at a particular location.

Off-Balance Sheet Arrangements
As of September 30, 2020, we did not have any off-balance sheet arrangements, as defined under applicable SEC rules.

Item 3. QuantitativeQuantitative and Qualitative Disclosures about Market Risk

As a “smaller reporting company” as defined by Item 10(f)(1) of Regulation S-K, the Company is not required to provide the information required by this Item.

Item 4. ControlsControls and Procedures

(a) Evaluation of Disclosure Controls and Procedures

As of the end of the period covered by this report, an evaluation was performed under the supervision and with the participation of our management, including our Chief Executive OfficerOfficers and Chief Financial Officers, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). Based on that evaluation, our management, including our Chief Executive OfficerOfficers and Chief Financial Officers, concluded that our disclosure controls and procedures are not effective as of SeptemberJune 30, 20202023 to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our Chief Executive OfficerOfficers and Chief Financial Officers, as appropriate to allow timely decisions regarding required disclosure.

(b) Changes in the Company’s Internal Controls Over Financial Reporting

There was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15(d)-15(f) under the Exchange Act) that occurred during the quarterly period ended SeptemberJune 30, 20202023 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Part

Part II. Other Information

Item 1.Legal Legal Proceeding

Not Applicable for the period covered by this report.

14
applicable.

Item 1A. RiskRisk Factors

Not applicable to smaller reporting companies.

Item 2.Unregistered Unregistered Sales of Equity Securities and Use of Proceeds

Not Applicable.

applicable.

Item 3.Defaults Defaults Upon Senior Securities

None.

Item 4.Mine Mine Safety Disclosures

Not Applicable.

12

Item 5.Other Other Information

None.

Not applicable.

Item 6.Exhibits

Exhibits

The following documents are filed as a part of this report:

Exhibit Number

Description

1.1Underwriting Agreement by and between Alset Inc. and Aegis Capital Corp., dated February 6, 2023 (incorporated by reference to Exhibit 1.1 to Current Report on Form 8-K filed with the SEC on February 8, 2023)
10.1(1)(2)Purchase and Sale Agreement, dated March 16, 2023, between 150 CCM Black Oak, Ltd. and Rausch Coleman Homes Houston, LLC (incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K filed with the SEC on March 28, 2023.
10.2(1)(2)Contract of Sale, dated March 17, 2023, between 150 CCM Black Oak, Ltd. and Davidson Homes, LLC (incorporated by reference to Exhibit 10.2 to Current Report on Form 8-K filed with the SEC on March 28, 2023.
31.1a*Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.1b*Certification of Co-Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2a*Certification of Co-Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2b*
Certification of Co-Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1**
Certifications of the Chief Executive Officer and Chief Financial Officers pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS
Promissory Note from HF Enterprises Inc. to Chan Heng Fai, dated as of August 20, 2020.
101.INS   Inline XBRL Instance Document
101.SCHInline XBRL Taxonomy Extension Schema Document
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document
101.LABInline XBRL Taxonomy Extension Label Linkbase Document
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document
104Cover Page Interactive Data File (embedded within the Inline XBRL document)

*Filed herewith.
**Furnished herewith.

(1) Certain of the exhibits and schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5). The Registrant agrees to furnish a copy of all omitted exhibits and schedules to the SEC upon its request.

(2) Portions of this exhibit (indicated by asterisks) have been omitted under rules of the SEC permitting the confidential treatment of select information. The Registrant agrees to furnish a copy of all omitted information to the SEC upon its request.

13
 * Previously Filed.
15
SIGNATURES

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

HF ENTERPRISESALSET INC.
August 14, 2023By: 
December 29, 2020By:  /s/ Chan Heng Fai

Chan Heng Fai

Chairman of the Board and

Chief Executive Officer

(Principal Executive Officer)
December 29, 2020August 14, 2023By:/s/ Chan Tung Moe
Chan Tung Moe
Co-Chief Executive Officer
(Principal Executive Officer)
August 14, 2023By:/s/ Rongguo Wei

Rongguo Wei

Co-Chief Financial Officer

(Principal Financial and Accounting Officer)
December 29, 2020August 14, 2023By:/s/ Lui Wai Leung Alan

Lui Wai Leung Alan

Co-Chief Financial Officer

(Principal Financial and Accounting Officer)

14
16